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During meiosis, diploid germ cells that will become eggs or sperm undergo a single 
round of DNA replication followed by two consecutive chromosomal divisions. The segregation 
of chromosomes at the first meiotic division is dependent in most organisms on at least one 
genetic exchange, or crossover event, between chromosome homologs. Homologs that do not 
receive a crossover frequently undergo nondisjunction at the first meiotic division, yielding 
aneuploid gametes. Such events have been linked to human disease and infertility.  Recent 
studies suggest that the Mlh1-Mlh3 complex is an endonuclease that resolves recombination 
intermediates into crossovers.  Interestingly, this complex also acts as a matchmaker in DNA 
mismatch repair (MMR) to remove DNA replication errors.   
How does Mlh1-Mlh3 act in two different processes?  I investigated this question by 
performing a mutational analysis of the baker’s yeast Mlh3 protein. This resulted in a 
comprehensive structure-function map that illustrates the effects of 60 new mlh3 alleles on both 
functions. From this map, I identified domains critical for one function but not the other. Five 
alleles (mlh3-6, -23, -42, -45, and -54) disrupt the MMR function while crossing over remains at 
nearly wild-type levels. Based on two-hybrid analysis, two of these five alleles (mlh3-42, and -
54) disrupt interaction with Mlh1. This information suggests that the weakened Mlh1-mlh3 
heterodimer is stabilized during crossing over by other protein factors. Alternatively, a weak 
defect in Mlh1-Mlh3 interaction may not be a limiting factor for crossover resolution in meiosis. 
 In addition, I identified one allele (mlh3-32) that disrupted crossing over while maintaining 
nearly wild-type MMR. Mlh1-mlh3 representatives for each class were purified and 
characterized. Both Mlh1-mlh3-32 (MMR+, crossover-) and Mlh1-mlh3-45 (MMR-, crossover+) 
displayed wild-type endonuclease activities in vitro.  Msh2-Msh3, an MSH complex that acts 
with Mlh1-Mlh3 in MMR, stimulated the endonuclease activity of Mlh1-mlh3-32 but not Mlh1-
mlh3-45, suggesting that Mlh1-mlh3-45 is defective in MSH interactions. Based on these and 
other observations, my work supports the model that protein-protein interactions with MMR or 
crossover specific factors are critical in regulating Mlh1-Mlh3’s enzymatic activity.  
Furthermore, I present five mlh3 mutations (mlh3-39, -40, -57, -58, 59) predicted to 
disrupt metal binding based on Pms1 structure, which conferred defects in both functions, 
suggesting the essential endonuclease active site in Mlh3 folds in a manner analogous to Pms1. 
Finally, whole genome recombination maps were constructed for wild-type and MMR+ 
crossover-, MMR- crossover+, endonuclease defective and null mlh3 mutants in an 
S288c/YJM789 hybrid background.  Compared to wild-type, all of the mlh3 mutants showed 
increases in the number of noncrossover events, consistent with recombination intermediates 
being resolved through alternative recombination pathways. Together, these data illustrate how 
defective meiotic components can alter the fate of meiotic recombination intermediates, 
providing new insights into how meiotic recombination pathways are regulated.    
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CHAPTER 1 
Introduction 
 
Mlh1-Mlh3: one endonuclease, two pathways 
The MutL homolog heterodimer Mlh1-Mlh3 plays a minor role in mismatch repair 
(MMR) and a major role in meiotic crossing over. The endonuclease activity of Mlh1-Mlh3 is 
required for both functions. An area of active study is how one endonuclease accurately nicks 
two different DNA structures as required in MMR and crossing over, which are two diverse and 
critical genomic integrity pathways. It is likely that Mlh1-Mlh3 participates in these processes 
through distinct mechanisms. I will review the studies that support a backup role for Mlh1-Mlh3 
in MMR and a central role in meiosis. Furthermore, I will present models that explain how one 
protein can be active in two seemingly unrelated processes. Finally, I will discuss recent 
unanticipated observations that reveal an in vitro endonuclease and DNA binding activity that is 
distinct from other meiotic nucleases and observations that imply more diverse functions for 
Mlh1-Mlh3 than initially characterized.  
 
Overview of DNA mismatch repair 
The eukaryotic MMR system is an evolutionarily conserved process that acts to correct 
mismatches that were generated during replication but escaped polymerase proofreading 
(reviewed in [1]–[4]). DNA polymerase misincorporation events can result in base-base 
mismatches or insertion-deletion loops. In eukaryotes, mismatches are recognized by MutS 
homologs (MSH), which in turn recruit the MutL homologs (MLH) to form ternary complexes 
containing mismatched DNA, MSH factors, and MLH factors. These interactions result in the 
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recruitment of downstream excision and resynthesis proteins to remove the error [1]–[4]. In 
Saccharomyces cerevisiae MMR, the heterodimers Msh2-Msh6 and Msh2-Msh3 recognize 
mismatches and recruit the MLH heterodimer, primarily Mlh1-Pms1, which acts as the major 
endonuclease in this process [5], [6]. The endonuclease activity of Mlh1-Pms1 is activated by the 
processivity clamp PCNA to introduce a nick in the newly synthesized strand, in a strand 
discrimination step that has yet to be determined but is hypothesized to involve pre-existing 
discontinuities [7]. This nick, 3′ or 5′ to the mismatch, serves as an entry point for the Exo1 
exonuclease to excise the newly synthesized strand and remove the mismatch thus permitting re-
synthesis by DNA polymerases followed by ligation [1]–[4] (Figure 1.1; Table 1.1). In addition 
to forming a heterodimeric complex with Pms1, Mlh1 can interact with either Mlh2 or Mlh3. A 
minor MMR pathway that involves mismatch recognition by Msh2-Msh3 followed by 
interaction with Mlh1-Mlh3 has also been observed [8]–[10]. Curiously, beyond its minimal 
participation in MMR, Mlh1-Mlh3 has been shown to play a central role in meiotic crossing 
over. 
 
Overview of meiotic crossing over 
Crossing over during Meiosis I creates physical connections between homologous 
chromosomes that are critical for their accurate segregation. Failure to achieve at least one 
crossover (CO) per homolog pair results in nondisjunction and the formation of aneuploid 
gametes [11]. Errors in meiotic chromosome segregation are a leading cause of spontaneous 
miscarriages and birth defects [12]. In baker’s yeast, the recombination process leading to CO 
formation begins in meiotic prophase, after DNA replication, with the programmed induction of 
~150-200 double strand breaks (DSBs) that appear throughout the genome. DSBs are resected to  
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Figure 1.1. Post replicative Mismatch repair (MMR).  
Overview of the eukaryotic MMR process. Insertion/deletion loops (deletion loop shown in red) 
are a result of polymerase slippage events, which can occur during the replication of repetitive 
DNA sequences. In eukaryotes, MMR proteins are hypothesized to travel with the replication 
fork. Recognition of a mismatch will trigger the assembly of a “repairosome” consisting of an 
MSH complex, an MLH complex, and PCNA (shown), in addition to RFC and RPA (not 
shown). This complex will identify the newly synthesized strand by an as yet undetermined 
mechanism involving a pre-existing nick. The MLH complex (primarily Mlh1-Pms1) will then 
introduce a nick at distal sites on the same strand (black arrow). Loading of ExoI will activate its 
5′-to-3′ exonuclease activity until the mismatch is removed. DNA polymerase δ will then fill in 
the resulting single-stranded gap, and DNA ligase will seal the remaining nick.  
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Table 1.1. Mismatch repair (MMR) and meiotic factors described in this chapter. 
 
Protein in Saccharomyces cerevisiae 
 
Function 
Msh2-Msh6 
Msh2-Msh3 
 
mismatch recognition complexes 
PCNA DNA polymerase processivity factor 
RFC PCNA loader 
RPA ssDNA binding protein 
Exo1 5′-3′ dsDNA exonuclease 
STR (Sgs1-Top3-Rmi1 complex) DNA helicase/topoisomerase 
ZMM proteins: 
Zip3 
Mer3 
Msh4-Msh5 
 
SUMO E3 ligase 
meiosis specific DNA helicase 
meiosis specific MSH dimer important for joint 
molecule intermediate stability  
Rad52 contains single-strand annealing activity 
Rad54 DNA dependent ATPase that stimulates strand 
exchange 
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create 3′ single stranded tails that can invade the homologous template to create a strand invasion 
intermediate known as a displacement-loop (D-loop). The D-loop can be extended to form a 
stable heteroduplex intermediate known as the single end invasion (SEI) [13]–[15]. Working 
models propose that the SEI intermediate can be processed by a number of pathways facilitated 
by the Sgs1-Top3-Rmi1 (STR) helicase/topoisomerase complex, which has recently been labeled 
as the master regulator of meiotic DSB repair [16]–[18] (Figure 1.2). 
Initially the STR complex was characterized as playing an anti-crossover role due to its 
role in promoting noncrossover (NCO) formation via unwinding of the SEI intermediate in a 
pathway known as synthesis dependent strand annealing (SDSA) [19]. However, recent studies 
have uncovered a pro-crossover function for the STR complex [16]–[18]. Taken together, these 
findings led to the “recombination intermediate chaperone model” in which the STR complex 
acts as a chaperone designating different resolution pathways for early strand invasion 
intermediates [16] (Figure 1.2). In this model the SEI intermediate is metabolized by the STR 
complex, to form early NCOs (via SDSA), or to facilitate the return of events to the original 
DSB state thus promoting capture and protection by the ZMM proteins (Zip1-4, Mer3, and 
Msh4-Msh5). In the ZMM pathway, SEI intermediates are stabilized by Msh4-Msh5 and subject 
to further processing by a second-end capture mechanism catalyzed by RPA, Rad52, and Rad54 
(Table 1.1) [20]. During second-end capture, the newly synthesized invading strand can re-
anneal and ligate to the other side of the DSB creating a joint molecule intermediate known as a 
double Holliday junction (dHJ).  
dHJs formed in the ZMM pathway are biased to resolve the two junctions 
asymmetrically, such that the resulting product is exclusively a CO, in steps requiring the 
endonuclease activity of Mlh1-Mlh3 and exonuclease-independent activities of Exo1 [21]. In this  
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Figure 1.2. Meiotic double strand break (DSB) repair pathways.  
DSBs, induced early in Meiosis I, are resected to create 3′ single stranded tails that can invade 
the homologous template. Early strand invasion intermediates can be extended to create a single 
end invasion (SEI) intermediate. The Sgs1-Top3-Rmi1 (STR) helicase/topoisomerase complex 
can disassemble the SEI intermediate to facilitate noncrossover formation via synthesis 
dependent strand annealing (SDSA). Alternatively, return of early strand invasion events to the 
original DSB state by STR activity facilitates capture by the ZMM proteins (Zip1-4, Mer3, and 
Msh4-Msh5). SEI stabilization by the ZMM proteins and subsequent second-end capture gives 
rise to the double Holliday junction (dHJ). dHJs are nicked in a biased manner (black arrows 
depicted in opposite orientations) to result exclusively in crossovers (class I) in a process that 
involves Mlh1-Mlh3 and Exo1. Strand invasion events that escape STR disassembly form 
unregulated joint molecules in addition to dHJs that are susceptible to the unbiased resolution of 
structure selective nucleases (SSNs) giving rise to both crossovers (class II) and noncrossovers. 
Model adapted from Kaur et al. [17].  
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pathway COs are interference-dependent and known as class I COs. Interference is a mechanism 
that regulates CO placement such that the presence of one CO reduces the probability of a 
second CO in a nearby region [22]. Class I COs account for the majority of COs in bakers yeast. 
Furthermore, in this model, it is proposed that strand invasion events which escape STR 
disassembly form unregulated joint molecules that can be resolved by the structure selective 
nucleases (SSNs: Mus81-Mms4, Slx1-Slx4, and Yen1) [23]. In this pathway the two junctions in 
a dHJ are resolved independently into both COs and NCOs. COs formed by SSNs are 
interference-independent and known as class II COs. It is important to note that there is 
redundancy in the joint molecule resolution pathways described above. Functional links exist 
between the different resolvases such that loss of one pathway results in a compensatory rise in 
the other [16], [23], [24].  
In addition to Mlh1-Mlh3’s involvement in the formation of COs, the MMR machinery 
has been shown to play other roles during meiotic DSB repair. When the donor DNA sequence 
differs from the acceptor, mismatches are formed in heteroduplex strand invasion intermediates. 
Mlh1-Pms1 has been shown to initiate repair of mismatches present in one chromosome by using 
sequences present on the other as a template. This process is known as gene conversion  (GC) 
[25], [26]. Furthermore, MMR proteins prevent recombination between divergent DNA 
sequences in a process known as heteroduplex rejection [27], [28]. These meiotic roles are 
similar to gene conversion and anti-recombination roles observed for MMR proteins during DSB 
repair in non-meiotic cells. It is important to note that Mlh1-Mlh2, also dubbed a minor MMR 
factor [9], has recently been shown to play an essential role in limiting GC tract lengths without 
affecting CO formation [29] (Figure 1.3).     
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Figure 1.3. Functional interactions of the MutL homologs (MLHs) and the MutS homologs 
(MSHs).  
MLHs are composed of globular N-and C-terminal domains (depicted as ovals and circles 
respectively) connected by a linker arm. Arrows indicate functional interactions between the 
MSH and MLH heterodimers and their DNA substrates. Dashed arrows (in black) denote minor 
roles. Mlh1-Mlh2 interacts with Mer3 (not shown) to limit gene conversion tract lengths in 
meiotic recombination, in addition to its minor MMR role. Mlh1-Mlh2 interacts with the single 
end invasion intermediate (not shown) that forms prior to the double Holliday junction (dHJ). 
Figure adapted from Reyes et al. [2].   
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Roles for Mlh1-Mlh3 in mismatch repair 
Eukaryotic MMR entails mismatch recognition by MSH proteins, followed by processing 
and repair events that involve MLH proteins. MSH and MLH proteins perform their functions as 
heterodimers (reviewed in [1]–[4]). In Saccharomyces cerevisiae MMR, there are two MSH 
complexes: MutSα (Msh2-Msh6) and MutSβ (Msh2-Msh3), and three MLH complexes: MutLα 
(Mlh1-Pms1), MutLβ (Mlh1-Mlh2) and MutLγ (Mlh1-Mlh3). Msh2-Msh6 and Msh2-Msh3 
recognize mismatches with partial redundancy (Figure 1.3). Msh2-Msh6 primarily recognizes 
base-base mismatches and small insertion/deletion loops, while Msh2-Msh3 primarily recognizes 
larger insertion deletion/loops. The major MMR pathway involves mismatch recognition by 
Msh2-Msh6 and the endonuclease activity of Mlh1-Pms1. Mlh1-Pms1 nicks the newly 
synthesized strand distal to the mismatch providing an entry point for downstream repair factors 
[5], [6]. Although Mlh1-Pms1 is central to the MMR process, both Mlh1-Mlh2 and Mlh1-Mlh3 
have been shown to minimally contribute to the repair of mutational intermediates [9].   
Mlh1-Mlh3 can partially substitute for Mlh1-Pms1 in MMR [8]–[10]. Flores-Rozas and 
Kolodner [8] showed that yeast strains deficient in Mlh3 display a 2-3-fold increase in mutation 
rates relative to wild-type, a small but significant effect in assays where a pms1 deletion displays 
a 50 to 300-fold increase. Likewise Harfe et al. [9] observed an increase in mutation rates in 
mlh3Δ strains of up to 21-fold relative to wild-type in assays where msh2Δ resulted in an 
approximately 10,000-fold increase. Furthermore, epistasis analysis of msh3 mlh3 double 
mutants suggest the two proteins function in the same repair pathway. Flores-Rozas and 
Kolodner [8] examined mutator phenotypes by determining the rate of reversion of the hom3-10 
and lys2-Bgl alleles, two assays that are particularly sensitive to defects in MMR. They observed 
that while msh6 mlh3 double mutants display synergistic increases in mutation rates as compared 
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to each single mutant, msh3 mlh3 double mutants had essentially the same mutation rates as each 
single mutant [8]. Thus, these data demonstrate that Mlh1-Mlh3 likely participates in the repair 
of some insertions/deletions in the Msh2-Msh3 but not the Msh2-Msh6 pathway. Although 
studies reported to date do not provide evidence for an interaction between Msh6 and Mlh3, it is 
important to note that other assays, utilizing different substrates, might detect such an interaction. 
Romanova and Crouse propose a model in which Mlh1-Mlh3 mediated repair requires 
Mlh1-Pms1 [10]. In this study, the authors aimed to investigate the different contributions of the 
MMR machinery in the repair of insertion versus deletion loops. Insertion and deletion loops are 
a result of polymerase slippage events, which can occur during the replication of repetitive DNA 
sequences [30]. Loops that form on the primer strand lead to insertions, whereas loops on the 
template strand lead to deletions. In order to compare the effects of insertion and deletion 
mismatches of the same size, the authors utilized two complementary reversion assays: the -1 
lys2ΔA746 and the +1 lys2ΔBgl frameshift alleles in the same LYS2 gene region. Loop mutations 
were generated in vivo via single-strand oligonucleotide (oligo) transformations. Oligos 
transform by serving as primers on either the leading or lagging strands. Additional nucleotides 
in the oligo will create a primer-strand loop resulting in an insertion mutation, while missing 
nucleotides in the oligo will create template-strand loop resulting in a deletion mutation. If the 
mismatch created by the oligo is not removed, a reverting frameshift will result in the next round 
of replication. From this analysis, Romanova and Crouse observed that deletion loop repair was 
more dependent on Msh2-Msh3 while insertion loops were more biased towards repair by Msh2-
Msh6 [10]. In accordance with these observations, Mlh1-Mlh3 was found to function in the 
repair of deletion loops, presumably mediated by Msh2-Msh3, and not insertion loops. mlh3Δ 
resulted in a 4-fold decrease in deletion loop repair in an assay where pms1 mutations exhibit a 
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92-fold decrease as Mlh1-Pms1 is needed for most repair. Interestingly, the authors observed that 
a PMS1 point mutant (pms1-H888R), which shows a deficiency in insertion repair, displayed a 
modest 2-fold decrease in deletion repair. Strikingly, given the small effect of each individual 
mutation, pms1-H888R mlh3Δ double mutants exhibited a synergistic 13-fold reduction in 
deletion repair. Thus, the authors conclude that deletion repair in pms1-H888R strains has a 
major dependence on Mlh1-Mlh3. Furthermore, in pms1-H888R mlh3Δ msh6Δ strains, where 
only Msh2-Msh3 is present, no further effect was observed. Taken together, these data suggest a 
model in which deletion loops are recognized by Msh2-Msh3 that acts to recruit Mlh1-Mlh3, 
which in turn facilitates interactions with Mlh1-pms1-H888R.  
 
Roles for Mlh1-Mlh3 in crossing over 
Accurate chromosome segregation in Meiosis I requires reciprocal exchange of genetic 
information between homologous chromosomes known as crossing over. In most eukaryotes, the 
majority of COs are formed through a DSB repair pathway that involves stabilization of joint 
molecule intermediates by the ZMM proteins, leading to their ultimate resolution by Mlh1-Mlh3 
and the exonuclease-independent functions of Exo1 [13]–[15], [31]. As outlined earlier in this 
chapter, current models propose a central role for the STR complex in this process [16]–[18]. A 
critical role for yeast MLH proteins in crossing over was established by Hunter and Borts [32]. 
The authors analyzed crossing over frequencies in many MMR mutants including mlh1, pms1, 
msh2, msh3, and msh6. Interestingly, they observed that the ability to promote crossing over is 
unique to Mlh1 among the MMR proteins tested. Furthermore, the authors observed that the 
mlh1 msh4 double mutant is indistinguishable from the msh4 single mutant. Hence, they 
concluded that Mlh1 acts in the same pathway as Msh4-Msh5 to generate COs. Msh4-Msh5 is a 
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meiosis-specific MSH complex with no role in MMR [33], [34] (Figure 1.3).    
Wang et al. [35] first identified a major role for Mlh3 in crossing over in a study that 
aimed to functionally characterize the three Mlh1-based heterodimers in meiosis. The authors 
investigated crossing over at a recombination hot spot on chromosome III in Saccharomyces 
cerevisiae and observed a 21-33% reduction in crossing over in mlh3 mutants, indistinguishable 
to reductions observed in mlh1. In addition, homolog nondisjunction rates were similarly 
elevated in mlh1 and mlh3 mutants relative to wild-type strains.   
Argueso et al. [24] proposed that competing pathways exist to promote COs during 
meiosis. These authors aimed to investigate the relationship between different complexes known 
to promote COs in yeast. Mus81-Mms4 is an endonuclease complex shown to be important for 
wild-type levels of crossing over. Interestingly, they observed the most significant decrease in 
crossing over (13 to 15-fold relative to wild-type) in mlh1Δ mms4Δ double mutants. Similar 
significant reductions in CO levels (6 to 17-fold relative to wild-type) were observed in mlh3Δ 
mms4Δ by Sonntag Brown et al. [36]. Furthermore, Zakharyevich et al. [23] performed a 
comprehensive analysis of joint molecule resolution during meiosis in budding yeast and 
concluded that Mlh1-Mlh3 together with the SSNs (Mus81-Mms4, Slx1-Slx4, and Yen1) 
ultimately account for all joint molecule resolution, and that they can sometimes compensate for 
each other.  
In their study, Zakharyevich et al. [23] used a DNA physical assay system to monitor 
recombination at a recombination hot spot. Interestingly, the authors observed efficient joint 
molecule formation and resolution in strains lacking the SSNs (mms4 slx4 yen1 triple mutants), 
with NCOs at wild-type levels and COs at about 70% of wild-type levels. The authors conclude 
that the SSNs are dispensable for the bulk of meiotic joint molecule resolution. More 
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importantly, the authors found that deleting either Sgs1 or Mlh3 in this background (mms4 slx4 
yen1) resulted in a similar reduction of CO levels, to just 10% of wild-type levels, suggesting a 
pathway where Sgs1-dependent COs require Mlh1-Mlh3. Similar results were observed in mms4 
slx4 yen1 strains deficient in Top3 or Rmi1 [17], [18]. Thus, these data indicate that the STR 
complex promotes the majority of COs in conjunction with a resolvase that is not Mus81-Mms4, 
Slx1-Slx4 or Yen1. However, it is important to note that while mms4 slx4 yen1 sgs1 quadruple 
mutants exhibit a severe defect in NCO levels, the mms4 slx4 yen1 mlh3 mutants do not, as Sgs1 
plays an integral role in both CO and NCO production. Similar conclusions were made by De 
Muyt et al. [16]. 
The studies described above indicate a critical role for Mlh1-Mlh3 in yeast meiosis. To 
examine Mlh1-Mlh3 in mammalian meiosis, Lipkin et al. generated Mlh3-/- mice [37]. The 
authors found that Mlh3-/- mice were viable but infertile. They observed smaller male testes in 
Mlh3-/- mice and severe depletion of spermatocytes due to aneuploidy, which resulted in 
apoptosis. Furthermore, chromosome preparations showed a significant defect in chiasma 
formation, the physical manifestation of CO sites. The authors did not observe a role for Mlh3 in 
mammalian MMR.  
 
Mlh1-Mlh3 is an MMR and meiotic crossing over endonuclease 
Based on homology with Pms1, Mlh3 contains a highly conserved ATP binding motif in 
the N-terminal domain (NTD), which is connected to the C-terminal domain (CTD) by a 
dynamic and unstructured linker arm. As in other MLH dimers, the Mlh3 CTD dimerizes with 
the Mlh1 CTD [38] (Figure 1.3). Kadyrov et al. categorized Mlh1-Pms1 in yeast (and Mlh1-
Pms2 in humans) as a latent endonuclease whose catalytic activity is dependent on the integrity 
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of a highly conserved metal-binding motif (DQHA(X)2E(X)4E) in the CTD of the Pms1 subunit 
[5], [6]. A study performed by Nishant et al. [39] investigated this motif in yeast Mlh3. They 
found a single point mutation within this motif (mlh3-D523N) conferred mlh3Δ like defects in 
both MMR and meiotic crossing over. A 7.9-fold increase in the mutation rate of mlh3-D523N 
strains was observed, similar to a 6.3-fold increase observed in mlh3Δ. CO frequency was 
measured in four genetic intervals on chromosome XV and about a 2-fold reduction in crossing 
over was observed in both mlh3-D523N and mlh3Δ. Similar reductions in spore viabilities were 
also detected in mlh3-D523N and mlh3Δ. Importantly, the mlh3-D523N mutation did not affect 
protein stability or interaction with Mlh1 as measured by yeast two-hybrid assays, 
chromatography and western blots. These data suggest that Mlh1-Mlh3 possesses a catalytic 
activity critical for its functions. 
The DQHA(X)2E(X)4E motif is hypothesized to be part of the Mlh1-Pms1 endonuclease 
active site. Indeed, in the crystal structures of the Mlh1-Pms1 CTDs solved from Saccharomyces 
cerevisiae, Gueneau et al. [38] found residues within this motif implicated in metal binding in 
addition to two other highly conserved motifs (ACR and C(P/N)HGRP). In particular, the 
authors identified five Pms1 residues, located within these motifs (H703, E707, C817, C848, 
H850), which form the metal binding site through folding of the Pms1 CTD. Based on this and 
on the study performed by Nishant et al. [39] described above, Al-Sweel et al. [40] identified the 
putative Mlh1-Mlh3 endonuclease active site. By sequence alignment and homology modeling of 
Mlh3 based on Pms1, the authors identified and mutated the following residues predicted to form 
the metal binding site in the Mlh3 CTD: H525, E529, C670, C701, and H703. They observed 
null-like phenotypes in MMR and crossing over, similar to defects observed in mlh3-D523N, 
indicating that these residues are essential for Mlh1-Mlh3 functions. Thus, the authors conclude 
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that the catalytic sites in yeast Pms1 and Mlh3 likely fold in a similar manner.  
Rogacheva et al. [41] and Ranjha et al. [42] purified yeast Mlh1-Mlh3 that was active in 
vitro. Rogacheva et al. observed that, like Mlh1-Pms1, Mlh1-Mlh3 has an intrinsic endonuclease 
activity that is dependent on the integrity of its endonuclease motif; Mlh1-Mlh3, but not the 
endonuclease mutant Mlh1-mlh3-D523N, was shown to nick supercoiled plasmid DNA in vitro. 
Surprisingly, unlike Mlh1-Pms1, the catalytic activity of Mlh1-Mlh3 was not stimulated by ATP 
or the replication factors RFC (clamp loader) and PCNA (processivity clamp). Rather, 
Rogacheva et al. observed stimulation by Msh2-Msh3. The authors conclude that physical 
interactions between Msh2-Msh3 and Mlh1-Mlh3 act to coordinate substrate nicking during 
MMR. Ranjha et al. [42] observed similar Mlh1-Mlh3 endonuclease activity on supercoiled 
plasmid DNA in vitro that was not stimulated by ATP or RFC and PCNA. Furthermore, the 
authors tested the binding selectivity of Mlh1-Mlh3 on different oligo-based DNA substrates and 
demonstrated a preference for binding the un-stacked or “open” form of a Holliday junction 
(HJ). However, in the following section, I will present arguments suggesting that, although 
Mlh1-Mlh3 can bind HJs, it is not the substrate for activation of the Mlh1-Mlh3 endonuclease.  
 
Mlh1-Mlh3 has unique in vitro DNA binding and endonuclease activities 
 Manhart et al. [43] propose a novel model in which Mlh1-Mlh3 is loaded onto DNA to 
form an activated polymer that, directed by other recombination proteins, cleaves recombination 
intermediates to form COs. The authors observe inhibition of Mlh1-Mlh3 endonuclease activity 
upon binding synthetic mismatched and HJ DNA substrates. Thus, they argue that Mlh1-Mlh3 
does not act according to archetypes set by canonical HJ resolvases that recognize and cleave 
branched DNA structures. Interestingly, they found Mlh1-Mlh3’s endonuclease activity to be 
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more active on circular DNA than on linear DNA and that this activity increases as substrate size 
increases, but is inhibited by disruptions in DNA, such as a loop mismatch or biotin-streptavidin 
linkages. Based on these and other findings, the authors conclude that multiple Mlh1-Mlh3 
molecules interact on the DNA substrate to form a polymer, which in turn licenses its nicking 
activity. In support of this model, the authors visualized, via electron microscopy, tightly packed 
protein-DNA clusters that form when circular DNA and Mlh1-Mlh3 are mixed together under 
conditions that result in optimal endonuclease activity. Similar higher-order protein-DNA 
structures were visualized by Claeys Bouuaert and Keeney [44] using atomic force microscopy 
(AFM).   
Claeys Bouuaert and Keeney [44] performed a detailed biochemical characterization of 
the DNA-binding properties of yeast Mlh1-Mlh3. When Mlh1-Mlh3 was pulled down using 
beads coated with different DNA substrates, efficient pull down was observed with HJs, as 
reported previously[42], and, surprisingly, with ssDNA. Moreover, they observed that Mlh1-
Mlh3’s DNA-binding activities to these two substrates are largely non-competing. This led the 
authors to hypothesize that the Mlh1-Mlh3-DNA binding sites are likely different for HJs and 
ssDNA, therefore raising the possibility that the complex can potentially bind two substrates at 
once. To test these ideas, the authors used hydroxyl radical footprinting to map the HJ and 
ssDNA-binding interfaces of Mlh1-Mlh3. Indeed, they observed that the DNA-binding interfaces 
for the two substrates only partially overlap, with HJ binding mapping predominantly to the 
linkers of Mlh1 and Mlh3, and ssDNA binding mapping to both the N-terminal domains and the 
linkers of Mlh1 and Mlh3. Furthermore, Claeys Bouuaert and Keeney incubated Mlh1-Mlh3 
with equimolar concentrations of biotin-labeled and radiolabeled substrates (HJ or ssDNA) and, 
after complex assembly, observed pull-down of radiolabeled substrates with streptavidin beads. 
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Thus the authors conclude that Mlh1-Mlh3 can bind multiple substrates simultaneously. In 
agreement with this model, Manhart et al. [43] showed that an active Mlh1-Mlh3-DNA 
nucleoprotein complex can interact with another DNA substrate in trans. They observed Mlh1-
Mlh3 nicking on small linear substrates only when incubated with large closed circular 
substrates.   
These studies reveal distinct DNA binding and endonuclease activities unique to Mlh1-
Mlh3 that do not conform to paradigms set by previously characterized dHJ resolvases. Rather, 
Mlh1-Mlh3 displays DNA binding properties similar to Mlh1-Pms1 that are critical for its MMR 
function. Thus, the authors hypothesized that such properties are utilized by Mlh1-Mlh3 in 
meiosis to resolve dHJs into COs.  
 
How does one endonuclease nick two different DNA substrates? 
Recent studies by Al-Sweel et al. [40] and Claeys Bouuaert and Keeney [44] have shown 
that the MMR and meiotic functions of Saccharomyces cerevisiae Mlh3 are genetically 
separable. Al-Sweel et al. created a structure-function map of Mlh3 by analyzing 60 new mlh3 
alleles. The authors applied a clustered charged-to-alanine scanning mutagenesis approach. They 
hypothesized that replacement of a charged patch from Mlh3’s surface with alanine residues 
would disrupt protein-protein or protein-DNA interactions with minimal affect on Mlh3 folding. 
Claeys Bouuaert and Keeney, on the other hand, mutated conserved residues that appear to be in 
proximity to DNA as judged from hydroxyl radical footprinting. In both studies the authors 
tested the effects of their mutations on MMR and meiotic functions in vivo. Although the two 
independent studies utilized different mutagenesis strategies, many of the same residues were 
targeted and comparable overall phenotypes were observed. N-terminal mutants were more 
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uniformly defective in MMR, suggesting the ATP-binding domain may be more critical for this 
function, while more severe defects in crossing over were observed in the linker mutants. 
Importantly, both studies identified mlh3 alleles with separable functions in MMR and crossing 
over. Similar observations regarding the importance of the Mlh3 ATP-binding domain in MMR 
were made by Sonntag Brown et al. [36] in a study that characterized eight mlh3 ATPase 
mutants in MMR and crossing over. 
 
In the following section, I will present models, which are not mutually exclusive, that can 
explain how one protein is regulated to act in two different genomic stability pathways (Figure 
1.4).  
 
a. Protein-protein interactions with MMR or pro-crossover factors direct endonuclease activity  
Al-Sweel et al. [40] propose a model in which the Mlh1-Mlh3 endonuclease activity on 
insertion/deletion loops vs. dHJs is activated and directed by protein-protein interactions with 
MMR or CO specific factors respectively. They hypothesize that the positioning of other protein 
factors on DNA provides a unique substrate for Mlh1-Mlh3 to act on such that these factors 
spatially and temporally coordinate its nicking activity to result in strand specific repair or CO 
products. The authors characterized two variants with opposing separation of function 
phenotypes. mlh3-32 conferred null-like defects in crossing over with MMR at levels nearly 
indistinguishable from wild-type. On the other hand, mlh3-45 conferred null-like defects in 
MMR with CO frequencies nearly indistinguishable from wild-type. Interestingly, they did not 
observe defects in the in vitro endonuclease, and by extension, DNA-binding activities of either 
Mlh1-mlh3 mutant complex tested. The authors found that, in agreement with the in vivo  
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Figure 1.4. Mlh1-Mlh3 endonuclease can nick two different DNA substrates that form 
during different genomic stability pathways.  
Factors that are hypothesized to regulate Mlh1-Mlh3 activity and subsequently direct and 
activate nicking of the MMR insertion/deletion substrate or the double Holliday junction (dHJ) 
substrate formed during meiotic recombination. Black arrowheads indicate nicking positions that 
would yield strand specific repair or crossover products.  
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phenotypes, the endonuclease activity of the MMR defective Mlh1-mlh3-45 complex was not 
stimulated by the MMR factor Msh2-Msh3, unlike the endonuclease activity of Mlh1-mlh3-32.  
Al-Sweel et al. [40] suggest that MLH complexes interact with MSH complexes via a 
common mechanism, and that defective interactions with Msh2-Msh3 are also indicative of 
defective interactions with Msh4-Msh5. Interestingly, mlh3-45 maintained COs at nearly wild-
type levels despite a possibly disrupted interaction with Msh4-Msh5. In addition, they identified 
two mlh3 alleles that weakened dimerization with Mlh1. While this affected the MMR function 
of these two alleles, no significant defects in crossing over were observed. Thus, the authors 
observed that destabilized protein-protein interactions were tolerated in meiosis but not MMR. 
Taken together, these findings support a model in which pro-crossover factors act in concert to 
stabilize weakened interactions during meiotic CO resolution in vivo. The authors propose that 
Mlh1-Mlh3 is part of a resolvase complex at dHJs that regulates the endonuclease activity of 
Mlh1-Mlh3 to generate COs. In agreement with this, Ranjha et al. [42], based on their in vitro 
observations that Mlh1-Mlh3 prefers to bind open HJs, propose that Mlh1-Mlh3 in vivo acts as a 
complex with other recombination factors that facilitate its access to the junction.   
Much remains to be understood about how biased resolution of dHJs in the ZMM 
pathway is implemented. A working model suggests that, in the steps leading to dHJ formation, 
the coordinated assembly of diverse protein factors at the two junctions imposes biased nicking 
(Figure 1.5). Consistent with this, a recent bioinformatics study identified a possible role for 
Zip3, a SUMO E3 ligase, in implementing asymmetric resolution [45]. Whole genome 
sequencing of recombination events in yeast spores derived from zip3 mutants showed biased 
cutting was lost while surprisingly maintained in msh4 mutants. Based on this and other findings, 
the authors propose that Msh4-Msh5 is required at the invading end of the DSB, to stabilize SEI  
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Figure 1.5. Distinct protein-protein interactions at the two junctions facilitate asymmetric 
nicking of the double Holliday junction (dHJ) by Mlh1-Mlh3.  
Early strand invasion intermediates are acted upon by different factors as they mature to form the 
dHJ. Single end invasion intermediates (SEI) are stabilized by Msh4-Msh5 (brown) giving rise to 
the first junction. Second-end capture processed via RPA, Rad52, Rad54, (gray) and possibly 
Zip3 (purple) results in the formation of the second junction. This implies a sequential loading of 
diverse factors at the two junctions such that a symmetric DNA intermediate is stabilized by 
asymmetric protein factors. These factors recruit Mlh1-Mlh3 and possibly direct biased 
resolution of the dHJ to form exclusively crossover products. Model adapted from Manhart and 
Alani [31].    
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intermediates, while Zip3 acts to promote second-end capture at the ligating end. It is tempting to 
propose that pro-crossover factors, present in precise positions on the dHJ substrate, recruit and  
subsequently orient Mlh1-Mlh3’s biased nicking activity. In support of this, cytological 
observations in mouse have shown that MLH1-MLH3 foci formation requires MSH4-MSH5 
[46]. Furthermore, Zakharyevich et al. [21] observed pro-crossover functions for Exo1 
independent of its exonuclease activity and dependent on its interaction with Mlh1-Mlh3.  
Additional studies suggest that specific protein-protein interactions influence and direct 
MLH endonuclease activity during MMR. In vitro studies performed by Kadyrov et al. [6] 
showed that RFC-loaded PCNA can activate Mlh1-Pms1, but this was not observed for Mlh1-
Mlh3 by Rogacheva et al. [41] or Ranjha et al. [42]. Mlh3 lacks a PCNA binding motif present in 
Pms1. Romanova and Crouse suggest that Mlh1-Mlh3 acts in conjunction with Mlh1-Pms1 in 
Msh2-Msh3 dependent MMR [10]. This observation helps address how Mlh1-Mlh3 is involved 
in MMR in the absence of a PCNA interaction. Mlh1-Mlh3 is recruited and activated by Msh2-
Msh3, and also forms a complex with Mlh1-Pms1, which can be directed by PCNA to promote 
efficient repair [7]. Al-Sweel et al. [40] hypothesize that if dimerization between Mlh1 and Mlh3 
is weakened, the ability to be recruited by Msh2-Msh3 and interact with Mlh1-Pms1 is likely 
inhibited; creating a defect in MMR that is minor because Mlh1-Pms1 is still active.  For meiotic 
crossing over, a relatively slow process compared to MMR at the replication fork, a weakened 
dimer can be compensated for by interactions with other meiotic factors (e.g. Msh4-Msh5, Exo1 
and STR). Alternatively, the defect observed in Mlh1-Mlh3 interaction is weak and may not be a 
limiting factor for CO resolution in meiosis. Taken together these observations provide further 
motivation to examine Mlh1-Mlh3 activity on recombination substrates in vitro in the presence 
of pro-crossover factors. 
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b. Different DNA-binding domains of Mlh1-Mlh3 exert substrate specificity  
Claeys Bouuaert and Keeney [44] suggest that distinct DNA-binding surfaces in the 
ATPase domains and linker arms of Mlh1-Mlh3 determine substrate specificity and exert 
separable contributions to MMR or CO functions. The authors mapped the DNA binding 
interface of Mlh1-Mlh3 by hydroxyl radical footprinting, and found that most contacts with HJ 
substrates were located in the linkers. Whereas ssDNA contacts mapped within the ATPase 
domains in the N-terminus as well as the linkers. Next, the authors mutated conserved residues 
within these protein surfaces that are inferred to contact DNA directly and tested the effects of 
these mutations on substrate binding in vitro in addition to their effect on MMR and CO 
functions in vivo. Interestingly, they observed binding defects in vitro that globally agreed with 
the predictions of the footprinting assay. For example, the mutants in the Mlh1 linker had a 
stronger defect in HJ binding than mutants in the NTD. But this was not as obvious for Mlh3. 
Nonetheless, the effects observed on in vivo function suggested that the Mlh3 linker is more 
important for crossing over, further supporting their model. Importantly, when the authors 
plotted the in vivo phenotypes of these binding mutants on MMR versus crossing over, an 
intriguing pattern emerged. The mutants clustered based on their location in the N-terminal 
domain or linker region, indicating that particular domains within the protein convey differential 
contributions to MMR and crossing over.   
 
c. Molecular switch modulated by an ATPase cycle 
MLH proteins act as dimers and contain long unstructured linkers that connect the N- and 
C-terminal domains of each subunit. The linkers vary in length and are resistant to amino acid 
substitutions [47]. Sacho et al. [48] imaged, via AFM, asymmetric global conformational  
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Figure 1.6. Mlh1-Mlh3 conformational changes mediated by an ATPase cycle.  
Sequential ATP binding facilitates formation of the one-arm and condensed state respectively. 
Hydrolysis and release of both nucleotides, either sequentially (dashed arrows) or at the same 
time returns the heterodimer to the extended conformation. Model adapted from Sacho et al. [48] 
based on data from Claeys Bouuaert and Keeney [44].   
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changes in yeast Mlh1-Pms1 regulated by an ATP binding, hydrolysis, and release cycle. The 
linker arms, which switch between extended and condensed states, facilitate the conformational 
changes (Figure 1.6). The extended state, in which only the CTDs of the subunits interact, 
corresponds to no nucleotide bound. Sequential binding of ATP to each subunit forms the one-
arm folded and the condensed state respectively. In the condensed state the NTDs of the subunits 
interact in addition to the CTDs. The authors hypothesize that these conformational changes 
expose different regions of the heterodimer to modulate diverse protein-protein or protein-DNA 
interactions in addition to mediating the timing of these interactions.  
Extending these ideas to Mlh1-Mlh3, Claeys Bouuaert and Keeney [44] imaged the 
heterodimer by AFM and indeed observed the different configurations. They also observed an 
increase in the population of condensed particles upon the addition of ATP, at the expense of 
extended and one-arm folded particles. They conclude that, like Mlh1-Pms1, Mlh1-Mlh3 
undergoes conformational changes, mediated by an ATPase cycle, that are likely critical in 
dictating diverse protein-protein or protein-DNA interactions (Figure 1.6). It is interesting to note 
that both Al-Sweel et al. [40] and Claeys Bouuaert and Keeney [44] identified two lysine 
residues in the Mlh3 linker arm (414K and 416K) that conferred a greater defect in crossing over 
than in MMR. It is tempting to speculate that mutating these residues obstructs the formation of a 
configuration that may be more important for facilitating interactions with recombination 
specific protein factors or substrates. 
Cotton et al. [49] constructed and tested mlh3 mutants predicted to disrupt either ATP 
binding (mlh3-N35A) or ATP hydrolysis (mlh3-E31A). They observed significant defects in 
MMR and crossing over, indistinguishable from mlh3Δ, in the binding mutant. In contrast, the 
hydrolysis mutant affected only the MMR function while COs were maintained at close to wild-
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type levels. Thus, they suggest that ATP binding, and the accompanying conformational change, 
is essential for both MMR and crossing over. Whereas ATP hydrolysis by Mlh3 is important 
only in MMR and is dispensable for crossing over. Based on the model proposed by Sacho et al. 
[48], ATP binding is required for formation of the condensed state. ATP hydrolysis was 
proposed to be required for the subsequent release of ADP and Pi and recycling of the protein 
complex. Cotton et al. [49] hypothesize that the inability to hydrolyze ATP prevents Mlh1-Mlh3 
from being free to undergo another round of ATP binding implying that the availability of Mlh1-
Mlh3 is rate limiting only for crossing over. However, in contrast to Cotton et al., Sonntag 
Brown et al. [36] observed meiotic defects in the mlh3 hydrolysis mutant. This is consistent with 
both ATP binding and hydrolysis being important for Mlh1-Mlh3 functions in MMR and 
crossing over.  
It is important to note that Mlh1-Mlh3 exhibited a low ATPase activity in vitro, a few 
fold lower than that observed for Mlh1-Pms1. The ATPase activity was not significantly 
stimulated by DNA [41],[44]. Furthermore, addition of ATP does not promote the in vitro 
endonuclease activity of Mlh1-Mlh3 in contrast to Mlh1-Pms1 [41],[42].  
 
d. Regulation of gene expression 
Wang et al. [35] propose a model in which repair or recombination substrates are 
channeled into the appropriate pathway through differential expression of Pms1 or Mlh3. Kramer 
et al. [50] and Chu et al. [51] demonstrate that in Saccharomyces cerevisiae the transcript level 
of MLH1, the common component in Mlh complexes, appears to be constant throughout mitotic 
and meiotic cell cycles, while both PMS1 and MLH3 transcript levels are cell cycle regulated. 
Transcription of PMS1 is induced around the time of DNA replication in vegetative and meiotic 
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cells in agreement with a role in MMR. Whereas, transcription of MLH3 is up-regulated during 
meiosis, somewhat later than PMS1, in agreement with a primary role in recombination required 
after bulk DNA replication [50]–[52]. Based on these observations, Wang et al. [35] hypothesize 
that the relative abundance of Mlh complexes is regulated via programmed changes in gene 
expression such that differential expression of Pms1 and Mlh3 could promote preferential 
formation of specific Mlh1-containing heterocomplexes.  
 
e. Posttranslational modifications 
Matos et al. [53] demonstrate that the endonuclease activities of the SSNs Mus81-Mms4 
and Yen1 are controlled by their phosphorylation states. The authors hypothesize that this 
regulatory system directs joint molecule resolution by timing the actions of resolvases according 
to cellular needs. They observed that Mus81-Mms4 is hyperactivated by the Polo-like kinase 
Cdc-5 at the onset of meiosis I, to generate some of the COs necessary for chromosome 
segregation, while Yen1 is activated by dephosphorylation at the onset of meiosis II to resolve 
persistent HJs. Manhart et al. [43] did not observe an effect on the in vitro endonuclease activity 
of Mlh1-Mlh3  upon phosphatase or kinase treatment, suggesting that it is unlikely to be 
regulated by phosphorylation. The authors do not rule out the possibility that other 
posttranslational modifications, such as SUMOylation, may play an as yet unknown role in 
controlling Mlh1-Mlh3’s activity. It is important to note that Qiao et al. [54] observed 
antagonistic roles for the ubiquitin ligase HEI10 and the SUMO ligase RNF212, mammalian 
ortholog of Zip3, that are balanced during meiotic recombination in mice to effect differential 
stabilization of recombination factors at CO and NCO sites. 
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Unanticipated observations infer diverse Mlh1-Mlh3 functions in meiotic recombination 
Al-Sweel et al. [40] propose that mlh3 mutants can alter the fate of meiotic recombination 
intermediates. The authors utilized high-resolution recombination maps to characterize wild-
type, mlh3Δ, and three mlh3 alleles; the endonuclease defective mutant, mlh3-D523N, in addition 
to two alleles that conferred stronger defects in one function relative to the other (MMR or 
crossing over). The mlh3 point and null mutants displayed genome-wide increases in NCO 
events as compared to wild-type strains. They hypothesize that in mutants defective in Mlh1-
Mlh3 functions, dHJs formed in the ZMM pathway become susceptible to the actions of the 
SSNs to form NCOs and COs indiscriminately. dHJs, in these mutant backgrounds, could also be 
acted upon by the STR complex through convergent migration of the two junctions until a 
hemicatenane can be removed by the topoisomerase. The authors propose a model in which 
Mlh1-Mlh3 acts in concert with the ZMM proteins to protect recombination intermediates from 
the actions of STR. They speculate that these observations provide new insights for how meiotic 
recombination pathways are regulated. In agreement with this, Zakharyevich et al. [23] propose 
that Mlh1-Mlh3 is required for Sgs1-dependent crossing over but is dispensable for efficient 
joint molecule resolution and formation of NCOs. The authors observed similar reductions in 
crossing over upon deletion of either Sgs1 or Mlh3 in yeast strains lacking the SSNs (mms4 slx4 
yen1). However deletion of Mlh3, in contrast to Sgs1, did not affect NCOs or joint molecule 
resolution.  
Claeys Bouuaert and Keeney [44] observed similarly decreased CO levels for mlh1Δ and 
mlh3Δ strains, as observed previously. Therefore, given the importance of crossing over in 
promoting accurate chromosome segregation, the authors anticipated to find similar chromosome 
segregation defects in mlh1Δ as compared to mlh3Δ. Surprisingly meiosis I nondisjunction was 2 
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to 3-fold more frequent in mlh3Δ. They speculate that in the absence of Mlh3 joint molecules are 
taken apart too early to facilitate chromosome biorientation, suggesting a role for Mlh3 in 
stabilizing joint molecules. Alternatively, in the absence of Mlh3, joint molecules may persist too 
long thereby interfering with chromosome separation. The authors do not rule out the possibility 
that the different contributions of Mlh1 and Mlh3 to meiotic recombination reflect the different 
complexes they inhabit. Mlh1 is a common subunit of three heterodimers, while Mlh3 is known 
to interact only with Mlh1. For example, Mlh1 interacts with Mlh2 to regulate GC tract lengths. 
Thus, the authors propose that the more severe mlh3Δ nondisjunction phenotype could arise from 
there no longer being a competition between Mlh3 and other proteins for binding Mlh1. Taken 
together, the authors conclude that these observations draw a more complex picture of the role of 
Mlh1-Mlh3 in meiotic recombination. It is important to note that the relative increase in homolog 
nondisjunction in mlh3Δ as compared to mlh1Δ, reported in thus study, was not observed in 
studies, described previously, based on spore viability measurements [35]. This discrepancy may 
be a result of chromosome-specific effects, as spore viability reflects segregation of all 
chromosomes, whereas in this study missegregation of only chromosome VIII was measured.   
Claeys Bouuaert and Keeney [44] also observed an unexpected preference of Mlh1-Mlh3 
to bind ssDNA. This is surprising because canonical DSB repair models do not predict that 
ssDNA will be present at the stage of the dHJ intermediate and Mlh1-Mlh3 involvement. The 
authors hypothesize that Mlh1-Mlh3 may play an earlier role than typically implicated. They 
propose that Mlh1-Mlh3 may be recruited to early strand invasion intermediates and initially 
binds ssDNA and then probes for nearby branched structures. In support of this, 
immunolocalization studies in mouse spermatocytes performed by Lipkin et al. [37] showed that 
Mlh3 foci appeared in early to mid pachynema consistently without Mlh1. Moreover, the 
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absence of Mlh3 results in a failure to load Mlh1. The authors conclude that preloading of Mlh3 
is required for binding of Mlh1 to sites of crossing over. Alternatively, the authors speculate that 
Mlh3 can homodimerize in early pachynema suggesting more diverse Mlh1-Mlh3 functions in 
meiotic recombination than previously proposed.  
 
Conclusions 
Mlh1-Mlh3 is part of the MMR family of proteins yet its endonuclease activity is utilized 
to provide a major contribution in meiotic recombination. Much remains to be determined 
regarding Mlh1-Mlh3 function at a mechanistic level. How one endonuclease can recognize and 
bind two different DNA substrates and introduce precise nicks is intriguing. I utilized a genetic 
approach to answer this question. In Chapter 2, I investigated the in vivo effect of 60 new mlh3 
mutants on both MMR and crossing over in Saccharomyces cerevisiae. This provides a structure 
function map of Mlh3 from which I identified six alleles that conferred stronger defects in one 
function vs. the other. Thus, I conclude the two functions of Mlh1-Mlh3 are genetically 
separable. These mutations were validated by different methods that measure frequency of 
crossing over. In addition, I identified the putative endonuclease active site in Mlh1-Mlh3 based 
on homology with Mlh1-Pms1. Further characterization of the CTD separation of function 
mutants by yeast-two hybrid revealed that a weakened interaction between Mlh1-Mlh3 is 
tolerable in meiosis but not MMR. Moreover, based on in vitro biochemical interactions between 
Msh2-Msh3 and an MMR deficient, CO proficient allele, I hypothesize that weakened MSH-
MLH interactions are also permitted in meiosis more than MMR. These observations lend 
support to the model that Mlh1-Mlh3 acts to promote COs as part of a larger resolvase complex. 
Finally, whole genome maps of recombination events in tetrads derived from null and point mlh3
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mutants revealed that defective Mlh1-mlh3 complexes can alter the fate of meiotic 
recombination intermediates, potentially through the dissolution activity of the STR complex. 
Thus, I hypothesize that Mlh1-Mlh3 acts to protect recombination intermediates from the actions 
of STR. In agreement with this, upon overexpression of the Sgs1 helicase, I observed a greater 
decrease in the spore viability of mlh3Δ strains but not in mutant strains where a structurally 
intact Mlh1-mlh3 complex is thought to be present. In Chapter 3, I discuss immediate future 
plans, based on these findings, in addition to remaining questions in the field and future projects.  
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Abstract 
Mlh1-Mlh3 is an endonuclease hypothesized to act in meiosis to resolve double Holliday 
junctions into crossovers. It also plays a minor role in eukaryotic DNA mismatch repair (MMR).  
To understand how Mlh1-Mlh3 functions in both meiosis and MMR, we analyzed in baker’s 
yeast 60 new mlh3 alleles. Five alleles specifically disrupted MMR, whereas one (mlh3-32) 
specifically disrupted meiotic crossing over. Mlh1-mlh3 representatives for each class were 
purified and characterized. Both Mlh1-mlh3-32 (MMR+, crossover-) and Mlh1-mlh3-45 (MMR-, 
crossover+) displayed wild-type endonuclease activities in vitro.  Msh2-Msh3, an MSH complex 
that acts with Mlh1-Mlh3 in MMR, stimulated the endonuclease activity of Mlh1-mlh3-32 but 
not Mlh1-mlh3-45, suggesting that Mlh1-mlh3-45 is defective in MSH interactions. Whole 
genome recombination maps were constructed for wild-type and MMR+ crossover-, MMR- 
crossover+, endonuclease defective and null mlh3 mutants in an S288c/YJM789 hybrid 
background. Compared to wild-type, all of the mlh3 mutants showed increases in the number of 
noncrossover events, consistent with recombination intermediates being resolved through 
alternative recombination pathways. Our observations provide a structure-function map for Mlh3 
that reveals the importance of protein-protein interactions in regulating Mlh1-Mlh3’s enzymatic 
activity. They also illustrate how defective meiotic components can alter the fate of meiotic 
recombination intermediates, providing new insights for how meiotic recombination pathways 
are regulated.    
 
Author Summary 
During meiosis, diploid germ cells that will become eggs or sperm undergo a single 
round of DNA replication followed by two consecutive chromosomal divisions. The segregation 
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of chromosomes at the first meiotic division is dependent in most organisms on at least one 
genetic exchange, or crossover event, between chromosome homologs. Homologs that do not 
receive a crossover frequently undergo nondisjunction at the first meiotic division, yielding 
gametes that lack chromosomes or contain additional copies. Such events have been linked to 
human disease and infertility.  Recent studies suggest that the Mlh1-Mlh3 complex is an 
endonuclease that resolves recombination intermediates into crossovers.  Interestingly, this 
complex also acts as a matchmaker in DNA mismatch repair (MMR) to remove DNA replication 
errors.  How does one complex act in two different processes?  We investigated this question by 
performing a mutational analysis of the baker’s yeast Mlh3 protein. Five mutations were 
identified that disrupted MMR but not crossing over, and one mutation disrupted crossing over 
while maintaining MMR. Using a combination of biochemical and genetic analyses to further 
characterize these mutants we illustrate the importance of protein-protein interactions for Mlh1-
Mlh3’s activity. Importantly, our data illustrate how defective meiotic components can alter the 
outcome of meiotic recombination events. They also provide new insights for the basis of 
infertility syndromes.    
 
Introduction 
During mismatch repair (MMR), insertion/deletion and base-base mismatches that form 
as the result of DNA replication errors are recognized by MutS homolog (MSH) proteins, which 
in turn recruit MutL homolog (MLH) proteins to form ternary complexes containing mismatched 
DNA, MSH factors, and MLH factors. These interactions result in the recruitment of 
downstream excision and resynthesis proteins to remove the error [1]. In S. cerevisiae repair of 
insertion deletion loops greater than one nucleotide in size primarily involves the MSH 
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heterodimer Msh2-Msh3 and the MLH heterodimer Mlh1-Pms1 [1]. The MLH heterodimer 
Mlh1-Mlh3 has been shown to play a minor role in this process and can partially substitute for 
Mlh1-Pms1 in Msh2-Msh3-dependent MMR [2-4]. However, Mlh1-Mlh3 has been shown to 
play a major role in meiotic crossing over [5-8]. Accurate chromosome segregation in Meiosis I 
in most eukaryotes requires reciprocal exchange of genetic information (crossing over) between 
homologs [9-12]. Failure to achieve at least one crossover (CO) per homolog pair results in 
homolog nondisjunction and the formation of aneuploid gametes. Errors in meiotic chromosome 
segregation are a leading cause of spontaneous miscarriages and birth defects [13].  
Yeast Mlh1-Pms1 and its human ortholog MLH1-PMS2 both exhibit an endonuclease 
activity that is essential for MMR [14-15]. This activity is dependent on the integrity of a highly 
conserved (DQHA(X)2E(X)4E) metal binding motif also found in Mlh3. Previous work 
demonstrated that a point mutation within this motif (mlh3-D523N) conferred mlh3Δ-like defects 
in MMR and crossing over.  These included a mutator phenotype, a decrease in spore viability to 
70% (from 97% in wild-type), and a two-fold reduction in genetic map distances [5]. Consistent 
with these observations, Mlh1-Mlh3 is an endonuclease that nicks circular duplex DNA in vitro, 
and Mlh1-mlh3-D523N is defective in endonuclease activity [16-17].  
Approximately 200 double strand breaks (DSBs) are induced throughout the genome in a 
S. cerevisiae cell in meiotic prophase, of which ~90 are repaired to form COs between 
homologous chromosomes, with the rest repaired to form noncrossovers (NCOs; [18-23]). In this 
pathway a DSB, which forms on one chromatid of a homologous pair, is resected by 5’ to 3’ 
exonucleases, resulting in the formation of 3′ single-strand tails on both sides of the DSB (Figure 
2.1). One of these tails invades the other unbroken homolog and is extended and stabilized to 
create a single-end invasion intermediate (SEI). A second invasion event initiating from the SEI, 
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Figure 2.1. DSB repair pathways in meiosis.  
Model adapted from Kaur et al. [30] depicting wild-type meiosis and the central role of the STR 
complex (Sgs1-Top3-Rmi1 helicase/topoisomerase) in disassembling strand invasion 
intermediates to facilitate synthesis dependent strand annealing (SDSA) or return of events to the 
original DSB state to allow capture and protection by the ZMM proteins and dHJ formation for 
ultimate resolution as class I crossovers by Mlh1-Mlh3 and Exo1. Events that escape STR 
disassembly form unregulated joint molecules that are resolved by the structure selective 
nucleases (SSNs-Mus81-Mms4, Yen1, Slx-Slx4) as noncrossovers or class II crossovers. The 
“E” classification of recombination classes was described in Oke et al. [34].  The majority event 
classes are presented here and result from MMR of heteroduplex DNA intermediates.  E1 events 
are simple noncrossovers (NCO), E2 are simple crossovers (CO) with or without continuous 
gene conversion, and E3 are COs with discontinuous gene conversion.  A set of definitions for 
these classes can also be found in Figure 2.6.  
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known as second-end capture, can re-anneal and ligate to the other side of the DSB resulting in 
the formation of a double Holliday junction (dHJ). The dHJ can be acted upon by Holliday 
junction (HJ) resolvases to form CO and NCO products. In baker’s yeast the majority of COs are 
formed through an interference-dependent CO pathway (class I COs) in which the vast majority 
of dHJs are resolved to form evenly spaced COs in steps requiring the ZMM proteins Zip1-4, 
Mer3, and Msh4-Msh5 as well as the Sgs1-Top3-Rmi1 (STR) helicase/topoisomerase complex, 
Mlh1-Mlh3, and Exo1 [8, 24-31]. These steps are biased to resolve the two junctions present in 
the dHJ so that the resulting product is exclusively a CO. A second interference-independent 
pathway was identified that accounts for a small (~10%) number of CO events (class II COs). In 
this pathway, which does not involve the ZMM proteins, the two junctions are resolved 
independently by the Mus81-Mms4 endonuclease, leading to a mixture of CO and NCO products 
[7, 8, 32, 33]. 
Genetic and physical studies summarized below support a major role for Mlh1-Mlh3 in 
promoting meiotic CO formation in the interference-dependent CO pathway. 1. Genetic studies 
performed in yeast showed that mlh1 and mlh3 mutants display approximately two-fold 
reductions in crossing over [7, 35, 36]. 2. There is significant redundancy of factors required to 
resolve dHJs into COs.  This redundancy involves the endonucleases Mlh1-Mlh3, Mus81-Mms4, 
Yen1, and Slx1-Slx4 [5, 7, 8], with Yen1 and Slx1-Slx4 acting in cryptic or backup roles. When 
all four factors were removed, crossing over was reduced to very low levels; however, in an 
mms4 slx4 yen1 triple mutant, in which Mlh1-Mlh3 is maintained, relatively high CO levels 
(~70% of wild-type levels) were observed, suggesting that Mlh1-Mlh3 is the primary factor 
required for CO resolution in the interference-dependent CO pathway [8]. 3. MLH1 and MLH3 
play critical roles in mammalian meiosis [37, 38].  For example, Mlh3-/- mice are sterile with an 
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85-94% reduction in the number of COs; germ cells in these mice fail to maintain homologous 
pairing at metaphase and undergo apoptosis [37, 39]. 
Much remains to be understood about how biased resolution of dHJs in the interference-
dependent pathway is achieved. A working model, supported by genetic and molecular studies 
outlined below, is that the STR complex and a subset of ZMM proteins process and interact with 
DSB repair and SEI intermediates to create a dHJ substrate that can be resolved by the Mlh1-
Mlh3 endonuclease and Exo1 to form primarily COs [5-8, 16, 29, 30, 31, 36, 40-46]. In this 
model, the biased cleavage of a dHJ suggests coordination between the two junctions that would 
likely require asymmetric loading of meiotic protein complexes at each junction. However, little 
is known at the mechanistic level about how such coordination could be accomplished. A recent 
bioinformatics study by the Fung group, which involved the analysis of CO-associated gene 
conversion patterns in yeast tetrads, suggested that Zip3, a SUMO E3 ligase, is required for 
biased cleavage [34]. Curiously, they found that biased resolution of dHJs was maintained in 
msh4 mutants. Based on these findings and other observations they propose that Msh4-Msh5 is 
required at the invading end of the DSB to stabilize recombination intermediates such as SEIs, 
while Zip3 acts to promote second-end capture steps at the ligating end of the DSB [34].  In 
support of this model, the ZMM heterodimer Msh4-Msh5 has been shown to promote COs in the 
same pathway as Mlh1-Mlh3, and human MSH4-MSH5 was shown to bind to SEI and Holliday 
junction substrates in vitro [7, 43]. Furthermore, cytological observations in mouse have shown 
that MSH4-MSH5 foci appear prior to MLH1-MLH3 [37, 44, 47, 48]. Consistent with these 
observations, MLH1 and MLH3 foci formation requires MSH4-MSH5 [48].  
Additional support for the above model was obtained from analysis of the STR complex 
[8, 30, 31, 46, 49].  The STR complex has recently been labeled the master regulator of meiotic 
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DSB repair, acting as both a positive and negative CO coordinator (Figure 2.1; [30, 49]). 
Initially, the Sgs1 helicase was characterized as anti-CO because it facilitates unwinding of DSB 
repair intermediates to promote NCOs via synthesis-dependent strand annealing (SDSA). 
However, deleting either Sgs1 or Mlh3 in yeast strains that lack all other meiotic resolvases 
(mms4, slx4, yen1) results in a similar reduction of CO levels (~10% of wild-type levels) 
suggesting a pathway where Sgs1-dependent COs require Mlh1-Mlh3 [8]. Similar results were 
observed in mms4, slx4, yen1 strains deficient in Top3 or Rmi1 [30, 31]. These data indicate that 
the STR complex promotes the majority of COs in conjunction with a resolvase that is not 
Mus81-Mms4, Slx1-Slx4 or Yen1.  
A role for Exo1 in crossing over is supported by genetic studies that show Exo1 and 
Mlh3 acting in the same CO pathway [29]. Interestingly, Exo1’s role in maintaining wild-type 
levels of crossing over is independent of its catalytic activity, suggesting a structural role for this 
pro-CO factor [29]. Consistent with the above observations, Msh4-Msh5, STR, Exo1 and Zip3 
have all been shown to interact with one another and/or with Mlh1-Mlh3 [50].  
In this study, we created a structure-function map of Mlh3 by analyzing 60 new mlh3 
alleles in S. cerevisiae.  Five alleles predicted to disrupt the Mlh1-Mlh3 endonuclease motif 
conferred defects in both MMR and crossing over, providing further support that endonuclease 
activity is required for both functions.  Importantly, we identified five mlh3 mutations that 
specifically disrupted MMR, and one mutation that specifically disrupted crossing over. By 
performing biochemical and genetic analyses of the separation of function Mlh1-mlh3 
complexes we suggest that the defects seen in our mutants can be explained by a weakening of 
protein-protein interactions, which can be tolerated in meiosis, but not MMR. Importantly, our 
high-resolution recombination mapping of these mutants revealed ways in which defective 
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meiotic components can alter the fate of meiotic recombination intermediates. 
 
Results  
Rationale for site-directed mutagenesis of MLH3.  
Mlh3 contains a highly conserved N-terminal ATP binding motif, a dynamic and 
unstructured motif known as the linker arm, and an endonuclease active site that overlaps with a 
C-terminal Mlh1 interaction domain [51]. We performed a clustered charged-to-alanine scanning 
mutagenesis of the S. cerevisiae MLH3 gene to create 60 mlh3 variants (Figure 2.2; Tables 2.1-
2.3). Charged residues were considered “clustered” if there were at least two charged residues, 
consecutive or separated by at most one amino acid, within the primary sequence of Mlh3.  Such 
a directed approach, in the absence of a complete crystal structure, is aimed at targeting the 
surface of a protein where clusters of charged residues likely reside, while minimizing changes 
within the interior. In this model, replacement of a charged patch from Mlh3’s surface with 
alanine residues would disrupt protein-protein or protein-DNA interactions without affecting 
Mlh3 structure. This unbiased mutagenesis has been successfully applied to study the functional 
domains of several proteins [52, 53], and has provided a comprehensive view of the functional 
organization of MLH1 [54]. As shown below, we identified a subset of mutations that caused 
strong defects in either MMR or crossing over, but not both, likely through disrupted interactions 
with Mlh1 and other MMR and meiotic CO factors. 
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Figure 2.2.  Site directed mutagenesis of MLH3.   
A. Functional organization of Mlh3 based on sequence homology and secondary structure 
prediction [51]. The vertical bars indicate the approximate position of the mlh3 mutations (except 
mlh3-60) analyzed in this study and described in panel B. mlh3-39, -40, -57, -58, and -59 colored 
in red are based on highly conserved residues in the endonuclease motifs of Pms1 which were 
shown in the crystal structure of Mlh1-Pms1 to form a single metal binding site [51] described in 
panel C.  B. Amino acid positions of charged-to-alanine substitutions presented in red on the 
primary sequence of Saccharomyces cerevisiae Mlh3. Each cluster of underlined residues 
represents one allele corresponding to the vertical bars in panel A.  mlh3-39, -40, -57, -58, and -
59 are colored in red as in panel A.  mlh3-60 represents the last 11 residues of Pms1 which 
constitute patch II of the heterodimerization interface of Mlh1-Pms1 [51].  C. Metal binding site 
of Pms1 (left panel) from [51] comprised of the five highlighted residues (H703, E707, C817, 
C848, and H850) were found to be highly conserved in Mlh3 (right panel) based on sequence 
alignment and structural modeling (H525, E529, C670, C701, and H703) and were targeted in 
the mutagenesis described in this study (alleles represented by red bars in A and red numbers in 
B).   
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Table 2.1. Yeast strains used in this study. 
 
Strain    Genotype 
EAY3252   MATα ho::hisG, ura3, leu2::hisG, trp1::hisG, ADE2, HIS4,   
   CEN8Tomato::LEU2, MLH3, lys2::insE-A14 
 
EAY3255   MATα ho::hisG, ura3, leu2::hisG, trp1::hisG, ADE2, his4xB,   
             CEN8Tomato::LEU2, mlh3Δ::NATMX, lys2::insE-A14 
        amino acid substitution 
EAY3490-91  Same as EAY3255, but mlh3-1::KANMX  H4A,R6A,K7A 
EAY3492-93  Same as EAY3255, but mlh3-2::KANMX  E14A,R15A,K17A 
EAY3494-95  Same as EAY3255, but mlh3-3::KANMX  R30A,E31A 
EAY3496-97  Same as EAY3255, but mlh3-4::KANMX  D38A,H40A 
EAY3498-99  Same as EAY3255, but mlh3-5::KANMX  D59A,D60A 
EAY3500-01  Same as EAY3255, but mlh3-6::KANMX  R66A,D68A 
EAY3502-03  Same as EAY3255, but mlh3-7::KANMX  K80A,R82A,K83A 
EAY3504-05  Same as EAY3255, but mlh3-8::KANMX  R96A,D98A 
EAY3506-07  Same as EAY3255, but mlh3-9::KANMX  K114A,K115A,K166A,D117A 
EAY3508-09  Same as EAY3255, but mlh3-10::KANMX  R124A,K125A 
EAY3510-11  Same as EAY3255, but mlh3-11::KANMX  R151A,R152A,K154A 
EAY3512-13  Same as EAY3255, but mlh3-12::KANMX  E162A,D163A 
EAY3514-15  Same as EAY3255, but mlh3-13::KANMX  R171A,R172A,R173A 
EAY3516-17  Same as EAY3255, but mlh3-14::KANMX  K176A,E177A,E178A 
EAY3518-19  Same as EAY3255, but mlh3-15::KANMX  K188A,D190A 
EAY3520-21  Same as EAY3255, but mlh3-16::KANMX  D209A,K210A,R212A 
EAY3522-23  Same as EAY3255, but mlh3-17::KANMX  R220A,K222A 
EAY3524-25  Same as EAY3255, but mlh3-18::KANMX  K230A, H231A 
EAY3526-27  Same as EAY3255, but mlh3-19::KANMX  K252A, K253A 
EAY3528-29  Same as EAY3255, but mlh3-20::KANMX  R273A, K275A, D276A 
EAY3530-31  Same as EAY3255, but mlh3-21::KANMX  R285A, R286A 
EAY3532-33  Same as EAY3255, but mlh3-22::KANMX  E307A, K308A 
EAY3534-35  Same as EAY3255, but mlh3-23::KANMX  K314A, K316A 
EAY3536-37  Same as EAY3255, but mlh3-24::KANMX  R323A, H325A 
EAY3538-39  Same as EAY3255, but mlh3-25::KANMX  D331A, R333A 
EAY3540-41  Same as EAY3255, but mlh3-26::KANMX  D339A, D340A 
EAY3542-43  Same as EAY3255, but mlh3-27::KANMX  K347A, K348A 
EAY3544-45  Same as EAY3255, but mlh3-28::KANMX  H354A, R356A 
EAY3546-47  Same as EAY3255, but mlh3-29::KANMX  D379A, K380A, D382A 
EAY3548-49  Same as EAY3255, but mlh3-30::KANMX  D399A, R401A 
EAY3550-51  Same as EAY3255, but mlh3-31::KANMX  K406A, R407A 
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Table 2.1 (continued) 
 
EAY3552-53  Same as EAY3255, but mlh3-32::KANMX  K414A, K416A 
EAY3554-55  Same as EAY3255, but mlh3-33::KANMX  E442A, K443A, K445A 
EAY3556-57  Same as EAY3255, but mlh3-34::KANMX  R448A, D450A 
EAY3558-59  Same as EAY3255, but mlh3-35::KANMX  E471D, D472A, D474A 
EAY3560-61  Same as EAY3255, but mlh3-36::KANMX  K492A, E494A 
EAY3562-63  Same as EAY3255, but mlh3-37::KANMX  D500A, K501A, K502A 
EAY3564-65  Same as EAY3255, but mlh3-38::KANMX  H514A, R516A 
EAY3566-67  Same as EAY3255, but mlh3-39::KANMX  D523A, H525A  
EAY3568-69  Same as EAY3255, but mlh3-40::KANMX  D528A, E529A, R530A 
EAY3570-71  Same as EAY3255, but mlh3-41::KANMX  R532A, E534A, E535A 
EAY3572-73  Same as EAY3255, but mlh3-42::KANMX  R552A, D553A, K555A, D556A 
EAY3574-75  Same as EAY3255, but mlh3-43::KANMX  D562A, R563A, E565A 
EAY3576-77  Same as EAY3255, but mlh3-44::KANMX  K570A, H571A 
EAY3578-79  Same as EAY3255, but mlh3-45::KANMX  K577A, K578A 
EAY3580-81  Same as EAY3255, but mlh3-46::KANMX  E596A, K598A 
EAY3582-83  Same as EAY3255, but mlh3-47::KANMX  D611A, K612A, D613A 
EAY3584-85  Same as EAY3255, but mlh3-48::KANMX  H622A, H624A, D625A 
EAY3586-87  Same as EAY3255, but mlh3-49::KANMX  K627A, D628A, K630A, K631A 
EAY3588-89  Same as EAY3255, but mlh3-50::KANMX  H638A, E640A, H642A 
EAY3590-91  Same as EAY3255, but mlh3-51::KANMX  D646A, K647A 
EAY3592-93  Same as EAY3255, but mlh3-52::KANMX  H662A, E663A 
EAY3594-95  Same as EAY3255, but mlh3-53::KANMX  D678A, E679A 
EAY3596-97  Same as EAY3255, but mlh3-54::KANMX  R682A, E684A 
EAY3598-99  Same as EAY3255, but mlh3-55::KANMX  R694A, H696A 
EAY3600-01  Same as EAY3255, but mlh3-56::KANMX  E713A, K715A 
EAY3701-02  Same as EAY3255, but mlh3-57::KANMX  C670A 
EAY3703-04  Same as EAY3255, but mlh3-58::KANMX  C701A 
EAY3705-06  Same as EAY3255, but mlh3-59::KANMX  H703A 
EAY3707-08  Same as EAY3255, but mlh3-60::KANMX  716-DWSSFSKDYEI 
 
EAY3819-20  Same as EAY3255, but mlh3-D523N::KANMX 
 
EAY3339  MATa ho::LYS2, lys2, ura3, leu2::hisG, trp1::hisG, THR1::m-Cerulean-TRP1 
EAY3486  Same as EAY3339, but mlh3Δ::NATMX 
 
EAY1112  MATα ho::hisG, trp1::hisG, leu2::hisG, lys2, ura3, ade2::hisG, his3Δ::hisG, 
  TRP1insertion@CENXV 
EAY1848  Same as EAY1112, but mlh3Δ::KANMX 
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Table 2.1 (continued) 
 
EAY3712  Same as EAY1112, but mlh3Δ::URA3 
EAY3713-14  Same as EAY1112, but mlh3-6::KANMX 
EAY3715-16  Same as EAY1112, but mlh3-23::KANMX 
EAY3717-18  Same as EAY1112, but mlh3-32::KANMX 
EAY3719-20  Same as EAY1112, but mlh3-42::KANMX 
EAY3721-22  Same as EAY1112, but mlh3-45::KANMX 
EAY3723-24  Same as EAY1112, but mlh3-54::KANMX 
 
EAY2413  MATa trp1:hisG, leu2::hisG, ho::hisG, ura3, lys2, URA3insertion@CENXV, 
  LEU2insertion@chromXV, LYS2 insertion at position 505193 on    
             chromosome XV, mlh3Δ::NATMX 
 
S288c   MATa ho lys5 
YJM789  MATα ho::hisG lys2 cyh 
KTY618  Same as YJM789, but SK1-MLH1::natMX4, mlh3Δ::kanMX4 
KTY610  Same as S288c, but SK1-MLH3::kanMX4, mlh1Δ::hphMX4 
KTY616  Same as S288c, but SK1-mlh3-23::kanMX4, mlh1Δ::hphMX4 
KTY614  Same as S288c, but SK1-mlh3-32::kanMX4, mlh1Δ::hphMX4 
KTY621  Same as S288c, but SK1-mlh3-D523N::kanMX4, mlh1Δ::hphMX4 
KTY626  Same as S288c, but mlh3Δ::kanMX4, mlh1Δ::hphMX4 
 
EAY3252, EAY3255 and derivatives, and EAY3486 are SK1 strains that contain spore 
autonomous fluorescent markers described in Thacker et al. [56]. EAY1112 and EAY2413 
contain chromosome XV markers described in Argueso et al. [7].  KTY strains were used for 
whole genome recombination mapping as described in Krishnaprasad et al. [64] and Oke et al. 
[34]. 
 
  
 
 
 
 
52 
Table 2.2. Diploid strains used to measure % tetratype, spore viability, meiotic progression, 
genetic map distances and for whole genome recombination mapping. 
 
Diploid strain     Relevant genotype 
Spore autonomous fluorescent protein assay [56], meiotic progression assay [93], and Sgs1 
overexpression. 
EAY3252/EAY3486    MLH3/mlh3Δ 
EAY3255/EAY3486    mlh3Δ/mlh3Δ 
EAY3490 to EAY3708/EAY3486  mlh3-1 to mlh3-60/mlh3Δ 
EAY3339/EAY3552-53   MLH3/mlh3-32 
EAY3819-20/EAY3486   mlh3-D523N/mlh3Δ 
 
Tetrad analysis [7] 
EAY1112/EAY2413    MLH3/mlh3Δ 
EAY1848/EAY2413    mlh3Δ/mlh3Δ 
EAY3713-14/EAY2413   mlh3-6/mlh3Δ 
EAY3715-16/EAY2413   mlh3-23/mlh3Δ 
EAY3717-18/EAY2413   mlh3-32/mlh3Δ 
EAY3719-20/EAY2413   mlh3-42/mlh3Δ 
EAY3721-22/EAY2413   mlh3-45/mlh3Δ 
EAY3723-24/EAY2413   mlh3-54/mlh3Δ 
 
Whole genome recombination mapping [34, 64] 
KTY618/KTY610    SK1-MLH1/mlh1Δ, SK1-MLH3/mlh3Δ 
KTY618/KTY616    SK1-MLH1/mlh1Δ, SK1-mlh3-23/mlh3Δ 
KTY618/KTY614    SK1-MLH1/mlh1Δ, SK1-mlh3-32/mlh3Δ 
KTY618/KTY621    SK1-MLH1/mlh1Δ, SK1-mlh3-D523N/mlh3Δ 
KTY618/KTY626    SK1-MLH1/mlh1Δ, mlh3Δ/mlh3Δ 
 
The indicated haploid strains were mated to form the diploids with the relevant genotype shown. 
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Table 2.3. Plasmids used in this study.  
   
A. MLH3 mutagenesis plasmids 
                                     allele     
pEAI254  MLH3 
pEAI325  mlh3-1     
pEAI326  mlh3-2     
pEAI327  mlh3-3     
pEAI328  mlh3-4     
pEAI329  mlh3-5     
pEAI330  mlh3-6     
pEAI331  mlh3-7     
pEAI332  mlh3-8     
pEAI333  mlh3-9     
pEAI334  mlh3-10    
pEAI335  mlh3-11    
pEAI336  mlh3-12    
pEAI337  mlh3-13    
pEAI338  mlh3-14    
pEAI339  mlh3-15    
pEAI340  mlh3-16    
pEAI341  mlh3-17    
pEAI342  mlh3-18    
pEAI343  mlh3-19    
pEAI344  mlh3-20    
pEAI345  mlh3-21    
pEAI346  mlh3-22    
pEAI347  mlh3-23    
pEAI348  mlh3-24    
pEAI349  mlh3-25    
pEAI350  mlh3-26    
pEAI351  mlh3-27    
pEAI352  mlh3-28    
pEAI353  mlh3-29    
pEAI354  mlh3-30    
pEAI355  mlh3-31    
pEAI356  mlh3-32    
pEAI357  mlh3-33    
pEAI358  mlh3-34    
pEAI359  mlh3-35    
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Table 2.3. (continued) 
 
pEAI360  mlh3-36    
pEAI361  mlh3-37    
pEAI362  mlh3-38    
pEAI363  mlh3-39    
pEAI364  mlh3-40    
pEAI365  mlh3-41    
pEAI366  mlh3-42    
pEAI367  mlh3-43    
pEAI368  mlh3-44    
pEAI369  mlh3-45    
pEAI370  mlh3-46    
pEAI371  mlh3-47    
pEAI372  mlh3-48    
pEAI373  mlh3-49    
pEAI374  mlh3-50    
pEAI375  mlh3-51    
pEAI376  mlh3-52    
pEAI377  mlh3-53    
pEAI378  mlh3-54    
pEAI379  mlh3-55    
pEAI380  mlh3-56    
pEAI394  mlh3-57 
pEAI395  mlh3-58  
pEAI396  mlh3-59 
pEAI397  mlh3-60   
pEAI252                     mlh3-D523N 
 
B. Two-hybrid plasmids    
relevant genotype 
pBTM116   pADH1-lexA, dummy vector  2µ, TRP1 
pEAM105   pADH1-lexA-MLH1SK1  2µ, TRP1 
pGAD424   pADH1-GAL4AD  2µ, LEU2 
pEAM234   pADH1-GAL4-AD-MLH3SK1  2µ, LEU2 
pEAM235   pADH1-GAL4-AD-mlh3-39 2µ, LEU2 
pEAM236   pADH1-GAL4-AD-mlh3-40 2µ, LEU2 
pEAM237   pADH1-GAL4-AD-mlh3-41 2µ, LEU2 
pEAM238   pADH1-GAL4-AD-mlh3-42 2µ, LEU2 
pEAM241   pADH1-GAL4-AD-mlh3-45 2µ, LEU2 
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Table 2.3 (continued) 
 
pEAM242   pADH1-GAL4-AD-mlh3-48 2µ, LEU2 
pEAM244   pADH1-GAL4-AD-mlh3-54 2µ, LEU2 
pEAM245   pADH1-GAL4-AD-mlh3-60 2µ, LEU2 
 
C.  2µ URA3 plasmids   
    Relevant genotype 
pRS426 (pEAO34)             Dummy vector 
pEAM266   SGS1 
pEAM270                               sgs1-K706A (sgs1-hd)  
 
A.  All MLH3 mutagenesis plasmids are derived from pEAI254, a 7.8 kb MLH3SK1::KANMX 
integrating vector. pEAI254 was mutagenized by QuickChange to create the alleles listed. The 
DNA sequence of the entire ORF, and 70 bp upstream and 150 bp downstream, were confirmed 
by DNA sequencing using primers EAO318, EAO319, EAO1778 and EAO321.  B. For the two-
hybrid analysis, pEAM105 contains the entire MLH1 gene derived from the SK1 strain inserted 
immediately after the lexA binding domain in pBTM116.  All GAL4 activating domain-mlh3 
plasmids are derived from pEAM234, which contains DNA sequence encoding SK1 MLH3 
amino acids 481 to 715 inserted immediately after the GAL4 activating domain in pGAD424.  C.  
SGS1 was cloned into pRS426 to make pEAM266 as described in the Methods. Site directed 
mutagenesis of pEAM266 was performed to make pEAM270 carrying the sgs1 helicase 
defective allele as described in the Methods.   
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Structure-function analysis of Mlh3.  
We analyzed the effect of mlh3 mutations on MMR in vegetatively grown cells and on 
meiotic COs in diploids induced to undergo sporulation.  For MMR we employed the lys2-A14 
reversion assay to assess the mutation rate in mlh3 haploid strains (Table 2.1; [55]).  In this 
assay, the median reversion rate of mlh3Δ is six-fold higher than wild-type (Figure 2.3; Figure 
2.4B; Table 2.4; [5, 6]).  To measure meiotic crossing over we crossed mutant mlh3 strains to 
mlh3Δ strains (MLH3 is haplosufficient [6]) to form diploids that were then sporulated (Table 
2.2). The resulting tetrads were directly visualized for chromosome VIII CO events using a spore 
autonomous fluorescence assay ([56]; Figure 2.4A). In mlh3Δ strains we observed a more than 
two-fold decrease in crossing over, as measured by percent tetratype, compared to wild-type 
(Figure 2.3; Figure 2.4B; Table 2.4).  Similar effects of the mlh3Δ mutation on crossing over 
were seen at other genetic intervals [5-8].  It is important to note that nonparental ditype (NPD) 
events were not scored because they cannot be distinguished from Meiosis I nondisjunction 
events [56].  
Similar to work performed on a smaller number of mlh3 alleles and a structure-function 
analysis of MLH1, we found that MLH3 MMR functions were more sensitive to mutagenesis 
than CO functions (Figure 2.3; [6, 54]).  Phenotypes exhibited by mlh3 strains containing 
mutations in the ATP-binding motif suggested that this region plays a more critical role in MMR 
compared to crossing over.  However, a region just beyond the ATP-binding domain appeared 
insensitive to mutagenesis. A null phenotype for both functions was observed in strains bearing 
mutations in endonuclease motifs, further confirming that endonuclease activity is essential for 
MMR and crossing over (Figure 2.3; Table 2.4; [5, 8, 16]).  
Comparison of the MMR and CO assay results for each individual allele led to the  
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Figure 2.3. Structure-function map of Saccharomyces cerevisiae Mlh3.  
Mismatch repair (top) and crossing over (bottom) phenotypes of mlh3 alleles analyzed in this 
study (except mlh3-60). Mismatch repair was measured using the lys2-A14 reversion assay [55] 
and crossing over was measured using the assay depicted in Figure 2.4A [56]. Bars represent the 
median reversion rates and percent tetratype normalized to MLH3 (1X). The vertical bars 
indicate the approximate position of the mlh3 mutations analyzed in this study with the height of 
each bar corresponding to the phenotype relative to MLH3 (1X). Red indicates a null phenotype, 
blue indicates wild-type (WT), and green indicates intermediate. For mismatch repair (top), bars 
represent reversion rates of at least 10 independently tested cultures from two independently 
constructed strains presented here normalized to MLH3 median rate 1X=1.43x10-6 (n=140). For 
crossing over (bottom), bars represent percent tetratype of at least 250 tetrads from two 
independently constructed strains presented here normalized to MLH3 percent tetratype 
1X=36.7% (n= 226). Blue and red dotted lines represent MLH3 and mlh3Δ respectively. Black 
stars indicate separation of function mutants (Table 2.4).   
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Figure 2.4. Identification and characterization of mlh3 separation of function alleles.  
A. Spore-autonomous fluorescent protein expression was used to quantify crossing over [56]. 
Shown is the starting parental configuration on chromosome VIII with a map distance of 20 cM 
separating the red fluorescent protein (RFP) marker and the blue fluorescent protein (CFP) 
marker. Percent tetratype at this interval in wild-type meiosis is 36.7%.  B. MMR (top) and CO 
(bottom) phenotypes for MLH3 and mlh3Δ, separation of function, endonuclease, and C-terminal 
tail (mlh3-60) mutants. Mismatch repair was measured using the lys2-A14 reversion assay [55] 
and crossing over was measured using the assay depicted in panel A. Bars represent the median 
reversion rates (error bars based on 95% confidence intervals) and percent tetratype normalized 
to MLH3 (1X). For mismatch repair (top), bars represent reversion rates of at least 10 
independently tested cultures from two independently constructed strains presented here 
normalized to MLH3 median rate of 1X=1.43x10-6 (n=140). For crossing over (bottom), bars 
represent percent tetratype of at least 250 tetrads from two independently constructed strains 
presented here normalized to MLH3 percent tetratype 1X=36.7% (n= 226; Table 2.4). Red 
indicates a null phenotype, blue indicates wild-type. Dotted lines represent MLH3 and mlh3Δ.  C. 
mlh3-42, -54 weaken Mlh1 interaction yet maintain crossover function.  Yeast two-hybrid 
interactions between lexA-Mlh1 (target) and Gal4-Mlh3 (amino acids 481-715; prey) or Gal4-
mlh3-39, -40, -41, -42, -45, -54, -60 derivative constructs, as measured in the ONPG assay for β-
galactosidase activity.  Error bars indicate standard error of mean from at least three independent 
assays. mlh3 separation of function alleles indicated in green font.     
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Table 2.4. Mismatch repair (MMR) and crossover (CO) phenotypes of the mlh3 variants as 
measured in lys2-A14 reversion and spore autonomous fluorescent assays. 
 
Allele      
Phenotype 
Reversion 
rate (x10-6) 
95% CI 
(x10-6) 
Relative 
to WT 
% tetratype 
 
Relative 
to WT MMR CO 
MLH3 1.43 1.23-1.65 1.00 36.70 1.00 + + 
mlh3Δ 9.07 7.4-10.28 6.34 16.10 0.44 − − 
mlh3-1 2.72 2.14-3.13 1.90 27.27 0.74 ± + 
mlh3-2 2.09 1.63-2.94 1.46 35.69 0.97 + + 
mlh3-3 4.03 3.21-5.39 2.82 33.86 0.92 ± + 
mlh3-4 6.89 4.16-8.68 4.82 20.51 0.56 − − 
mlh3-5 7.93 6.79-9.65 5.55 17.30 0.47 − − 
mlh3-6 5.80 2.44-10.7 4.06 31.52 0.86 − + 
mlh3-7 7.46 5.59-10.16 5.22 22.33 0.61 − − 
mlh3-8 3.84 2.77-5.10 2.68 31.37 0.85 ± + 
mlh3-9 5.46 3.78-6 3.82 27.02 0.74 ± + 
mlh3-10 8.80 7.72-11.98 6.16 18.89 0.51 − − 
mlh3-11 2.49 1.57-2.83 1.74 39.77 1.08 + + 
mlh3-12 8.22 6.2-14.44 5.75 24.00 0.65 − ± 
mlh3-13 9.69 6.08-25.7 6.77 24.10 0.66 − ± 
mlh3-14 2.64 1.57-3.99 1.85 35.85 0.98 + + 
mlh3-15 8.25 5.84-9.6 5.77 19.85 0.54 − − 
mlh3-16 2.27 1.7-4.78 1.59 32.49 0.89 ± + 
mlh3-17 3.62 2.7-6.39 2.53 30.71 0.84 ± + 
mlh3-18 4.42 2.74-6.40 3.09 30.51 0.83 ± + 
mlh3-19 3.93 3.65-5.23 2.75 23.57 0.64 ± − 
mlh3-20 4.12 3.19-6.05 2.88 25.56 0.70 ± ± 
mlh3-21 3.99 3.41-5.32 2.79 25.81 0.70 ± ± 
mlh3-22 1.71 1.17-2.96 1.19 35.92 0.98 + + 
mlh3-23 5.69 4.37-7.56 3.98 28.54 0.78 − + 
mlh3-24 4.37 2.57-10.26 3.05 27.31 0.74 − ± 
mlh3-25 5.03 4.57-6.22 3.52 37.50 1.02 ± + 
mlh3-26 7.54 3.97-12.11 5.28 21.56 0.59 − − 
mlh3-27 5.05 2.75-6.78 3.53 35.60 0.97 ± + 
mlh3-28 3.81 2.49-4.51 2.66 34.25 0.93 ± + 
mlh3-29 1.91 0.61-4.69 1.33 41.29 1.13 + + 
mlh3-30 2.36 1.7-3.6 1.65 35.00 0.95 ± + 
mlh3-31 3.23 2.01-6.91 2.26 37.06 1.01 ± + 
mlh3-32 2.00 1.54-2.22 1.40 21.40 0.58 + − 
mlh3-33 1.97 1.65-2.58 1.38 35.49 0.97 + + 
mlh3-34 1.54 1.25-2.82 1.07 38.06 1.04 + + 
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Table 2.4 (continued) 
 
mlh3-35 2.26 0.65-3.21 1.58 36.43 0.99 + + 
mlh3-36 3.54 2.37-5.45 2.47 34.66 0.94 ± + 
mlh3-37 4.25 2.54-5.15 2.97 22.04 0.60 ± − 
mlh3-38 2.26 1.14-3.94 1.58 40.94 1.12 + + 
mlh3-39 16.11 10.54-19 11.26 12.42 0.34 − − 
mlh3-40 11.46 5.81-16.57 8.02 18.45 0.50 − − 
mlh3-41 6.94 3.56-9.1 4.85 17.11 0.47 − − 
mlh3-42 7.70 5.38-12 5.39 35.20 0.96 − + 
mlh3-43 5.31 4.09-7.23 3.71 26.61 0.73 ± + 
mlh3-44 3.59 2.87-4.25 2.51 29.65 0.81 ± + 
mlh3-45 5.92 3.49-11.7 4.14 34.79 0.95 − + 
mlh3-46 2.38 1.75-3.01 1.66 37.27 1.02 ± + 
mlh3-47 4.10 2.98-5.29 2.87 27.72 0.76 ± + 
mlh3-48 5.80 4.01-8.93 4.06 15.41 0.42 − − 
mlh3-49 4.24 3.6-9.72 2.97 16.98 0.46 − − 
mlh3-50 2.75 2.24-3.33 1.92 41.26 1.12 ± + 
mlh3-51 1.83 1.04-3.23 1.28 40.84 1.11 + + 
mlh3-52 1.17 0.79-2.7 0.82 35.04 0.95 + + 
mlh3-57 6.07 4.74-9.4 4.25 17.60 0.48 − − 
mlh3-53 3.74 2.52-6.9 2.62 35.61 0.97 ± + 
mlh3-54 7.34 5.59-9.97 5.13 38.93 1.06 − + 
mlh3-55 3.72 2.22-5.45 2.60 32.41 0.88 ± + 
mlh3-58 7.45 5.23-10.63 5.21 20.00 0.54 − − 
mlh3-59 5.71 4.28-8.19 3.99 20.31 0.55 − − 
mlh3-56 4.65 3.53-6.11 3.25 33.09 0.90 ± + 
mlh3-60 2.50 1.18-4.45 1.75 33.83 0.92 + + 
 
Two independently constructed strains with mlh3 variants were analyzed in the EAY3255 
background which contains the lys2::insE-A14 for MMR testing and the red fluorescent protein 
for meiotic testing. Haploid strains were examined for reversion to Lys+. At least n=10 reversion 
assays were performed per allele. Median reversion rates are presented with 95% confidence 
intervals (CI), and relative reversion rates compared with the wild-type strain are shown. The 
haploid strains were mated to EAY3486, which contains the blue fluorescent protein to make 
diploids suitable for meiotic testing. Diploid strains were induced for meiosis and % tetratype 
was measured. At least 250 tetrads were counted for each allele. WT, wild-type.  +, 
indistinguishable from WT as measured by 95% CI (for reversion rates) or χ2 (p<0.01, for % 
tetratype).  -, indistinguishable from null as measured by 95% CI or χ2 (p<0.01). +/-, 
distinguishable from both wild-type and null as measured by 95% CI or χ2 (p<0.01).  
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identification of six separation of function mutations, defined as showing strong defects in one 
function (e.g. MMR) relative to another (e.g. CO), in the Mlh3 ATP-binding motifs, N-terminal 
domain beyond the ATP-binding motifs, linker arm, and the interaction domain (Figure 2.4B; 
Figure 2.3, indicated by stars).  One of these alleles (mlh3-32) conferred a nearly wild-type 
phenotype for MMR and a null phenotype for crossing over on chromosome VIII (hereafter 
referred to as MMR+, CO-).  The remaining five mutations (mlh3-6, mlh3-23, mlh3-42, mlh3-45, 
and mlh3-54) conferred null MMR phenotypes and nearly wild-type levels of crossing over 
(hereafter referred to as MMR-, CO+).  As indicated below, mlh3-23 displayed different CO 
phenotypes in different strain backgrounds, and so its designation as a separation of function 
allele is less clear.  
The phenotypes observed in the separation of function mutants may result from a defect 
in DNA binding/substrate specificity, endonuclease activity, interactions with specific MMR and 
meiotic CO factors, or changes in protein conformation. It is important to note that a co-crystal 
structure of the N-terminal domain of E. coli MutL (LN40) and E. coli MutS was recently 
solved.  This work showed that conformational changes license MutS-MutL interaction and are 
essential for MMR [57, 58].  
 
The endonuclease active sites in Mlh3 and Pms1 appear to be similar.  
S. cerevisiae Mlh1-Pms1 and Mlh1-Mlh3 and human MLH1-PMS2 display latent 
endonuclease activities dependent on the integrity of a highly conserved metal binding motif 
DQHA(X)2E(X)4E [14-17]. This motif is critical for Mlh3’s MMR and meiotic functions [5]. 
Two additional motifs were implicated in MLH family endonuclease function based on sequence 
alignment: ACR and C(P/N)HGRP [59]. In the Mlh1-Pms1 C-terminal domains crystal structure, 
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five Pms1 residues, located in the three conserved motifs (H703, E707, C817, C848, H850), 
form a metal binding site through folding of the Pms1 C-terminal domain (Figure 2.2C; [51]). 
This organization was also seen in the crystal structure of the C-terminal domain of B. subtilis 
endonuclease MutL (all but H703 are conserved; [60]).   
We performed a sequence alignment of Mlh3, Pms1, and B. subtilis MutL and found all 
three possess conserved metal binding motifs, with the following five residues predicted to form 
the endonuclease active site in Mlh3: H525, E529, C670, C701, and H703. In addition, we 
constructed a homology model of S. cerevisiae Mlh3, and found the C-terminal domain can 
potentially fold in a similar manner to Pms1 such that these five conserved residues form a single 
putative metal binding site (Figure 2.2C). These residues were targeted for site directed 
mutagenesis of MLH3 (Figure 2.2B, shown in red). As shown in Figure 2.3 (represented in the 
C-terminal domain by dotted white squares) and Figure 2.4B and Table 2.4, mutations in the 
putative conserved metal binding motifs of Mlh3 (mlh3-39(D523A, H525A), -40(D528A, E529A, 
R530A), -57(C670A), -58(C701A), and -59(H703A)) conferred null phenotypes for MMR and 
crossing over, indicating they are essential for Mlh3 function. Thus, these genetic data, combined 
with the high sequence homology, suggest that H525, E529, C670, C701, and H703 in the C-
terminal domain of Mlh3 form the catalytic active site (Figure 2.2C). 
The endonuclease motifs in Mlh3 overlap with the C-terminal Mlh1 interaction domain. 
To determine if mutations in the Mlh3 endonuclease motifs disrupted interaction with Mlh1, 
three alleles spanning the DQHA(X)2E(X)4E endonuclease motif (mlh3-39, -40, and -41) were 
analyzed by yeast two-hybrid for interaction with Mlh1. We also tested these alleles because a 
previously characterized mutation in the DQHA(X)2E(X)4E endonuclease motif (mlh3-E529K) 
disrupts Mlh1-Mlh3 interactions [5].  As shown in Figure 2.4C, these mutations disrupted Mlh1-
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Mlh3 interactions, possibly by altering the endonuclease active site structure. This idea is 
supported by the Mlh1-Pms1 crystal structure.  In this model, heterodimer stability is maintained 
through interactions between the C-terminal domain of Mlh1 and the endonuclease active site of 
Pms1 [51].  We cannot rule out the possibility that the null phenotypes observed for MMR and 
crossing over in mlh3-39, -40, and -41 were caused by specifically mutating residues that 
comprise the Mlh1-Mlh3 dimerization interface without causing a gross disruption in protein 
folding.    
The Mlh1-Pms1 C-terminal domain structure reveals three patches constituting the 
heterodimerization interface of Mlh1-Pms1 [51]. Patch I is a pseudosymmetric hydrophobic 
core, Patch II is composed of the last 12 residues of Pms1 and contributes two salt bridges, and 
Patch III involves the C-terminus of Mlh1 and contributes to the Pms1 metal binding site [51]. 
Patches I and III are likely maintained in the Mlh1-Mlh3 heterodimerization interface, but Mlh3 
lacks the last 11 residues that comprise the bulk of Patch II. This finding gives a likely 
explanation for partial disruption of the Mlh1-Mlh3 complex when we attempted to analyze it 
further by gel-filtration [16]. We hypothesized that restoring Patch II to the Mlh1-Mlh3 
interaction interface will strengthen this interaction.  We engineered a fusion construct of Mlh3 
carrying the last 11 residues of Pms1 (mlh3-60, Figure 2.2B in red). As shown in Figure 2.4C, 
when we inserted the last 11 residues of Pms1 after the C-terminal residue of Mlh3, we observed 
a striking increase in the strength of the interaction between Mlh1 and Mlh3 as measured in the 
yeast two-hybrid assay (2.6 ± 0.5 Miller units of β-galactosidase activity for wild-type Mlh1-
Mlh3 compared to 14.2 ± 2.1 for Mlh1-mlh3-60). We initially hypothesized that such an 
enhanced interaction would be detrimental to MMR because it would sequester Mlh1 from the 
major MMR endonuclease Pms1.  Surprisingly we did not observe a significant effect of the 
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mlh3-60 mutation on MMR or on crossing over (Figure 2.4B; Table 2.4), suggesting that 
strengthening the interaction between Mlh1-Mlh3 does not affect formation of the Mlh1-Pms1 
heterodimer. 
 
mlh3-42 and mlh3-54 weaken interaction with Mlh1 yet maintain wild-type levels of 
crossing over. 
Three of the five MMR-, CO+ alleles (mlh3-42, -45, and -54) contained mutations that 
mapped to the Mlh1 interaction interface.  We performed a two-hybrid assay to test whether 
these mutations affected Mlh1-Mlh3 dimerization. The mlh3-45 mutation did not alter Mlh1-
Mlh3 interactions; however, both the mlh3-42 and mlh3-54 mutations disrupted this interaction 
(Figure 2.4C). While such a result could explain the null MMR phenotype conferred by mlh3-42 
and mlh3-54, it does not explain why these strains are functional for meiotic crossing over.  One 
explanation is that additional pro-CO factors act as structural scaffolds to stabilize the weakened 
Mlh1-mlh3 heterodimer, thus allowing it to perform its function at dHJs.  Several observations 
support this idea:  1. The pro-CO factors Msh4-Msh5, Sgs1-Top3-Rmi1, Zip3, and Exo1 interact 
with one another and/or with Mlh1-Mlh3 [29, 40, 41, 42, 61, 62].  2. Studies in mice showed that 
MLH1 and MLH3 do not form a complex until mid to late pachytene; at early to mid pachytene, 
only MLH3 foci are seen [37, 44].  3. Exo1’s role in crossing over is independent of its 
enzymatic activity; it is suggested to play a structural role, acting as a platform for pro-CO 
factors [29].  Together these observations support the presence of a resolvase complex at CO 
sites that regulates the endonuclease activity of Mlh1-Mlh3 (see Discussion). Alternatively, a 
weak Mlh1-Mlh3 interaction defect is sufficient to inhibit a yeast-two hybrid interaction, but not 
affect meiotic recombination if the strength of the Mlh1-Mlh3 interaction is not a limiting factor 
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for CO resolution. 
 
Cumulative genetic distance and spore viability measurements confirm fluorescent assay 
results for mlh3 separation of function alleles. 
The meiotic CO phenotype for the separation of function mutants was determined at four 
consecutive intervals in chromosome (XV) using traditional genetic map distance analyses 
(Figure 2.5A; [5-7]). The overall effect of mlh3 mutations in crossing over on chromosome XV 
was similar to that determined on chromosome VIII (Figure 2.4B; Figure 2.5B; Table 2.4; Table 
2.5). mlh3-6, mlh3-42, mlh3-45, and mlh3-54 appear similar to wild-type; mlh3-23 displays an 
intermediate phenotype, and mlh3-32 appears similar to the null (Fig 2.5B; Table 2.5). Thus, 
these mutants, phenotypes of which are summarized in Table 2.6, were confirmed as separation 
of function alleles, and are candidates for in-depth characterization and high-resolution 
recombination mapping. 
It is important to note that the spore viability and genetic distance measurements of the 
six separation of function alleles indicated that CO levels, represented by genetic distance 
measurements in Chr. XV, can be reduced from 115 cM to ~70 cM without compromising spore 
viability (Figure 2.5C; Table 2.6).  A similar observation was made with msh4/5 hypomorph 
alleles where crossing over in the four same intervals in Chr. XV could be reduced to ~50 cM 
without affecting spore viability [63-64].  Together, these observations and the high resolution 
mapping below indicate that the baker's yeast meiotic cell does not require the full amount of 
COs maintained by CO homeostasis (~90; see [65]) for accurate chromosome segregation and to 
form viable spores.  
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Figure 2.5. Cumulative genetic distance and spore viability of mlh3 separation of function 
mutants.  
A. Distribution of genetic markers on chromosome XV used to determine genetic distances in 
the EAY1112/EAY2413 background (Table 2.1). The solid circle indicates the centromere. The 
distances between markers are not drawn to scale. The actual physical and genetic distances in 
the wild-type diploid are given numerically for each interval and for the entire region between 
CENXV and HIS3 [7].  B. Cumulative genetic distances between URA3 and HIS3 markers from 
tetrads of MLH3 and indicated mlh3 variants. Each bar is further divided into sectors that 
correspond to the four genetic intervals that span URA3-HIS3 (Table 2.5).  C. Spore viabilities 
are plotted vs. genetic map distances from panel B for MLH3 (dark blue), mlh3Δ (red), and the 
separation of function mutants (light blue). Yellow diamonds represent data from Sonntag 
Brown et al. [6]. 
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Table 2.5. Genetic map distances for mlh3 separation of function mutants on chromosome 
XV from single spores and tetrads. 
All mlh3 mutants are isogenic derivatives of EAY1112/EAY2413 (Table 2.2; Methods). For 
single spores, recombination frequencies (recombinant spores/total spores) were multiplied by 
100 to yield genetic map distances (cM). For tetrads, genetic distance in centimorgans (cM) was 
calculated using the RANA software without considering aberrant segregants (Argueso et al. [7]). 
The Stahl Laboratory Online Tools website (http://molbio.uoregon.edu/~fstahl/) was used to 
calculate standard error (SE) around the genetic distance for tetrads. n; number of single spores, 
N; four spore viable tetrads analyzed; Par, parental single spores; Rec, recombinant single spores. 
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Table 2.5 (continued) 
 
 
Single Spores Tetrads        
Genotype n Par. Rec. cM N PD TT NPD cM SE 
URA3-LEU2 
         
 
MLH3 896 641 255 28.5 205 93 106 4 32.0 3.2 
mlh3Δ 1028 876 152 14.8 210 146 61 2 17.5 2.5 
mlh3-6 907 691 216 23.8 205 110 84 5 28.6 3.5 
mlh3-23 480 391 89 18.5 105 69 32 1 18.6 3.6 
mlh3-32 995 836 159 16.0 205 140 61 1 16.6 2.1 
mlh3-42 731 551 180 24.6 154 79 73 1 25.8 2.7 
mlh3-45 925 709 216 23.4 204 103 99 0 24.5 1.8 
mlh3-54 694 533 161 23.2  155 79 70 2 27.2 3.3 
LEU2-LYS2 
         
 
MLH3 896 680 216 24.1  205 103 99 1 25.9 2.2 
mlh3Δ 1028 923 105 10.2  210 166 43 0 10.3 1.4 
mlh3-6 907 738 169 18.6  205 129 68 2 20.1 2.6 
mlh3-23 480 397 83 17.3 105 69 33 0 16.2 2.3 
mlh3-32 995 854 141 14.2 205 144 58 0 14.4 1.6 
mlh3-42 731 564 167 22.9 154 81 71 1 25.2 2.7 
mlh3-45 925 739 186 20.1 204 123 78 1 20.8 2.2 
mlh3-54 694 550 144 20.8 155 90 61 0 20.2 2.0 
LYS2-ADE2 
         
 
MLH3 896 815 81 9.0 205 168 35 0 8.6 1.3 
mlh3Δ 1028 988 40 3.9 210 193 16 0 3.8 0.9 
mlh3-6 907 812 95 10.5 205 158 41 0 10.3 1.4 
mlh3-23 480 454 26 5.4  105 92 10 0 4.9 1.5 
mlh3-32 995 930 65 6.5  205 176 26 0 6.4 1.2 
mlh3-42 731 663 68 9.3 154 124 29 0 9.5 1.6 
mlh3-45 925 856 69 7.5 204 172 29 1 8.7 1.9 
mlh3-54 694 627 67 9.7 155 121 30 0 9.9 1.6 
ADE2-HIS3 
         
 
MLH3 896 560 336 37.5 205 63 129 11 48.0 4.5 
mlh3Δ 1028 829 199 19.4 210 130 79 0 18.9 1.7 
mlh3-6 907 665 242 26.7 205 98 95 6 32.9 3.8 
mlh3-23 480 352 128 26.7 105 46 55 1 29.9 3.6 
mlh3-32 995 811 184 18.5 205 129 70 3 21.8 2.9 
mlh3-42 731 491 241 33.0 154 58 89 6 40.8 4.7 
mlh3-45 925 650 275 29.7 204 85 116 1 30.2 2.2 
mlh3-54 694 469 225 32.4 155 58 88 5 39.1 4.4 
 
 
  
 
 
 
 
69 
Table 2.6. Summary of mlh3 separation of function phenotypes. 
 
 
Genotype 
 
%SV  
Genetic map 
distance (cM) 
 
% tetratype 
Reversion rate 
X10-6 (95%CI) 
β-gal units 
(±SEM) 
MLH3 93.3 114.5 36.7 1.4 (1.2-1.7) 2.6 (±0.5) 
mlh3Δ 74.9 50.5 16.1 9.1 (7.4-10.3) ND 
mlh3-6 91.4 91.9 31.5 5.8 (2.4-10.7) ND 
mlh3-23 90.9 69.6 28.5 5.7 (4.4-7.6) ND 
mlh3-32 78.5 59.2 21.4 2.0 (1.5-2.2) ND 
mlh3-42 91.8 101.3 35.2 7.7 (5.4-12.0) 0.20 (±0.04) 
mlh3-45 92.9 84.2 34.8 5.9 (3.5-11.7) 3.3 (±0.6) 
mlh3-54 92.3 96.4 38.9 7.3 (5.6-10.0) 0.16 (±0.03) 
 
Data were obtained from Table 2.4 (% tetratype, reversion rate), Table 2.5 (% spore viability 
(SV), genetic distance in cM), Figure 2.4C (β-gal units in the two-hybrid assay).  ND, not 
determined. 
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High-resolution recombination maps illustrate unexpected effects of mlh3 mutants on 
resolving meiotic recombination intermediates. 
We characterized three mlh3 alleles (mlh3-23-MMR-, CO+, mlh3-32-MMR+, CO-, mlh3-
D523N) in a genome-wide meiotic recombination assay [66].  mlh3-23 and mlh3-32 were chosen 
as they confer stronger defects in one function relative to the other. The mlh3-D523N 
endonuclease mutation contains an aspartic acid to asparagine substitution in the 
DQHA(X)2E(X)4E metal binding motif of Mlh3.  This mutation does not disrupt formation of the 
Mlh1-Mlh3 complex; however, it conferred a null phenotype for MLH3 functions in MMR and 
meiotic CO assays, and the Mlh1-mlh3-D523N complex is defective for endonuclease activity 
[5, 16].  
  The SK1 MLH3, mlh3Δ, mlh3-23, mlh3-32, and mlh3-D523N alleles were analyzed in the 
S288c/YJM789 hybrid background (Figure 2.6A; Table 2.1; Table 2.2; Methods; [64, 66]).  To 
avoid genetic incompatibilities between Mlh1 and Mlh3, we analyzed SK1 MLH3, SK1 mlh3 
mutations, and mlh3Δ in the presence of SK1 MLH1 (Methods). The spore viabilities of mlh3-23 
(84%), mlh3-32 (82%), and mlh3-D523N (82%) were similar to mlh3Δ (80%) and the wild-type 
hybrid containing SK1-MLH1/3 (82%; Table 2.7).  Why do wild-type and mlh3 strains show 
similar viability in the S288c/YJM789 hybrid?  mlh3Δ mutants display a range of spore 
viabilities (70 to 92%) that appear to depend on strain background [5, 6, 67].  This is likely to be 
a partial explanation; however, another study suggested that sequence divergence present in the 
hybrid strains can affect spore viability through mismatch repair or rejection mechanisms that act 
on heteroduplex DNA formed during genetic recombination [68].  
 
 
 
 
 
 
 
71 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Genome-wide increase in simple noncrossover events (E1) compared to wild-
type in mlh3-23, mlh3-32, mlh3-D523N and mlh3Δ mutants.  
A. Generation of S288c/YJM789 isogenic strains with SK1 MLH1, MLH3 and the mlh3-23, 
mlh3-32, mlh3-D523N and mlh3Δ mutant alleles (Methods). B. Cartoon description of simple 
NCO (E1; 3:1 tract on one chromatid, not within 5 kb of another CO or NCO), simple CO (E2; 
CO with or without an associated gene conversion (GC) tract, and not within 5 kb of another CO 
or NCO), simple CO with discontinuous gene conversion tracts (E3; same definition as for E2, 
except with one or more gene conversions within 5 kb and on one of the same chromatids as the 
CO chromatid), and discontinuous NCOs (E4; two or more NCOs consecutively on one 
chromatid, with 2:2 marker segregation separating them) as presented in Oke et al. [34].  C. 
Crossover (CO, E2+E3) and noncrossover (NCO, E1) counts per meiosis for wild-type, mlh3-23, 
mlh3-32, mlh3-D523N, and mlh3Δ.  The minimum, first quantile, median, third quantile and 
maximum count are indicated in the box plot. The ratio of CO to NCO events is presented above 
the box plots. The proficiency of the mlh3 alleles in mismatch repair is shown as +, MMR 
proficient, or –, MMR deficient. D. Average number of simple NCO (E1) and NCO with 
discontinuous tract (E4) events per tetrad (+/- standard error). * p < 0.05 compared to wild-type 
(Table 2.7).   
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Table 2.7. Spore viability (SV), crossover (CO) and noncrossover (NCO) values for mlh3-
23, mlh3-32, mlh3-D523N, and mlh3Δ mutants in the S288c/YJM789 hybrid. 
 
Genotype: 
S288c x YJM789 
with SK1-MLH1 N % SV 
Tetrads 
genotyped 
Avg. CO 
(E2 + E3)   
+ SEM 
(Median) 
Avg. NCO 
(E1)            
+ SEM 
(Median) 
Avg. NCO 
(E4)            
+ SEM 
(Median) 
SK1-MLH3 168 82 10 
81±3 
(82) 
41±2 
(41) 
2.0±0.6 
(1.0) 
SK1-mlh3-23 80 84 7 
81±6 
(73) 
51±3 
(51) 
3.1±0.9 
(3.0) 
SK1-mlh3-32 80 82 7 
65±4 
(64) 
56±3 
(55) 
2.7±0.6 
(3.0) 
SK1-mlh3-D523N 88 82 10 
59±2 
(59) 
50±2 
(51) 
2.4±0.7 
(2.0) 
mlh3Δ 80 80 10 
55±3 
(56) 
49±2 
(51) 
1.3±0.4 
(1.5) 
 
N = number of tetrads dissected for measuring spore viability (SV).  The E classes were all 
analyzed in groupEvents.  E2 +E3 = total crossovers; E1= simple noncrossover and E4 = 
discontinuous noncrossover. SEM, standard error of the mean. 
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Seven four-viable spore tetrads each of mlh3-23 and mlh3-32, and ten four-viable spore 
tetrads each of mlh3-D523N, mlh3Δ, and MLH3 were used for sequencing (Table 2.8).  The 
sequence data for all the above mlh3 point and null mutants along with the control strain are 
available from the National Centre for Biotechnology Information Sequence Read Archive under 
the accession numbers SRP096621 and SRP110341.  The segregation of the SNPs in all 44 
tetrads is shown in Appendix A.  The CO and NCO counts for all tetrads and the average CO and 
NCO counts per chromosome are shown in Table 2.9 and Table 2.10, respectively.    
As described below, high-resolution recombination mapping analysis using groupEvents 
[34] revealed overall patterns of average CO and NCO events that grouped mlh3-23 close to 
wild-type, and mlh3-D523N and mlh3-32 close to mlh3Δ (Figure 2.6).  Importantly, this analysis 
showed that mlh3 point and null mutants displayed, compared to wild-type, genome-wide 
increases in NCO events.  We did not obtain any evidence that the number of DSBs increased in 
mlh3 point mutants based on measuring the total number of interhomolog (IH) events (Figure 
2.7A); such an increase would have provided a simple explanation for why an increase in NCO 
events was observed, though it is important to note that small changes in total events are 
challenging to interpret, partly because NCO events can escape detection due to a lack of a 
polymorphic marker, and we do not have a good estimate of how many such invisible events 
exist, or how they could be altered by differences in conversion tract length.  Thus, we recognize 
that analyzing total events does not provide a particularly good proxy for DSB (e.g. [69]) levels.  
Together, these data provide evidence for mlh3 mutants altering the resolution of meiotic 
recombination intermediates (see Discussion).  
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Table 2.8. Sequencing statistics for spores derived from wild type, mlh3-23, mlh3-32, mlh3-
D523N and mlh3∆ in S288c/YJM789 hybrid bearing SK1-MLH1/MLH3 alleles. 
 
Spore ID SNPs genotyped Coverage Depth (X) 
wt_2a 73593 66.40 
wt_2b 74058 79.95 
wt_2c 73682 70.88 
wt_2d 73565 73.79 
wt_5a 71120 31.09 
wt_5b 74269 71.53 
wt_5c 71985 40.23 
wt_5d 71278 39.96 
wt_6a 73967 31.05 
wt_6b 73838 39.35 
wt_6c 73779 40.65 
wt_6d 72914 30.12 
wt_7a 72106 17.09 
wt_7b 70109 10.83 
wt_7c 71589 12.98 
wt_7d 73637 48.78 
wt_8a 73934 26.02 
wt_8b 72929 27.20 
wt_8c 72853 23.29 
wt_8d 72057 20.39 
wt_9a 72729 25.17 
wt_9b 73773 34.92 
wt_9c 73366 29.59 
wt_9d 72637 27.90 
wt_10a 73326 88.63 
wt_10b 73176 25.16 
wt_10c 73198 30.37 
wt_10d 73612 22.72 
wt_11a 73020 40.30 
wt_11b 73309 43.98 
wt_11c 73553 31.89 
wt_11d 73034 37.50 
wt_12a 72904 30.86 
wt_12b 73006 20.06 
wt_12c 74485 29.35 
wt_12d 74593 28.81 
wt_13a 73772 39.24 
wt_13b 73934 46.79 
wt_13c 73051 37.72 
wt_13d 73012 29.61 
mlh3_23_6a 72821 26.00 
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Table 2.8 (continued) 
 
mlh3_23_6b 73731 30.46 
mlh3_23_6c 74242 74.35 
mlh3_23_6d 73587 38.45 
mlh3_23_7a 73307 31.01 
mlh3_23_7b 72910 30.35 
mlh3_23_7c 74113 26.86 
mlh3_23_7d 73731 33.87 
mlh3_23_8a 73652 42.29 
mlh3_23_8b 73500 23.72 
mlh3_23_8c 73523 35.44 
mlh3_23_8d 73019 27.51 
mlh3_23_9a 72890 24.92 
mlh3_23_9b 72762 39.19 
mlh3_23_9c 73009 23.54 
mlh3_23_9d 73289 28.28 
mlh3_23_10a 74434 34.56 
mlh3_23_10b 71249 13.69 
mlh3_23_10c 72944 27.91 
mlh3_23_10d 73138 36.67 
mlh3_23_11a 74791 44.61 
mlh3_23_11b 72578 39.03 
mlh3_23_11c 73377 30.72 
mlh3_23_11d 74015 35.07 
mlh3_23_12a 72112 20.22 
mlh3_23_12b 72717 19.77 
mlh3_23_12c 72680 23.84 
mlh3_23_12d 72243 21.08 
mlh3_32_6a 73361 36.57 
mlh3_32_6b 73183 37.66 
mlh3_32_6c 72332 24.60 
mlh3_32_6d 71679 22.96 
mlh3_32_7a 72832 198.87 
mlh3_32_7b 71095 11.60 
mlh3_32_7c 73330 31.58 
mlh3_32_7d 73238 26.67 
mlh3_32_8a 72758 217.13 
mlh3_32_8b 70392 29.44 
mlh3_32_8c 70315 27.33 
mlh3_32_8d 72879 149.71 
mlh3_32_9a 74387 98.47 
mlh3_32_9b 63895 45.17 
mlh3_32_9c 72482 141.67 
mlh3_32_9d 73950 204.92 
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Table 2.8 (continued) 
 
mlh3_32_11a 73202 29.09 
mlh3_32_11b 73770 27.74 
mlh3_32_11c 72274 34.69 
mlh3_32_11d 73102 31.94 
mlh3_32_12a 73497 41.42 
mlh3_32_12b 72933 31.95 
mlh3_32_12c 73648 32.22 
mlh3_32_12d 73847 32.89 
mlh3_32_13a 73579 34.68 
mlh3_32_13b 73554 34.46 
mlh3_32_13c 74400 71.42 
mlh3_32_13d 72551 20.67 
mlh3DN_1a 74093 53.98 
mlh3DN_1b 74212 54.27 
mlh3DN_1c 74196 52.60 
mlh3DN_1d 74018 78.47 
mlh3DN_2a 73782 67.29 
mlh3DN_2b 73893 98.45 
mlh3DN_2c 73947 104.45 
mlh3DN_2d 74717 131.11 
mlh3DN_3a 74808 91.32 
mlh3DN_3b 73523 53.45 
mlh3DN_3c 73649 55.91 
mlh3DN_3d 73680 51.84 
mlh3DN_4a 73994 46.26 
mlh3DN_4b 74042 63.36 
mlh3DN_4c 74334 85.10 
mlh3DN_4d 74398 51.04 
mlh3DN_5a 74793 49.82 
mlh3DN_5b 74596 60.02 
mlh3DN_5c 74230 47.14 
mlh3DN_5d 73957 58.53 
mlh3DN_6a 74602 57.33 
mlh3DN_6b 74329 72.08 
mlh3DN_6c 74203 48.69 
mlh3DN_6d 74376 77.95 
mlh3DN_7a 74205 48.52 
mlh3DN_7b 74246 58.80 
mlh3DN_7c 74130 60.66 
mlh3DN_7d 73308 65.19 
mlh3DN_8a 73246 36.71 
mlh3DN_8b 74400 55.49 
mlh3DN_8c 74116 78.77 
 
 
 
 
78 
Table 2.8 (continued) 
 
mlh3DN_8d 73848 62.79 
mlh3DN_9a 74698 64.18 
mlh3DN_9b 74851 76.91 
mlh3DN_9c 73978 50.63 
mlh3DN_9d 73810 66.36 
mlh3DN_10a 73932 66.84 
mlh3DN_10b 74272 89.49 
mlh3DN_10c 74783 91.61 
mlh3DN_10d 74421 78.58 
mlh3null_1a 72746 23.75 
mlh3null_1b 71493 66.08 
mlh3null_1c 73461 27.09 
mlh3null_1d 73062 36.04 
mlh3null_2a 73687 30.53 
mlh3null_2b 73350 28.38 
mlh3null_2c 70835 70.07 
mlh3null_2d 71034 18.25 
mlh3null_3a 72707 26.01 
mlh3null_3b 73321 29.99 
mlh3null_3c 74005 37.19 
mlh3null_3d 72088 24.08 
mlh3null_4a 74052 32.98 
mlh3null_4b 72938 49.10 
mlh3null_4c 74692 52.23 
mlh3null_4d 73792 32.23 
mlh3null_5a 73803 31.86 
mlh3null_5b 74048 33.79 
mlh3null_5c 72848 33.27 
mlh3null_5d 72772 21.49 
mlh3null_6a 71196 69.15 
mlh3null_6b 73701 38.79 
mlh3null_6c 71783 76.77 
mlh3null_6d 71928 19.94 
mlh3null_7a 73097 36.67 
mlh3null_7b 72210 36.42 
mlh3null_7c 75003 60.87 
mlh3null_7d 73297 35.11 
mlh3null_8a 73597 44.31 
mlh3null_8b 73050 56.57 
mlh3null_8c 73092 40.96 
mlh3null_8d 73375 41.63 
mlh3null_9a 73689 38.75 
mlh3null_9b 72537 41.30 
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Table 2.8 (continued) 
 
mlh3null_9c 73632 36.13 
mlh3null_9d 73622 34.73 
mlh3null_10a 74117 34.20 
mlh3null_10b 71858 30.54 
mlh3null_10c 73608 39.18 
mlh3null_10d 73109 36.95 
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Table 2.9. Crossovers (CO) and noncrossovers (NCO) in tetrads of wild-type, mlh3-23, 
mlh3-32, mlh3-D523N and mlh3∆. 
 
Tetrad_ID CO (E2+E3) NCO (E1) 
wt_2 73 53 
wt_5 82 43 
wt_6 71 37 
wt_7 100 47 
wt_8 78 37 
wt_9 76 44 
wt_10 83 46 
wt_11 81 28 
wt_12 85 34 
wt_13 82 38 
mlh3_23_6 92 63 
mlh3_23_7 73 53 
mlh3_23_8 63 43 
mlh3_23_9 84 49 
mlh3_23_10 73 55 
mlh3_23_11 112 46 
mlh3_23_12 70 51 
mlh3_32_6 64 51 
mlh3_32_7 72 45 
mlh3_32_8 58 64 
mlh3_32_9 56 64 
mlh3_32_11 53 50 
mlh3_32_12 73 55 
mlh3_32_13 80 61 
mlh3DN_1 61 45 
mlh3DN_2 51 53 
mlh3DN_3 58 49 
mlh3DN_4 66 43 
mlh3DN_5 58 55 
mlh3DN_6 66 58 
mlh3DN_7 55 57 
mlh3DN_8 64 44 
mlh3DN_9 52 46 
mlh3DN_10 59 52 
mlh3null_1 44 54 
mlh3null_2 36 56 
mlh3null_3 47 46 
mlh3null_4 53 49 
mlh3null_5 48 44 
mlh3null_6 55 57 
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Table 2.9 (continued) 
 
mlh3null_7 55 58 
mlh3null_8 52 60 
mlh3null_9 50 72 
mlh3null_10 52 56 
 
Crossovers are E2+E3 events and noncrossovers are E1 events [34]. 
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Table 2.10. Average crossovers (CO) and noncrossovers (NCO) per chromosome for WT 
(wild type), mlh3-23, mlh3-32, mlh3-D523N and mlh3Δ  mutants.  
 
Chromosome WT mlh3-23 mlh3-32 mlh3-D523N mlh3Δ 
I 1.6 1.4 1.4 1.1 1.7 
II 4.3 5.9 5.0 4.7 3.4 
III 3.1 3.0 1.7 2.4 1.9 
IV 9.5 8.6 8.1 6.1 6.3 
V 3.4 4.4 2.9 2.2 2.5 
VI 2.3 2.1 1.9 2.0 1.6 
VII 7.0 8.0 4.0 5.3 4.4 
VIII 4.7 4.1 3.1 2.7 3.1 
IX 3.2 2.9 3.0 2.5 2.3 
X 5.3 4.7 3.1 3.1 3.3 
XI 4.7 5.0 4.0 3.8 3.5 
XII 7.3 7.0 5.3 5.2 4.8 
XIII 6.5 5.0 6.0 4.3 4.3 
XIV 4.6 5.3 4.1 3.7 2.8 
XV 7.5 7.0 5.7 4.8 5.1 
XVI 6.1 6.6 5.7 5.1 4.2 
Total_CO 81.0 81.0 65.0 59.0 55.0 
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Table 2.10 (continued) 
 
Chromosome WT mlh3-23 mlh3-32 mlh3-D523N mlh3Δ  
I 1.2 1.3 1.0 1.0 1.4 
II 4.0 4.1 4.0 4.1 3.3 
III 0.8 0.7 2.1 1.9 0.9 
IV 4.5 7.1 7.3 5.9 5.6 
V 2.6 3.3 2.3 3.7 2.9 
VI 1.3 1.4 1.1 0.8 1.4 
VII 4.3 4.0 5.9 4.1 5.9 
VIII 1.4 1.4 3.1 2.3 1.8 
IX 1.0 1.9 2.0 1.9 1.7 
X 1.9 3.6 3.7 3.1 3.5 
XI 1.8 2.1 3.3 2.4 2.1 
XII 2.5 3.9 5.7 4.1 4.3 
XIII 3.3 5.7 3.7 3.2 3.4 
XIV 3.2 2.6 3.0 2.9 2.9 
XV 3.4 4.9 4.1 6.1 4.8 
XVI 3.5 3.4 3.3 2.7 3.3 
Total_NCO 41.0 51.0 56.0 50.0 49.0 
 
Crossovers are E2+E3 events and noncrossovers are E1 events [34]. 
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Figure 2.7. Total interhomolog events and distribution of gene conversion tract lengths 
associated with NCO and CO events in wild-type, mlh3-23, mlh3-32, mlh3-D523N and 
mlh3Δ mutants.   
A. Total average inter-homolog events (IH; Table 2.11), and each event type (E1-E7) as a 
fraction of the total, in MLH3, mlh3-23, mlh3-32, mlh3-D523N, and mlh3Δ mutants. * p < 0.05 
compared to wild-type.  B.  Average number of tracts ordered by size for simple CO (E2) and 
simple NCO (E1) events. Median CO and NCO tract sizes are also presented, and events were 
assigned as described by Oke et al. [34]. The Y-axis represents pooled data from all tetrads, 
normalized by dividing the number of tetrads.  
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i. mlh3-23, mlh3-32, and mlh3-D523N display distinct CO phenotypes.  We used 
groupEvents ([34]; 5 kb threshold for merging nearby events) to categorize all IH events, 
focusing primarily on the major CO (E2, E3) and NCO events (E1; Figure 2.1; Figure 2.6B), but 
also examining minority NCO (E4) events that can provide information on whether events 
resulted from defective mismatch repair or multiple invasion intermediates (Figure 2.6; Figure 
2.7; Figure 2.8; Table 2.7; Table 2.11; Methods). 
Wild-type and mlh3-23 displayed the same average number of CO events (E2+E3) 
(p=0.99), and mlh3Δ, mlh3-D523N, and mlh3-32 displayed CO levels lower than wild-type (p 
<0.01).  mlh3-D523N and mlh3Δ displayed similar average CO levels (p =0.23), but mlh3-32 
displayed levels higher than mlh3Δ (p=0.05) (Figure 2.6C and Table 2.7).  An analysis of 
average CO counts per chromosome was consistent with these observations; mlh3-23 had a CO 
distribution similar to wild-type, and mlh3-32 and mlh3-D523N had distributions similar to 
mlh3Δ (Figure 2.9).  Significant reduction in crossovers were observed primarily on medium (0.5 
to 0.9 Mb-II, V, VIII, X, XI, XIV) and large (>0.9 Mb-IV, VII, XII, XIII, XV, XVI) 
chromosomes in mlh3Δ (III, VIII, X, XIV, XIII, XVI, XII, VII, XV, IV), mlh3-D523N (VIII, X, 
XIII, VII, XV, IV) and mlh3-32 (X, VII; Figure 2.9B; [70]).  Together, these observations are 
consistent with the analysis of map distances at specific loci, though the mlh3-23 mutant 
displayed an improved CO phenotype in the S288c/YJM789 background compared to the SK1 
background (Figure 2.4; Figure 2.5; Figure 2.6C).  
The median gene conversion tract lengths associated with COs (E2 events; Figure 2.7B; 
Figure 2.8; Table 2.12) were significantly longer (p < 0.03) for mlh3Δ (2.19 kb) compared to 
MLH3 (1.79 kb) and mlh3-32 (1.84 kb), but were not significantly longer (p > 0.18) for mlh3-23 
(1.96 kb), and mlh3-D523N (1.96 kb).  We found this interesting because MLH3 and mlh3-32  
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Figure 2.8. Distribution of gene conversion tract lengths associated with crossovers and 
noncrossovers (NCOs) for wild-type, mlh3-23, mlh3-32, mlh3-D523N, and mlh3Δ.   
A. Distribution of gene conversion tract lengths associated with simple NCO (E1) and CO (E2) 
events.  B. Distribution of gene conversion tract lengths associated with simple NCO (E1) and 
discontinuous NCO (E4) events. * p < 0.05 comparing mlh3Δ to mlh3-32. In A and B the 
minimum, first quantile, median, third quantile, and maximum count are indicated in the box 
plot. Outlier points are not shown. 
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Table 2.11. Summary of all event categories, as defined in Oke et al. [34], in wild-type 
(WT), mlh3-23, mlh3-32, mlh3-D523N and mlh3Δ. 
 
  WT mlh3-23 mlh3-32 mlh3-D523N mlh3Δ 
Number of tetrads 10.00 7.00 7.00 10.00 10.00 
Total E1 407.00 360.00 390.00 502.00 492.00 
E1 per tetrad 40.70 51.43 55.71 50.20 49.20 
E1 length mean 1821.22 1804.54 1748.45 1811.19 1895.31 
E1 length median 1464.50 1415.75 1335.00 1482.50 1501.00 
Total E2 728.00 485.00 407.00 519.00 501.00 
E2 per tetrad 72.80 69.29 58.14 51.90 50.10 
E2 length mean 1418.21 1530.45 1512.03 1570.09 1775.29 
E2 length median 1166.00 1146.50 1153.00 1263.00 1433.50 
E2 length(>0) median 1795.00 1964.00 1842.00 1962.00 2192.00 
Total E3 83.00 82.00 49.00 71.00 51.00 
E3 per tetrad 8.30 11.71 7.00 7.10 5.10 
E3 length mean 3154.80 3253.14 2565.66 3588.28 3396.47 
E3 length median 3069.00 3036.25 2545.50 3163.00 2870.00 
E3 track length mean 1254.65 1094.16 800.45 1079.31 1258.72 
E3 tract length median 974.00 920.50 709.00 850.25 966.50 
E3 GC length mean 669.32 772.35 641.97 741.70 542.78 
E3 GC length median 340.50 304.25 189.00 331.00 0.00 
E3 gap length mean 1352.59 1520.39 1247.16 1718.63 1474.08 
E3 gap length median 870.50 1128.00 972.00 1488.25 1352.00 
Total E4 20.00 22.00 19.00 24.00 13.00 
E4 per tetrad 2.00 3.14 2.71 2.40 1.30 
E4 length mean 3113.55 2924.32 2762.08 2961.08 2514.19 
E4 length median 3008.00 2034.50 2227.50 2587.00 2279.50 
E4 track length mean 1182.68 1006.43 806.79 810.73 907.46 
E4 tract length median 802.00 649.50 661.50 493.50 553.50 
E4 gap length mean 572.66 681.32 741.15 968.88 584.50 
E4 gap length median 440.75 484.00 520.75 701.50 276.75 
Total E5 29.00 39.00 27.00 45.00 34.00 
E5 per tetrad 2.90 5.57 3.86 4.50 3.40 
E5 length mean 3358.71 3685.97 3389.41 3616.73 3718.44 
E5 length median 2438.50 3654.50 3305.00 3682.50 3364.00 
Total E5A 17.00 16.00 16.00 23.00 21.00 
E5A per tetrad 1.70 2.29 2.29 2.30 2.10 
E5A length mean 2550.94 3695.19 3305.63 3260.50 3714.02 
E5Alength median 2408.00 3350.50 3211.25 3571.50 3360.00 
Total E6 80.00 53.00 40.00 50.00 43.00 
E6 per tetrad 8.00 7.57 5.71 5.00 4.30 
E6 length mean 3724.04 4055.31 3863.69 3992.64 4050.65 
E6 length median 3199.75 3663.00 3368.25 3520.50 3829.00 
Total E7 10.00 5.00 3.00 15.00 8.00 
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Table 2.11 (continued) 
 
E7 per tetrad 1.00 0.71 0.43 1.50 0.80 
E7 length mean 3499.25 3163.50 4589.33 3299.13 5029.06 
E7 length median 3832.00 2661.00 3392.50 3832.00 4572.75 
Total JM 930.00 664.00 526.00 700.00 637.00 
Total JM per tetrad 93.00 94.86 75.14 70.00 63.70 
Total NCO 427.00 382.00 409.00 526.00 505.00 
Total NCO per tetrad 42.70 54.57 58.43 52.60 50.50 
Total IH 1357.00 1046.00 935.00 1226.00 1142.00 
Total IH per tetrad 135.70 149.43 133.57 122.60 114.20 
 
  
 
 
 
 
89 
 
 
 
 
 
Figure 2.9. Crossover and noncrossover distribution on chromosomes for wild-type, mlh3-
23, mlh3-32, mlh3-D523N and mlh3Δ .  
A. and C. Scatter plot of average crossover (CO, E2+E3) and noncrossover (NCO, E1) counts 
per chromosome against chromosome size [34]. The equations for the regression lines are:    
wild-type (CO= 5.85 x 10-6 x chr. size + 0.65; NCO= 2.99 x 10-6 x chr. size + 0.28);  
mlh3-23 (CO= 5.6 x 10-6 x chr. size + 0.84; NCO= 4.46 x 10-6 x chr. size - 0.15);  
mlh3-32 (CO= 4.79 x 10-6 x chr. size + 0.45; NCO= 4.51 x 10-6 x chr. size + 0.08);  
mlh3-D523N (CO= 3.8 x 10-6 x chr. size + 0.77; NCO= 3.75 x 10-6 x chr. size + 0.31);  
mlh3Δ (CO= 3.65 x 10-6 x chr. size + 0.69; NCO= 3.94 x 10-6 x chr. size + 0.1).  
B. and D. Bar plot of average crossover and noncrossover counts per chromosome.  The asterisk 
symbol (*) marks chromosomes that have significant difference (two tailed t-test for difference 
in mean; P<0.05) in crossover / noncrossover counts compared to wild-type.  Chromosomes are 
arranged by size from left to right.  Error bars are mean ± standard error. 
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Table 2.12. Gene conversion tract lengths in mlh3Δ , wild-type, mlh3-23, mlh3-32 and mlh3-
D523N mutants.   
 
E1, E2, E4 are classified by groupEvents [34].  P-values show statistical significance of 
difference in median CO and NCO gene conversion tract lengths of wild-type and mlh3 alleles 
compared to mlh3Δ using the Wilcoxon rank sum test (Methods).    
 
  
Strain 
E2 
median 
(kb) P value 
E1 
median 
(kb) P value 
E4 
median 
(kb) P value 
  
mlh3Δ 2.19  1.50  2.28  
  
Wild-type 
1.79 0.005 1.46 0.51 3.01 0.37 
  
mlh3-23 
1.96 0.18 1.42 0.37 2.03 0.69 
  
mlh3-32 
1.84 0.034 1.34 0.045 2.23 0.65 
  
mlh3-D523N 1.96 0.49 1.48 0.43 2.59 0.40   
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mutants appeared similarly functional for MMR, whereas mlh3Δ, mlh3-23, and mlh3-D523N all  
displayed MMR defects (Table 2.4).  These observations encouraged us to test if Mlh1-Mlh3 
MMR functions affected the processing of gene conversion tracts (see below and Discussion).  
 
ii. Genome-wide increase in noncrossovers in mlh3-23, mlh3-32, mlh3-D523N and mlh3Δ  
mutants.  The average numbers of NCOs (E1 events) in mlh3Δ (49), mlh3-23 (51), mlh3-32 
(56), and mlh3-D523N (50) were significantly higher than the wild-type value (41; t-test, p = 
0.01, 0.0067, 0.0012, 0.0044, respectively; Table 2.7; Figure 2.6D; Figure 2.9C).  This was 
unexpected because CO levels were similar to wild-type for mlh3-23 mutants and similar to 
mlh3Δ for mlh3-32 and mlh3-D523N mutants (see Discussion).  Compared to mlh3Δ, the average 
number of NCO events in mlh3-23, mlh3-32, and mlh3-D523N was similar (p = 0.48, 0.080, 
0.70, respectively).   Significant increases in NCOs on chromosomes were observed for mlh3-32 
(X and VII), mlh3-D523N (VIII, X, XIII, VII, XV, IV), mlh3Δ (III, VIII, X, XIV, XIII, XVI, XII, 
VII, XV, IV). No increase in NCOs on specific chromosomes was observed for mlh3-23 (Figure 
2.9B).  
It is possible that some of the increase in NCOs seen in mlh3 mutants was due to the 
presence of discontinuous gene tracts that arose from the same initiating DSB. Such 
discontinuous tracts could have resulted from defective MMR but are not included in the E1 
NCO class above. The E4 class (Figure 2.6B) is a minority discontinuous NCO event that is 
hypothesized to arise from defective MMR or multiple invasion intermediates [34].  As shown in 
Figure 2.6D, none of the E4 events in the mlh3 mutants were significantly different from wild-
type (p=0.33 to 0.80).  This suggests that discontinuous tracts are unlikely to significantly 
contribute to the increased level of NCO events seen in mlh3 mutants. 
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The average NCO (E1) tract lengths were similar to wild-type (1.46 kb) in all of the mlh3 
mutants analyzed (1.34 to 1.50 kb; p = 0.23 to 0.91; Figure 2.8).  The NCO tract length 
distribution suggested an enrichment of short NCO tract lengths (<1 kb) in the mlh3 mutants 
compared to wild-type (Figure 2.7B).  We found this potentially interesting because Oke et al. 
[34] identified such an enrichment in sgs1 mutants; they hypothesized that the short NCO class 
arose from joint molecules or joint molecule-like intermediates that were resolved by the activity 
of structure-selective nucleases (SSNs).  However, both Kolmogorov–Smirnov and Wilcoxon 
Rank-Sum tests indicated that an apparent enrichment of short NCO tract lengths in mlh3 
mutants, compared to wild-type, was not significant.  A similarly weak pattern (an insignificant 
increase in mlh3 mutants compared to wild-type) was seen for the E5A class (Table 2.11, [34]), 
which is thought to represent double COs and is predicted to arise if joint molecule resolution is 
not biased (Class II COs resolved by SSNs; Figure 2.1).   
One explanation for the increase in NCO events seen in mlh3Δ, mlh3-23, mlh3-32 and 
mlh3-D523N mutants is that these mutants experienced meiotic progression delays that resulted 
in the continued accumulation of NCOs, possibly through increased DSB formation. Increases in 
NCO events and a meiotic delay were observed in ndt80 and the ZMM zip1, zip3 and msh5 
mutants as a result of impeding feedback circuits that inhibit DSB formation [27, 30, 49, 71, 
72].  To investigate this possibility, we examined total interhomolog (IH) events, which consists 
of the average of all joint molecule (E2, E3, E5, E6, E7) and NCO (E1, E4) events, and serves as 
a rough estimate of double-strand break levels [34].  As shown in Figure 2.7A and Table 2.11, 
the IH value for wild-type was 135.7 events per tetrad.  None of the mlh3 mutants displayed a 
significantly higher value than wild-type, but mlh3-D523N (122.6 events, p = 0.011) and mlh3Δ 
(114.2 events, p = 0.002) displayed lower values.   
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We also examined meiotic progression in MLH3, mlh3Δ, mlh3-32, mlh3-23 and mlh3-
D523N SK1 strains by measuring the completion of the first meiotic division. This would be 
difficult to do in S288c/YJM789 strains because they do not show the highly synchronous and 
efficient meiotic progression profile seen in SK1. As shown in Figure 2.10, MLH3, mlh3Δ, mlh3-
32, mlh3-23, and mlh3-D523N mutants showed similar kinetics for completion of at least the first 
meiotic division (MI+MII). These data suggest that the increase in NCO events in mlh3Δ, mlh3-
32, mlh3-23, and mlh3-D523N cannot simply be explained by an increase in DSB levels, MMR 
defects, or a meiotic progression delay.  
In summary, the increase in NCO events in mlh3 mutants is consistent with a possible 
role for SSNs and/or the STR complex (see Discussion), and is unlikely to be explainable by an 
increase in DSBs or MMR defects. 
 
Mlh1-mlh3-32 and Mlh1-mlh3-45 display wild-type endonuclease activities but only Mlh1-
mlh3-32 endonuclease is stimulated by Msh2-Msh3.  
We examined Mlh1-mlh3 mutant complexes for endonuclease activity [16, 17], focusing 
on opposite separation of function mutants Mlh1-mlh3-32 (MMR+, CO-), Mlh1-mlh3-6, and 
Mlh1-mlh3-45 (MMR-, CO+). Mlh1-mlh3-45, located in the C-terminal Mlh1 interaction 
domain, was chosen because it is the only separation of function mutant in that domain that 
displayed wild-type Mlh1-Mlh3 interactions as measured in the two-hybrid assay (Figure 2.4C).  
As shown in Figure 2.11 and Figure 2.12, all three mutant complexes purified as heterodimers 
and display endonuclease activities similar to wild-type.  When this work was initiated we 
thought that separation of function mutant complexes might show endonuclease defects  
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Figure 2.10. mlh3 mutants display normal meiotic prophase progression as measured by 
the completion of the first meiotic division.   
Representative time courses showing the completion of the MI division (MI+MII) in wild-type, 
mlh3-23, mlh3-32, mlh3-D523N and mlh3Δ strains. Cells with two, three, or four nuclei were 
counted as having completed MI (MI+MII). All strains for a single time course were grown in 
the same batch of media under identical conditions. Two independent transformants were 
measured per allele.  
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Figure 2.11. Mlh1-mlh3-32 and Mlh1-mlh3-45 display wild-type endonuclease activities 
that are differentially stimulated by Msh2-Msh3.  
A. SDS-PAGE analysis of purified Mlh1-Mlh3, Mlh1-mlh3-32 and Mlh1-mlh3-45.  Coomassie 
Blue R250-stained 8% Tris-glycine gel.  0.5 µg of each protein is shown. MW = Molecular 
Weight Standards from top to bottom- 200, 116, 97, 66, 45 kD).  B, C. Mlh1-Mlh3, Mlh1-mlh3-
32 and Mlh1-mlh3-45 (18, 37, 70 nM) were incubated with 2.2 nM supercoiled pBR322 DNA, 
and analyzed in agarose gel electrophoresis (C) and the endonuclease activity was quantified 
(average of 6 independent experiments presented +/-SD) as described in the Methods.  Ladder: 1 
kb DNA ladder (New England BioLabs). Migration of closed circular (cc), nicked (nc) and linear 
(l) pBR322 DNA is indicated. D. Endonuclease assays were performed as in B., but contained 20 
nM of the indicated wild-type or mutant Mlh1-Mlh3 complex and 40 nM Msh2-Msh3 when 
indicated.  Reactions were performed in triplicate, samples were resolved on agarose gels, and 
the fraction of nicked DNA was quantified, averaged, and the standard deviation between 
experiments was calculated. The average fraction of supercoiled substrate cleaved is presented 
+/-S.D. below the gel. (bkg) background, (cc) closed circular DNA, (nc) nicked DNA.   
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Figure 2.12. Mlh1-mlh3-6 exhibits wild-type endonuclease and ATPase activity.   
A. SDS-PAGE analysis of purified Mlh1-Mlh3 and Mlh1-mlh3-6.  Coomassie Blue R250-
stained 8% Tris-glycine gel.  0.5 µg of each protein is shown. MW = Molecular Weight 
Standards from top to bottom-116, 97, 66, 45, 31 kD).  B, C. Mlh1-Mlh3 and Mlh1-mlh3-6 (18, 
37, 70 nM) were incubated with 2.2 nM supercoiled pBR322 DNA, analyzed in agarose gel 
electrophoresis, and endonuclease activity was quantified (average of 6 independent experiments 
presented +/-SD) as described in the Methods. C. ATPase assays were performed as described in 
Rogacheva et al. [16], but contained the indicated amounts of Mlh1-Mlh3 and Mlh1-mlh3-6 
incubated with 100 µM 32P-g-ATP.  Reactions were performed in duplicate for two separate 
purifications of each, and the average values, +/-SD, are presented.  
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indicating that this activity is more critical for MMR or crossing over, or show no endonuclease 
defects because mutant complexes were defective in interacting with MMR or CO specific 
factors. Our finding that all three mutants have enzymatic activity comparable to wild-type is 
consistent with the interaction defect model (see below).  The mlh3-6 mutation maps close to 
conserved sites in the ATP binding motif (Figure 2.3).  We then tested whether the mutant 
complex displayed a defect in ATPase activity.  As shown in Figure 2.12C, Mlh1-Mlh3 and 
Mlh1-mlh3-6 displayed similar ATPase activities. 
 Because Mlh1-Mlh3’s endonuclease activity is enhanced by Msh2-Msh3 [16], we tested 
whether the opposite separation of function phenotypes of Mlh1-mlh3-32 and Mlh1-mlh3-45 
could be explained by defective interactions with MSH complexes. As shown in Figure 2.11D, 
Mlh1-mlh3-32 endonuclease activity but not Mlh1-mlh3-45 could be stimulated by Msh2-Msh3. 
These data are consistent with the MMR-, CO+ phenotype exhibited by mlh3-45 mutants 
resulting from a defect in interacting with the MMR component Msh2-Msh3, and the mlh3-32 
mutant likely being defective in interactions with meiosis-specific factors. In a first step to test if 
mlh3-32 mutants are defective in interactions with meiotic CO factors, we determined if the 
mlh3-32 mutation is dominant; such a phenotype could provide hints on the nature of the mlh3-
32 meiotic defect.  We mated EAY3552 (mlh3-32, CEN8Tomato::LEU2) to EAY3339 (relevant 
genotype MLH3, THR1::m-Cerulean-TRP1; Table 2.1; Table 2.2), and the sporulated progeny 
displayed a tetratype frequency similar to wild-type (40.9%, n = 252 tetrads), indicating that 
mlh3-32 is recessive. 
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Sgs1 but not sgs1-hd overexpression differentially affects spore viability in mlh3Δ vs. mlh3-
32. 
As presented in Figure 2.1, the STR complex can act as both a negative and positive 
regulator of CO formation in meiotic prophase [8, 30, 31, 46, 49]. In its role as a negative 
regulator, STR is thought to prevent the formation of aberrant recombination structures by 
disassembling branched recombination intermediates to form early NCOs via synthesis 
dependent strand annealing (SDSA), or by re-forming the DSB intermediate.  In its role as a pro-
CO factor STR promotes stabilization of ZMM complexes on recombination intermediates, 
leading to the resolution of dHJs by an interference-dependent CO pathway (class I) that requires 
the Mlh1-Mlh3 endonuclease. In sgs1Δ mutants COs have been shown to be ZMM independent 
[73]. Strand invasion intermediates that escape STR disassembly are thought to be resolved as 
COs or NCOs using an alternative interference-independent CO pathway (class II) that involves 
the SSNs Mus81-Mms4, Yen1, and Slx1-Slx4.  
The increase in NCO events seen in mlh3 mutants is suggestive of their formation 
through SSN or STR activities.  To test for genetic interactions between SGS1 and MLH3, we 
expressed SGS1 via its native promoter on a 2µ multi-copy vector.  Sgs1 overexpression 
enhanced the mlh3Δ spore viability defect (Figure 2.13: 76% in mlh3Δ+2µ vs. 69% in 
mlh3Δ+SGS1-2µ; p<0.05, χ2 test) and conferred a more apparent MI nondisjunction pattern (an 
excess of 4, 2, 0 viable spore tetrads compared with 3 and 1 viable tetrads ([6]; Figure 2.13). In 
contrast, Sgs1 overexpression modestly suppressed the mlh3-32 spore viability defect (Figure 
2.13: 76% in mlh3-32+2µ vs. 84% in mlh3-32+SGS1-2µ; p<0.05, χ2 test).  Suppression or 
enhancement of phenotypes was not observed upon overexpression of the sgs1-K706A helicase 
defective mutant protein (sgs1-hd), indicating that these effects were dependent on Sgs1 helicase 
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Figure 2.13. Sgs1 but not sgs1-hd overexpression differentially affects spore viability in 
mlh3Δ vs. mlh3-32.   
Distribution of viable spores in tetrads of MLH3, mlh3Δ, mlh3-23, mlh3-32, and mlh3-D523N 
strains containing no insert (2µ), pSGS1-2µ, or psgs1-hd-2µ (helicase defective mutant). In all 
plots, the horizontal axis corresponds to the classes of tetrads with 4, 3, 2, 1 and 0 viable spores, 
and the vertical axis corresponds to the frequency of each class given in percentage.  The overall 
spore viability (SV) and the total number of spores counted (n) are shown. *p<0.05 ( χ2 test), 
comparing spore viability for the indicated strain transformed with a 2µ SGS1 plasmid to that of 
the same strain transformed with a 2µ no insert plasmid. 
  
 
 
 
 
100 
activity (Figure 2.13: 80% in mlh3Δ+sgs1-hd-2µ and 78% in mlh3-32+sgs1-hd-2µ). In addition, 
no effect was seen upon overexpression of Sgs1 or sgs1-hd in MLH3 (Figure 2.13: 96% in 
MLH3+2µ vs. 95% in MLH3+SGS1-2µ and 96% in MLH3+sgs1-hd-2µ), mlh3-23 (86% in mlh3-
23+2µ vs. 90% in mlh3-23+SGS1-2µ and 87% in mlh3-23+sgs1-hd-2µ) and mlh3-D523N (82% 
in mlh3-D523N+2µ vs. 79% in mlh3-D523N+SGS1-2µ, and 79% in mlh3-D523N+sgs1-hd-2µ) 
strains.  Although mlh3-32 and mlh3-D523N both confer null-like meiotic defects, they did not 
confer phenotypes similar to mlh3Δ in response to Sgs1 overexpression. This observation 
suggests potential roles for Mlh1-Mlh3 that are independent of its enzymatic activity.  
 
Discussion  
We performed a structure-function analysis of Mlh3, a factor that acts in both MMR and 
meiotic crossing over. This work was pursued because little is known about how Mlh1-Mlh3 acts 
as a meiotic endonuclease.  This is due in part to Mlh1-Mlh3 sharing little in common with the 
well-characterized structure-selective endonucleases (SSNs; Mus81-Mms4, Slx1-Slx4, and 
Yen1) in terms of homology and intrinsic behavior in vitro (reviewed in [50]).  Obtaining new 
mechanistic insights has been complicated by the fact that Mlh1-Mlh3 can bind to model HJ 
substrates, but cannot cleave them, and by genetic studies suggesting that Mlh1-Mlh3 acts in 
concert with other pro-CO factors [16, 17, 50, 74]. Recent work has suggested that multiple 
Mlh1-Mlh3 heterodimers are required to activate the endonuclease and that the complex is at 
least partially inhibited by incorporation of a DNA secondary structure that is not part of a 
continuous homoduplex substrate [74].  These data suggest that other protein factors likely 
recruit and position Mlh1-Mlh3 complexes during meiotic recombination. The identities of these 
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factors are for the most part known, though it is not understood how they directly contribute to 
Mlh1-Mlh3’s ability to nick DNA in the directed manner required to generate COs.  
Our analysis of mlh3-32 (MMR+, CO-) and mlh3-45 (MMR-, CO+), support the above 
hypothesis that protein-protein interactions are critical for directing Mlh1-Mlh3 endonuclease 
activity (Table 2.6; Figure 2.11). Mlh1-Mlh3 has been shown genetically to act downstream of 
Msh4-Msh5 [40, 41, 44, 47]; this order of events is analogous to steps in DNA MMR where 
MLH acts following MSH recognition [14, 75]. As outlined in the introduction, Msh4-Msh5, 
STR, Exo1 (independent of its enzymatic activity) and Zip3 have been classified as pro-CO 
factors, and have all been shown to interact with one another and/or with Mlh1-Mlh3 (reviewed 
in [50]). Our biochemical studies are consistent with Mlh1-mlh3-45 having interaction defects 
that prevent its endonuclease activity from being stimulated by Msh2-Msh3 in MMR.  We 
hypothesize that MLH complexes interact with MSH complexes via a common mechanism, and 
that defective interactions with Msh2-Msh3 are also indicative of defective interactions with 
Msh4-Msh5, but during meiotic CO resolution, additional factors act in concert to strengthen a 
possibly weakened Msh4-Msh5-Mlh1-mlh3-45 interaction. This model also helps explain why 
we identified several MMR- CO+ mlh3 mutants (mlh3-42 and -54) in which the mutant mlh3 
protein fails to interact with Mlh1.  For the Mlh1-mlh3-32 complex, the MSH interaction and 
enhancement is retained, but interaction with other critical meiotic factors is likely lost, possibly 
resulting in an unstable complex that cannot resolve dHJs.  
 
Mlh1-Mlh3 in DNA mismatch repair 
In MMR the asymmetric loading of PCNA by the RFC complex is thought to direct the 
endonuclease activity of MutLa (Mlh1-Pms1 in S. cerevisiae, MLH1-PMS2 in humans) to act in 
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strand-specific repair [76]. Additional studies suggest that specific protein-protein interactions 
influence and activate MLH endonuclease activity, and direct nicking to a specific location.  For 
example, in vitro studies performed with yeast proteins showed that RFC-loaded PCNA can 
activate Mlh1-Pms1 but not Mlh1-Mlh3 endonuclease on circular plasmids (Mlh3 lacks a PCNA 
binding motif present in Pms1; [15-17; 74]. Our finding that endonuclease active site residues 
are highly conserved between Mlh1-Mlh3 and Mlh1-Pms1, which has no role in meiotic crossing 
over, suggests that the different functions of the two complexes are a result of the different 
protein-protein interactions.  
Data from the Crouse lab suggest that Mlh1-Mlh3 acts in conjunction with Mlh1-Pms1 in 
Msh2-Msh3 dependent MMR [4]. This observation helps address how Mlh1-Mlh3 is involved in 
MMR in the absence of a PCNA interaction.  In one scenario consistent with the above, Mlh1-
Mlh3 is recruited and activated by Msh2-Msh3, and also forms a complex with Mlh1-Pms1, 
which can be directed by PCNA to promote efficient repair.  If dimerization between Mlh3 and 
Mlh1 is weakened, the ability to be recruited by Msh2-Msh3 and interact with Mlh1-Pms1 is 
likely inhibited, creating a defect in MMR that is minor because Mlh1-Pms1 is still active.  For 
meiotic crossing over, a relatively slow process compared to MMR at the replication fork, we 
suggest that a weakened dimer can be compensated for by interactions with other meiotic factors 
(e.g. Msh4-Msh5, Exo1 and STR).  Thus, our work provides further motivation to examine 
Mlh1-Mlh3 activity on recombination substrates in the presence of pro-CO factors. 
 
Mlh1-Mlh3 in meiotic recombination 
Current models for meiotic DSB repair postulate an enzymatic role for Mlh1-Mlh3 in the 
class I CO pathway after DSB intermediates have been captured and stabilized by the ZMM 
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proteins [8, 30, 49]. In these models DSB intermediates that escape capture by ZMM proteins are 
resolved into class II COs or NCOs by SSNs, though NCOs mostly arise from the action of the 
STR complex through synthesis dependent strand annealing (SDSA; [30, 49]; Figure 2.1).  
We observed a genome-wide increase in NCOs compared to wild-type in mlh3-23, mlh3-
32, mlh3-D523N, and mlh3Δ mutants. This suggested to us that in mutants defective in Mlh1-
Mlh3 functions, dHJs formed in the ZMM pathway become susceptible to the actions of SSNs to 
form COs and NCOs. They could also be acted upon by STR through unwinding and convergent 
migration of the two HJs until a single pair of crossing strands in a hemicatenane can be removed 
by topoisomerase activity, giving rise to NCOs [30,31].  In this model Mlh1-Mlh3, in concert 
with the ZMM proteins, acts to protect recombination intermediates from STR. In support of this 
idea, we identified genetic interactions between Mlh1-Mlh3 and Sgs1 that suggest an active 
interplay (Mlh1 and Mlh3 both interact with Sgs1 [42,77]) between these factors: Sgs1 
overexpression decreased the spore viability of mlh3Δ strains but not MLH3, mlh3-23, or mlh3-
D523N strains, where a structurally intact Mlh1-Mlh3 complex is thought to be present, and 
modestly increased the spore viability of mlh3-32 mutants (Figure 2.13).  
We also observed an increase in tract length for gene conversion events associated with 
COs in mlh3Δ compared to wild-type (Figure 2.8; Table 2.11; Table 2.12). The latter observation 
is interesting because recent work from Duroc et al. [78] provided evidence that another MLH 
complex, Mlh1-Mlh2, which lacks endonuclease activity, acts to limit the extent of meiotic gene 
conversion.  They found that gene conversion tract lengths associated or not associated with COs 
increased from ~1 kb in wild-type to ~2 kb in mlh2Δ.  Thus, regulating gene conversion tracts 
may be a common property of the MLH complexes that act in meiotic recombination, and is 
consistent with the fact that Mlh1 has been shown to physically interact with helicases that can 
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modulate heteroduplex extension/migration.  
An alternative explanation for the increase in NCO events in mlh3 mutants is that delays 
in meiotic progression result in the accumulation of NCO events as the result of increased DSB 
formation [72].  However, we did not observe such delays in any of the mlh3 mutant 
backgrounds or any dramatic change in DSB formation based on an analysis of total 
interhomolog events in mlh3 mutants, though a direct measure of DSB levels is critical to resolve 
this issue (Figure 2.7A; Figure 2.10; Table 2.11; [69]).  
 
Mlh3’s linker arm is critical for its meiotic function. 
MLH proteins act as dimers and contain long unstructured linkers that connect the N- and 
C-terminal domains of each subunit. These linkers vary in length and are resistant to amino acid 
substitutions [54]. Previous work showed that the Mlh1-Pms1 heterodimer undergoes large 
global conformational changes in an ATP binding and hydrolysis cycle [79]. In this cycle the 
linkers act as arms that can switch between extended and condensed states. These conformational 
changes are hypothesized to be important to expose different domains of the heterodimer for new 
protein-protein or protein-DNA interactions in addition to mediating the timing of these 
interactions [79], and have also been implicated in B. subtilis MutL for “licensing” its latent 
endonuclease activity [60]. In addition, a series of truncation mutants in Mlh1-Pms1 indicate that 
the Pms1 linker arm appears more important than the Mlh1 linker arm for DNA binding [80]. 
Extending these ideas to Mlh1-Mlh3, it is interesting to note that the MMR+,CO- mlh3-32 allele 
maps to the unstructured linker, suggesting that this domain is particularly important in crossing 
over (Figure 2.3; Table 2.4), possibly facilitating interactions with CO promoting factors that in 
turn direct and position Mlh3’s endonuclease activity on recombination substrates.  It is 
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important to note that Claeys Bouuaert and Keeney [81] identified mutations in the Mlh3 linker 
domain based on a biochemical analysis of Mlh1-Mlh3 that overlap with residues mutated in the 
mlh3-32 allele.  Interestingly, the mutations that they identified also conferred a greater defect in 
crossing over than in MMR, consistent with our analysis of mlh3-32.  In addition, they found that 
mutations within and near the mlh3-32 allele compromised DNA binding activity of Mlh1-Mlh3, 
suggesting that DNA binding within the linker region may be important for meiotic functions, 
though we did not detect any apparent defect in the endonuclease activity of Mlh1-mlh3-32.    
Alanine-scan mutagenesis of Mlh1 [54] and Mlh3 have provided us with additional 
information regarding the unstructured linkers in Mlh proteins.  Previously we used protein 
structure prediction and molecular analyses to map the Mlh1 unstructured linker to amino acids 
336 to 480 [80]; a similar analysis mapped the Mlh3 unstructured linker to amino acids 373 to 
490 [16].  As in the analysis of the Mlh3 random coil, few mutations were identified in the Mlh1 
unstructured linker that conferred defects in MMR and crossing over.  For example, in Mlh1, no 
mutations were identified between amino acids 427 and 490 that conferred mutator phenotypes. 
However, similar to results seen for Mlh3 (Figure 2.3; Table 2.4), mutations were identified just 
before the unstructured linker in Mlh1 (253-312) that conferred strong mutator phenotypes [54].  
Curiously, the corresponding region in MutL contains residues that have been linked through 
crystallographic analysis to DNA binding [82], suggesting that the organization of the DNA 
binding and unstructured linker domains in the MLH proteins is conserved.  Finally, in both 
Mlh1 and Mlh3, a localized set of mutations within the center of the unstructured linker (390-403 
in Mlh1, 414-416 in Mlh3) affect function, suggesting that this specific region is likely to play an 
important function beyond serving as a random coil.   
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Closing thoughts.  
Mlh1-Mlh3 appears to be acting in CO resolution through a novel mechanism distinct 
from that of known structure-selective endonucleases [75]. Mlh1-Mlh3 does not share 
conservation with the known endonuclease superfamilies (XPF, URI-YIG, Rad2/XPG), and does 
not appear capable of resolving model HJ substrates [50, 74].  As mentioned previously, dHJ 
resolution by Mlh1-Mlh3 results in only CO products whereas the interference-independent CO 
pathway, which is dependent on Mus81-Mms4, resolves dHJs into a mixture of CO and NCO 
products [8].  Thus, Mlh1-Mlh3’s distinct activity suggests that its nicking is positioned by pro-
CO factors such as Msh4-Msh5, Zip3, the STR complex, and Exo1. Such factors are likely to 
orient Mlh1-Mlh3 to promote asymmetric cleavage of dHJs in a highly regulated and 
coordinated manner. Thus our work provides further motivation to examine Mlh1-Mlh3 activity 
on recombination substrates in the presence of pro-CO factors. 
Polymorphisms in human MLH3 genes have been associated with male and female 
infertility [83-85], and errors in meiotic chromosome segregation are considered a leading cause 
of spontaneous miscarriages and birth defects [13]. It is interesting to note that the mlh3-23 
mutation, which only weakly affected crossing over, conferred an alteration in meiotic 
recombination outcomes that was similar to that seen in mlh3 mutants that conferred more severe 
defects (Figure 2.6).  This observation suggests that some polymorphisms in meiotic 
recombination genes could cause more severe defects on human fertility than expected.  
 
Methods 
Media.  
S. cerevisiae SK1, S288c, and YJM789 strains were grown on either yeast extract-peptone-
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dextrose (YPD) or minimal complete media at 30°C [86]. For selection purposes, minimal 
dropout media lacking uracil was used when needed. Geneticin (Invitrogen, San Diego),  
Nourseothricin (Werner BioAgents, Germany) and Hygromycin (HiMedia) were added to media 
when required at recommended concentrations [87, 88]. Cells were sporulated as described by 
Argueso et al. [7].  
 
Site-directed mutagenesis of MLH3.  
60 mlh3 alleles were constructed, resulting in the mutagenesis of 139 amino acids in the 715 
amino acid Mlh3 polypeptide (Table 2.1). The single-step integration vector (pEAI254), 
containing the SK1 MLH3 gene with a KANMX4 selectable marker inserted 40 bp downstream of 
the stop codon [5], was used as a template to create plasmids (Table 2.3) bearing the mlh3 
mutant alleles via QuickChange site directed mutagenesis (Stratagene, La Jolla, CA).  mlh3-60, 
in which the last 11 residues of Pms1 (DWSSFSKDYEI) were inserted before the MLH3 stop 
codon, was also made by QuickChange. Mutations were confirmed by sequencing the entire 
open reading frame (Sanger method), as well as 70 bp upstream and 150 bp downstream. Primer 
sequences used to make and sequence these variants are available upon request.  
 
Mlh3 homology model.  
The amino acid sequence of S. cerevisiae Mlh3 (YJM789) was used to construct a homology 
model from HHpred (http://toolkit.tuebingen.mpg.de/hhpred) and Modeller software. PyMOL 
was used for imaging.  
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Construction of strains to measure meiotic crossing over and MMR. 
The SK1 strain EAY3255 (Table 2.1) was constructed to allow for the simultaneous analysis of 
mlh3 MMR and meiotic crossing over phenotypes.  It carries a spore autonomous fluorescent 
protein marker (RFP) on chromosome VIII to monitor chromosome behavior (crossing over and 
nondisjunction; [56]) as well as the lys2::InsE-A14 cassette to measure reversion to Lys+ [55]. 
pEAI254 and mutant derivatives described above and in Table 2.3 were digested with BamHI 
and SalI and introduced into EAY3255 by gene replacement using the lithium acetate 
transformation method as described in Gietz et al. [89]. At least two independent transformants 
for each genotype (verified by sequencing) were made resulting in a total of 120 haploid strains 
bearing the mlh3 variants described in this study (Table 2.1). These haploid strains were used to 
measure the effect of mlh3 mutations on reversion rate and were mated to EAY3486, an mlh3Δ 
strain containing the CFP marker, resulting in diploid strains suitable for analysis of crossing 
over (Table 2.2). Diploids were selected on media lacking the appropriate nutrients and 
maintained as stable strains. Meiosis was induced upon growing the diploid strains on 
sporulation media as described in Argueso et al. [7]. Wild-type strains carrying the fluorescent 
protein markers used to make the above test strains were a gift from the Keeney lab.  
 
Lys+ reversion assays.  
The haploid strains described above were analyzed for reversion to Lys+ as described in Tran et 
al. [55]. At least 10 independent cultures were analyzed for each mutant allele alongside wild-
type or mlh3Δ controls. Analyses were performed for two independent transformants per allele. 
Reversion rates were measured as described [90, 91], and each median rate was normalized to 
the wild-type median rate (1X) to calculate fold increase. Alleles were classified into a wild-type, 
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intermediate, or null phenotype based on the 95% confidence intervals which were determined as 
described [92]. 
 
Spore autonomous fluorescent protein expression to measure percent tetratype.  
Diploids in the EAY3255/EAY3486 background described above (Table 2.2) were sporulated on 
media described in Argueso et al. [7]. Spores were treated with 0.5% NP40 and briefly sonicated 
before analysis using the Zeiss AxioImager.M2 [56]. At least 250 tetrads for each mlh3 allele 
were counted to determine the % tetratype. Two independent transformants were measured per 
allele. A statistically significant difference (p<0.01) from wild-type and mlh3Δ controls based on 
χ2 analysis was used to classify each allele as exhibiting a wild-type, intermediate, or null 
phenotype. 
 
Meiotic time courses. 
Meiotic time course were performed as described in Sonntag Brown et al. [93] for the diploid 
strains EAY3252/EAY3486 (MLH3), EAY3255/EAY3486 (mlh3Δ), EAY3534-35/EAY3486 
(mlh3-23), EAY3552-53/EAY3486 (mlh3-32), and EAY3819-20/EAY3486 (mlh3-D523N; Table 
2.2). Strains in single time courses were grown in the same batch of media under identical 
conditions.  Aliquots of cells at specific time points were stained with DAPI to determine the 
percentage of cell that completed the first meiotic division (cells in which 2, 3, or 4 nuclei were 
observed by DAPI staining, presented as MI+MII).  Cells were visualized using a Zeiss Axio 
Imager M2 microscope equipped with a DAPI filter.  At least 150 cells were counted for each 
time point. Two independent transformants were analyzed per allele. 
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Yeast two-hybrid analysis.  
The L40 strain [94] was co-transformed with bait and target vectors. Residues 481-715 of the 
Mlh3 C-terminus were PCR amplified from pEAI254 (SK1 MLH3 described above) and mutant 
derivatives, and then sub-cloned into the target vector pEAM98 (S288C MLH3) to make 
pEAM234 (SK1 MLH3) and mutant derivatives (Table 2.3). pEAM98 contains a fusion between 
the GAL4 activation domain in pGAD10 and residues 481-715 of the Mlh3 C-terminus [5, 36]. 
The resulting SK1 derived target vectors were confirmed by sequencing (Sanger method). The 
bait vector used was pEAM105 (pBTM-MLH1-SK1). Expression of the LACZ reporter gene was 
determined by the ortho-nitrophenyl-β-D-galactopyranoside (ONPG) assay as described in [95].   
 
Purification of Mlh1-Mlh3 and mutant complexes from baculovirus- infected Sf9 cells.  
Mlh1-Mlh3 and Mlh1-mlh3 mutant derivatives were purified from Sf9 cells infected with Bac-
to-Bac baculovirus expression system using pFastBacDual constructs [16]. Mutant Mlh1-mlh3 
complexes were purified using the same protocol developed to purify wild-type Mlh1-Mlh3.  
This involved the use of successive nickel-nitroloacetic acid-agarose (Qiagen) and heparin 
sepharose (GE Healthcare) column purifications.  Mlh1-Mlh3 and mutant derivative yields were 
~150 µg per 5 x 108 cells; aliquots from the final heparin purification were frozen in liquid 
N2 and stored at -80°C. Protein concentrations were determined by Bradford assay [96] using 
BSA standard.  The mlh3-6, mlh3-32 and mlh3-45 mutations were introduced into pEAE358 
(pPH-His10-MLH3-HA pFastBacDual construct; Rogacheva et al. [16]) by Quick Change 
(Stratagene).  His10-mlh3-HA fragments were individually subcloned by restriction digestion into 
pEAE348 to form pFastBacDual constructs pEAE382 (Mlh1-mlh3-6), pEAE383 (Mlh1-mlh3-
32) and pEAE384 (Mlh1-mlh3-45), in which the MLH1-FLAG gene is downstream of the p10 
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promoter and the His10 -mlh3-HA gene is downstream of the pPH promoter.  The sequence of the 
restriction fragments inserted into pEAE348 were confirmed by DNA sequencing (Cornell 
Biotechnology Resource Center).  Msh2-Msh3 was purified as described previously [97].   
 
Endonuclease assay on supercoiled plasmid DNA and ATPase assay.   
Mlh1-Mlh3 nicking activity was assayed on supercoiled pBR322 or pUC18 (Thermo Scientific). 
DNA (2.2 nM) was incubated in 20 µl reactions containing indicated amounts of Mlh1-Mlh3 and 
Msh2-Msh3 [97] in 20 mM HEPES-KOH pH 7.5, 20 mM KCl, 0.2 mg/ml BSA, 1% glycerol, 
and 1 mM MgCl2 for 1 h at 37°C. Reactions were quenched by incubation for 20 min at 37°C 
with 0.1% SDS, 14 mM EDTA, and 0.1 mg/ml proteinase K (New England Biolabs) (final 
concentrations). Samples were resolved by 1% agarose gel with 0.1 µg/ml ethidium bromide run 
in 1X TAE buffer for 50 min at 95 V.  All quantifications were performed using GelEval 
(FrogDance Software, v1.37).  The amount of nicked product was quantified as a fraction of the 
total starting substrate in independent experiments.  bkg indicates that amount of nicked product 
was not above background levels established by negative controls.  ATPase assays were 
performed as described [16].   
 
Genetic map distance analysis.  
Diploids from the SK1 congenic strain background EAY1112/1108 [5-7] were used for genetic 
map distance analyses. EAY1112/2413 (MLH3/mlh3Δ::NATMX) and EAY1848/2413 
(mlh3Δ::KANMX/mlh3Δ::NATMX) were used as wild-type and null controls respectively (Table 
2.2). mlh3 alleles of interest were integrated into EAY3712 (same as EAY1112 but 
mlh3Δ::URA3) using standard techniques [89]. The resulting haploid strains (EAY3713-
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EAY3724) were mated to EAY2413 (mlh3Δ::NATMX) giving rise to diploids carrying markers 
suitable for genetic distance measurements (Table 2.2). Two independent transformants were 
analyzed per allele. Diploids were selected on media lacking the appropriate nutrients and 
maintained as stable strains. Diploids were sporulated as described [7]. Tetrads were dissected on 
synthetic complete media and germinated at 30°C after an incubation of 2-3 days. Spore clones 
were then replica-plated on various selective media to be scored after 1 day of incubation at 
30°C. Chromosome behavior was analyzed using the recombination analysis software RANA to 
measure genetic map distances and spore viabilities [7]. Genetic map distances ± SE were 
calculated using the formula of Perkins [98] through the Stahl Laboratory Online Tools portal 
(http://molbio.uoregon.edu/~fstahl/).  
 
Construction of strains for whole genome sequencing.  
Whole genome sequencing was performed using S288c/YJM789 hybrid diploids. The Mlh1 
protein sequence has four amino acid differences between SK1 and YJM789 strains and five 
amino acid differences between SK1 and S288c strains.  The SK1 Mlh3 protein has 11 amino 
acid differences with respect to S288c Mlh3 and seven with respect to YJM789 Mlh3. To avoid 
genetic incompatibilities between Mlh1 and Mlh3, we analyzed the SK1 mlh3 mutations, 
including the wild-type and mlh3Δ controls in the presence of SK1 MLH1 in the S288c/YJM789 
hybrid.  Strain genotypes are shown in Table 2.1 and Table 2.2. SK1-MLH1 and MLH3 alleles 
were introduced into wild-type YJM789 and S288c mlh3Δ::natMX4, respectively, using 
plasmids pEAA214 and pEAI254. The SK1 MLH1 specific SNPs were confirmed by Sanger 
sequencing.  The mlh3-23::kanMX4, mlh3-32::kanMX4, and mlh3-D523N::kanMX4 mutations 
were introduced using plasmids pEAI347, pEAI356, and pEAI252, respectively into the S288c 
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mlh3Δ::natMX4 background.  The S288c mlh1Δ::hphMX4 and YJM789 mlh3Δ::kanMX4 strains 
were made using an mlh1Δ::hphMX4 construct amplified by PCR and the mlh3Δ::kanMX4 
deletion construct pEAI168, respectively.  
 
Genome wide mapping of meiotic recombination events in the S288c/YJM789 hybrid. 
Genomic DNA was extracted from spore colonies of four viable spore tetrads of the mlh3 point 
mutants, isogenic wild type, and isogenic mlh3∆ mutants as described previously [64].  Whole 
genome sequencing on the Illumina Hi-Seq 2500 platform was performed at Fasteris, 
Switzerland.  Raw sequence reads were processed and SNPs genotyped as described in 
Krishnaprasad et al. [64] and Chakraborty et al. [70], with 4:0 marker segregations shared 
between tetrads removed from the analysis.  Analysis of genome wide recombination events was 
performed as described in Oke et al. [34] (Tables 2.8 to 2.12).  Custom R scripts were used to 
generate the segregation file (input file for the CrossOver program (v6.3) of the ReCombine [99] 
program suite (v2.1)). The output of the CrossOver program was used as input for groupEvents 
(v15).  Median crossover associated tract lengths were calculated from E2 events with non-zero 
tracts [34].  For all count data, the t-test was used to examine the difference in the mean between 
samples.  For tract lengths, the Wilcoxon Rank-Sum test was used to test the difference in the 
median between samples. 
The segregation files, CrossOver program output files, groupEvents output files and the custom 
R scripts are available online at the Dryad digital repository 
(http://dx.doi.org/10.5061/dryad.bb702).  Sequence data are available from the National Centre 
for Biotechnology Information Sequence Read Archive (Accession numbers SRP096621 and 
SRP110341). 
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Overexpression of Sgs1 and sgs1-hd.  
SGS1 (native promoter, ORF, and termination sequence) was PCR amplified from SK1 genomic 
DNA obtained from NKY730 (MATa/alpha, ura3Δ::hisG/ura3Δ::hisG, leu2::hisG/leu2::hisG, 
lys2/lys2) and cloned into the high copy vector pRS426 (2µ, ampR, URA3) to make pEAM266 
(Table 2.3). The correct DNA sequence was confirmed by Sanger sequencing the entire insert. 
sgs1-K706A the helicase defective variant of SGS1 (sgs1-hd) was made by site-directed 
mutagenesis of pEAM266 (New England BioLabs Q5 kit). The correct sgs1-hd, 2µ, and URA3 
sequences were confirmed by Sanger sequencing.  Primer sequences used to make these 
constructs are available upon request. The high copy vector (with or without the SGS1 or sgs1-hd 
insert) was transformed into stable diploids of EAY3534-35/EAY3468 (mlh3-23/mlh3Δ), 
EAY3552-53/EAY3486 (mlh3-32/mlh3Δ), EAY3819-20/EAY3486 (mlh3-D523N/mlh3Δ), 
EAY3252/EAY3486 (MLH3/mlh3Δ), and EAY3255/EAY3486 (mlh3Δ/mlh3Δ) (Table 2.2). 
Meiosis was induced as described in Argueso et al. [7] and vector selection was maintained by 
growing the diploid strains on minimal media lacking uracil prior to sporulation.  In addition, 
sporulation media lacked uracil. For spore viability measurements, tetrads were dissected on 
synthetic complete media and germinated at 30°C after an incubation of 2-3 days. At least two 
independent transformants were analyzed per high copy vector. Differences in spore viability 
were assessed for significance using the χ2 test.  
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CHAPTER 3 
Future Directions 
 
Working model of Mlh1-Mlh3 function 
Mlh1-Mlh3 is a minor mismatch repair endonuclease with (MMR) and major role in 
meiotic recombination. Yet the mechanism by which one endonuclease contributes minimally to 
MMR and centrally to crossing over is not well understood. Mlh1-Mlh3 shares little in common 
with the well-characterized structure-selective nucleases (SSNs; Mus81-Mms4, Slx1-Slx4, and 
Yen1) in terms of homology or intrinsic behavior in vitro (reviewed in [1]).  For example, the 
SSNs have been shown to bind and cleave branched DNA structures such as a single Holliday 
junction (HJ) in vitro. Whereas, Mlh1-Mlh3 can bind such branched substrates, but has not been 
shown to cleave them [2], [3]. Furthermore, resolution of double Holliday Junctions (dHJs) by 
SSNs results in a mixture of crossover (CO) and noncrossover (NCO) products, while Mlh1-
Mlh3 gives rise to CO products exclusively. Thus, Mlh1-Mlh3 appears to be acting in a novel 
mechanism that does not conform to models set by previously characterized dHJ resolvases [3].  
Interestingly, recent work in our lab suggests that multiple Mlh1-Mlh3 heterodimers are 
required to activate the endonuclease activity and that the complex is at least partially inhibited 
by incorporation of a DNA secondary structure that is not part of a continuous homoduplex DNA 
substrate [3]. Taken together, these data point towards a model in which Mlh1-Mlh3 is loaded 
onto DNA to form an activated polymer that, positioned and directed by other recombination 
proteins, cleaves recombination intermediates to form COs. This behavior is consistent with 
activities seen for the MMR endonuclease Mlh1-Pms1. In addition, the endonuclease activity of 
human MLH1-PMS2 (Mlh1-Pms1 in yeast) is strand specifically activated by PCNA [4], which 
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suggests that protein factors could dictate Mlh1-Mlh3 specificity in a similar manner. It is 
tempting to speculate that such MLH conserved properties are utilized by Mlh1-Mlh3 in meiosis 
to resolve dHJs into COs. The multifaceted assembly of the dHJ involves distinct meiotic factors 
that create and stabilize sequential joint molecule intermediates resulting in formation of the final 
dHJ substrate. This is in support of the working model that Mlh1-Mlh3 likely relies on other 
protein factors, such as Msh4-Msh5 (and other ZMM proteins), for recruitment, positioning, and 
coordination of its endonuclease activity.  
In Chapter 1, I summarized data that outlines the two different functions of Mlh1-Mlh3. 
In addition, I discussed models, which are not mutually exclusive, that can explain how Mlh1-
Mlh3 is regulated to preform its dual role. In Chapter 2, I presented studies, performed by myself 
in collaboration with others, that support the model described above in which protein-protein 
interactions with MMR or CO specific protein factors are key to Mlh1-Mlh3 activity. This work 
was based on a structure-function map of Mlh3 that I built from the analysis of 60 new mlh3 
alleles in MMR and crossing over (Chapter 2, Figures 2.2 and 2.3; Table 2.4). From this map, I 
identified six separations of function mutants, five of these alleles specifically disrupted the 
MMR function of Mlh3 (MMR-, CO+; mlh3-6, mlh3-23, mlh3-42, mlh3-45, and mlh3-54), while 
one (mlh3-32) specifically disrupted crossing over (MMR+, CO-) (Chapter 2, Figure 2.4; Table 
2.6). Biochemical, genetic, and yeast two-hybrid analyses suggest that the defects observed in 
these mutants can be explained by disrupted protein-protein interactions that are tolerated in 
meiosis but not MMR. Thus, I hypothesize that for meiotic CO resolution, Mlh1-Mlh3 acts as 
part of a resolvase complex that facilitates access to a unique DNA substrate that can be 
recognized and nicked by Mlh1-Mlh3. Based on these and other findings, my work supports the 
working model that the Mlh1-Mlh3 endonuclease is recruited and coordinated by distinct MMR 
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or CO promoting factors which recognize and bind the DNA substrate to spatially and 
temporally coordinate Mlh1-Mlh3 nicking on a given structure.  
In this Chapter, in section one, I will discuss immediate future plans (and ongoing work) 
based on the mutants presented in Chapter 2. In the second section, I will present two future 
projects that remain an active area of study in the meiotic recombination field. I will propose 
experiments, based on work presented in this dissertation, that will contribute significantly to 
these projects. The first project is the complete biochemical reconstitution of the Mlh1-Mlh3 
reaction in vitro. The second is exploring the disease relationship of the meiotic recombination 
defects presented in Chapter 2.  
 
1- Remaining questions and immediate future plans 
In Chapter 2, I identified an MMR+, CO- allele, mlh3-32, that displayed an in vitro 
endonuclease activity similar to wild-type, and can similarly be stimulated by the MMR factor 
Msh2-Msh3 (Chapter 2, Figure 2.11). This indicates that the meiotic defect observed in this 
mutant is likely the result of a disrupted interaction with a specific pro-crossover factor. To test 
this idea, I created overexpression constructs of a large number of meiotic genes, including 
SGS1, MSH4-MSH5, EXO1, ZIP3, and MER3. These constructs were transformed into MLH3, 
mlh3Δ, and mlh3-32 backgrounds to test for suppression of the meiotic defect. Interestingly, as 
shown in Chapter 2 (Figure 2.13), I observed that Sgs1 overexpression enhanced the spore 
viability defect in mlh3Δ but modestly suppressed the spore viability defect in mlh3-32. These 
effects were dependent on the helicase activity of Sgs1 and were not observed upon 
overexpression of a helicase defective variant of Sgs1. Mer3 is a helicase that acts as part of the 
ZMM family of proteins (Zip1-4, Mer3, and Msh4-Msh5) important in the Class I CO pathway 
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[5]–[8]. It would be interesting to test how the effects of overexpressing wild-type and helicase-
defective MER3 in MLH3, mlh3Δ, and mlh3-32 backgrounds would differ from SGS1 
overexpression. Sgs1 helicase acts as a master regulator of meiotic double strand break (DSB) 
repair at steps prior to the involvement of Mer3 and the formation of the ZMM-protein protected 
joint molecule intermediate [9], [10]. Preliminary analysis shows that MER3 overexpression also 
suppresses the spore viability defect of mlh3-32, but has no effect on the spore viability of 
mlh3Δ. 
In Chapter 2, I show that introducing the last 11 residues of Pms1 onto the C-terminal 
domain of Mlh3 (mlh3-60) strengthens the Mlh1-Mlh3 interaction (Chapter 2, Figure 2.4C). This 
effect is likely the result of two additional salt bridges contributed by the last 11 residues of 
Pms1, that are not conserved in Mlh3, as shown in the crystal structure of Mlh1-Pms1 [11]. I 
hypothesized that strengthening the interaction between Mlh1-Mlh3, via the mlh3-60 mutant, 
would be detrimental to MMR as it may hinder the formation of the Mlh1-Pms1 heterodimer that 
is more critical in this process. Curiously, I did not observe an effect on MMR or crossing over 
in an mlh3-60 background (Chapter 2, Figure 2.4B). This suggests that strengthening the 
interaction between Mlh1-Mlh3 does not sequester Mlh1 from Pms1. Consequently it would be 
interesting to test an mlh3-60 pms1Δ double mutant. In this strain background, I hypothesize that 
strengthening the Mlh1-Mlh3 interaction will partially alleviate the MMR defects observed as a 
result of pms1 deletion. 
 
2- Future projects  
a. complete biochemical reconstitution of the Mlh1-Mlh3 reaction in vitro 
The segregation of chromosomes at the first meiotic division is dependent in most 
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organisms on at least one CO event between homologous chromosomes. Homologs that do not 
receive a CO frequently undergo nondisjunction at the first meiotic division, yielding aneuploid 
gametes. Such events have been linked to human disease and infertility [15]. As described above, 
the Mlh1-Mlh3 complex is an endonuclease involved in resolving recombination intermediates 
into COs and appears to be acting through a novel mechanism distinct from that of known SSNs 
[3]. SSNs have been shown to recognize and symmetrically cleave branched DNA structures 
such as single HJs in vitro (reviewed in [1]). Although, Mlh1-Mlh3 can bind branched DNA 
substrates, it has not been shown to cleave them. In vitro, Mlh1-Mlh3 displays a non-specific 
nicking activity on circular plasmid DNA ([2] and [12]) and does not conform to paradigms set 
by previously characterized dHJ resolvases [3]. Rather, data presented in Chapter 2 highlights 
the importance of protein-protein interactions in presenting a unique substrate that Mlh1-Mlh3 
can recognize and act on. Thus, the full biochemical reconstitution of the Mlh1-Mlh3 reaction in 
vitro remains an essential goal in the meiotic recombination field.    
In Chapter 2, I presented two MMR-, CO+ alleles (mlh3-42 and mlh3-54) that weaken the 
interaction with Mlh1 (Figure 2.4; Table 2.6). The disrupted Mlh1-mlh3-42 and -54 interaction 
provides a likely explanation for the null-like phenotype observed for these alleles with regard to 
their MMR function, but it is surprising that crossing over in these mutants is maintained at wild-
type levels. I hypothesize that during meiotic recombination additional pro-crossover factors 
present at the dHJ act as a scaffold to structurally support a weakened Mlh1-mlh3 interaction. In 
support of this, the pro-crossover factors Sgs1-Top3-Rmi1 (STR), Zip3, Msh4-Msh5, and Exo1 
have all been shown to interact with one another and/or with Mlh1-Mlh3 [1]. To test this 
hypothesis, I propose deleting one copy of different meiotic genes (listed below), involved in 
various stages of meiotic recombination, in a diploid mutant strain background. If my hypothesis 
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is correct, and the dose of meiotic proteins, that are serving the role of structural support to 
Mlh1-mlh3, is lowered, then the Mlh1-mlh3-42 or -54 complex will fall apart and, consequently, 
CO levels will decrease. I have assembled a comprehensive list of such meiotic genes to test 
including those presented in Chapter 1, Table 1.1 such as the ZMM family of proteins, Exo1, and 
the STR complex. In addition to the cohesin protein, Rec8, and the meiotic checkpoint protein 
Cdc5. Furthermore, it will be interesting to test proteins involved in strand invasion (Rad51, 
Rad52, Rad54, Dmc1) and synaptonemal complex formation (Red1, Ecm11, Gmc2). Such a 
comprehensive analysis will lend support to the model that Mlh1-Mlh3 is directed in CO 
resolution as part of a resolvase complex and ultimately contribute to the biochemical 
reconstitution of an active complex in vitro. In addition, this analysis can potentially reveal novel 
genetic interactions between proteins involved in various stages of meiotic Prophase I.   
In Chapter 2, I identified one MMR+, CO- mutation (mlh3-32) in the linker arm of Mlh3 
(Figure 2.3). Further characterization of mlh3-32 using biochemical and genetic analyses did not 
reveal why this mutation specifically disrupts crossing over. Interestingly, mlh3-32 lies within 
the linker arm of Mlh3 and the linker arms of Mlh1-Mlh3 have been implicated in mediating 
conformational changes via an ATPase cycle. Such conformational changes expose different 
regions of the heterodimer to modulate diverse protein-protein or protein-DNA interactions in 
addition to mediating the timing of these interactions. I hypothesize that mlh3-32 obstructs the 
formation of a configuration that may be more important for facilitating interactions with 
recombination specific protein factors. Overexpression of MSH4-MSH5, EXO1, and ZIP3 in an 
mlh3-32 background did not suppress the CO defect, and only mild suppression was observed 
upon SGS1 overexpression. Such a selective testing approach, in which a limited number of 
meiotic genes were chosen, was unlikely to reveal the causative genetic interactions. 
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Furthermore, the complete protein interaction network of wild-type Mlh1-Mlh3 during meiotic 
recombination remains largely unknown. Thus, for the purpose of identifying novel Mlh1-Mlh3 
meiotic interacting partners in addition to those likely defective in Mlh1-mlh3-32, I propose an 
immunoprecipitation approach. For this analysis, purified wild-type Mlh1-Mlh3 protein and 
purified Mlh1-mlh3-32 can be used to pull down their respective interacting partners from 
meiotic extracts, followed by mass spectrometry. Such an approach can be extended to extracts 
from vegetative cells to reveal the full complement of Mlh1-Mlh3 interactions in MMR. If my 
hypothesis is correct, a mutant that disrupts CO specific functions, such as mlh3-32, will be 
defective in pulling down a CO specific interacting partner (observed in wild-type pull-downs) 
and likewise for a mutant that specifically disrupts MMR.  
In mouse spermatocytes, MSH4 co-localizes with MLH1 at early to mid pachytene [13]. 
Yeast Msh4 has been observed to localize on chromosomes predominantly during pachytene 
[14]. It would be interesting to use an immunofluorescence assay to investigate the temporal and 
dynamic relationship of Msh4-Msh5 and Mlh1-Mlh3 localization in yeast meiosis. In particular, 
it would be useful to compare MMR+, CO- mutants to wild-type localization patterns. This will 
provide an in vivo perspective and validation of the immunoprecipitation experiments outlined 
above. I hypothesize that wild-type Mlh1-Mlh3 will co-localize with Msh4-Msh5 but not the 
MMR+, CO- separation of function mutant likely due to defective interactions with recruiting 
factors. 
Taken together the experiments proposed above will help build the Mlh1-Mlh3 meiotic 
interactome and will prove essential in bringing the Mlh1-Mlh3 community one step closer to the 
ultimate goal of reconstituting the dHJ resolution reaction in vitro.  
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b. clinical impact and association to human infertility 
Errors in meiotic chromosome segregation are considered a leading cause of spontaneous 
miscarriages and birth defects [15]. Furthermore, polymorphisms in human MLH3 genes have 
been associated with male and female infertility [16]–[18]. The following section will describe 
experiments aimed at investigating the disease relationship of the alleles presented in Chapter 2. 
 I propose, in collaboration with the Schimenti lab, utilizing Baker’s yeast as a model for 
a quick functional interrogation of potentially deleterious nonsynonymous SNPs identified in 
human populations [19]. I hypothesize that a CO defective phenotype in yeast, resulting from a 
mutation based on human SNPs in a residue that is highly conserved from yeast to human, will 
likely result in infertility if mimicked in mice. This method can be used to quickly screen in yeast 
disease causing genetic variants from human populations to be modeled and validated in mice. In 
collaboration with the Schimenti lab, MLH3 SNPs found in humans were identified in amino 
acid residues that are highly conserved from yeast to human and lie within the functionally 
important ATPase and endonuclease domains of Mlh3. I hypothesize yeast bearing these 
“humanized” alleles will likely result in a CO defect. More importantly, if my hypothesis is 
correct, such variants can be chosen for modeling in mice and will likely give rise to an infertility 
phenotype thus validating disease causing variants in humans. Of particular interest are SNPs 
that align with mlh3-40 and mlh3-41 that gave a null phenotype in both MMR and crossing over 
as shown in Chapter 2 (Figure 2.3; Table 2.4).  
In Chapter 2 I presented work, in collaboration with K.T. Nishant’s lab, that implicates 
mlh3 mutants in altering the fate of meiotic recombination intermediates (Figure 2.6; Table 2.7). 
High-resolution recombination maps revealed that mlh3 mutants increase NCOs genome wide. 
Of particular interest is mlh3-23 (MMR-, CO+), because although it did not significantly affect 
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CO levels, as compared to wild-type, it displayed increased NCO levels similar to those observed 
in mlh3 mutants with more severe CO defects (Figure 2.6 Table 2.7). I propose DNA physical 
assays, briefly described below [20], to determine which specific steps of meiotic recombination 
are altered in this mutant. DNA physical assays can be used to monitor recombination at a given 
hotspot by analyzing DNA fragments diagnostic for DSBs, joint molecules, COs, and NCOs 
[20]. In addition, three types of joint molecules can be detected: early single-end invasion 
intermediates, dHJs, and multichromatid joint molecules. Such insight would be valuable in an 
mlh3-23 strain to determine the possible formation of defective joint molecule intermediates in 
this background and the relative timing of their formation. This will provide information on the 
particular stage during the formation of joint molecule intermediates that is likely disrupted by 
mlh3-23.  
Finally, mouse Mlh3-/- mutants are viable but infertile due to meiotic defects [21]. 
Mutations such as mlh3-23 suggest that some mutants in meiotic recombination genes could 
have more severe defects on fertility than others. The separation of function mutants identified in 
Chapter 2, such as mlh3-23 and mlh3-32, are present in regions conserved between yeast MLH3 
and mouse Mlh3. It would be of interest to investigate the effects of equivalent mutations in 
mouse Mlh3 on mammalian meiosis and infertility.  
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APPENDIX A 
Segregation of SNPs in all 44 tetrads as labeled in Chapter 2, Table 2.9. 
 
S288c and YJM789 SNPs are shown in red and blue, respectively. 
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Mismatch repair incompatibilities in diverse yeast populations 
 
Duyen T. Bui*&, Anne Friedrich,+ Najla Al-Sweel*, Gianni Liti#, Joseph Schacherer,+ Charles F. 
Aquadro,* and Eric Alani* 
*Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, United 
States of America 
+Université de Strasbourg, CNRS, GMGM UMR 7156, F-67000, Strasbourg, France 
#Institute for Research on Cancer and Ageing of Nice (IRCAN), 06107, Nice, France 
&Present address: Department of Microbiology and Immunology, University of California, San 
Francisco, CA 94143-2200 
 
 
 
 
This work was published in Genetics on 2/13/17: 
D. T. Bui, A. Friedrich, N. Al-Sweel, G. Liti, J. Schacherer, C. F. Aquadro, and E. Alani, 
“Mismatch Repair Incompatibilities in Diverse Yeast Populations,” Genetics, 205(4):1459-1471. 
Feb. 2017. 
 
Contributions: N.A.S. perfomed the work, shown in Figure 6 and Table S7, to determine that the 
suppression of incompatibility in YJM555 appears to involve more than one locus. All other 
work was contributed by D.T.B., A.F., G.L., J.S., C.F.A., and E.A.  
 
 
 
 
185 
Abstract 
An elevated mutation rate can provide cells with a source of mutations to adapt to 
changing environments.  We identified a negative-epistatic interaction involving naturally 
occurring variants in the MLH1 and PMS1 mismatch repair (MMR) genes of Saccharomyces 
cerevisiae.  We hypothesized that this MMR incompatibility, created through mating between 
divergent S. cerevisiae strains, yields mutator progeny that can rapidly but transiently adapt to an 
environmental stress.  Here we analyzed the MLH1 and PMS1 genes across 1,010 S. cerevisiae 
natural isolates spanning a wide range of ecological sources (tree exudates, Drosophila, fruits, 
various fermentation and clinical isolates) and geographical sources (Europe, America, Africa, 
and Asia). We identified one homozygous clinical isolate and eighteen heterozygous isolates 
containing the incompatible MMR genotype.  The MLH1-PMS1 gene combination isolated from 
the homozygous clinical isolate conferred a mutator phenotype when expressed in the S288c 
laboratory background. Using a novel reporter to measure mutation rates, we showed that the 
overall mutation rate in the homozygous incompatible background was similar to that seen in 
compatible strains, indicating the presence of suppressor mutations in the clinical isolate that 
lowered its mutation rate.  This observation and the identification of eighteen heterozygous 
isolates, which can lead to MMR incompatible genotypes in the offspring, are consistent with an 
elevated mutation rate rapidly but transiently facilitating adaptation.  To avoid long-term fitness 
costs the incompatibility is apparently buffered by mating or by acquiring suppressors.  These 
observations highlight effective strategies in eukaryotes to avoid long-term fitness costs 
associated with elevated mutation rates. 
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Introduction  
Most spontaneous mutations that occur in natural populations are neutral or deleterious 
(Kimura 1967; Eyre-Walker and Keightley 2007).  However, in changing environments bacteria 
and yeast can display mutator phenotypes, often through the loss of DNA mismatch repair 
(MMR) function, that provide a competitive advantage by increasing the chance of obtaining the 
first adaptive mutation(s) (LeClerc et al. 1996; Boe et al. 2000; Denamur et al. 2000; Taddei et 
al. 1997; Tanaka et al. 2003; Townsend et al. 2003; Giraud et al. 2001; Chao and Cox 1983; Bui 
et al. 2015). Ultimately, such benefits are lost due to long-term fitness costs caused by the 
accumulation of deleterious mutations.  However, in the case of MMR defective bacteria, once 
adapted to an environment, cells can recover MMR functions through horizontal gene transfer 
(Denamur et al. 2000).  In support of this idea, Taddei et al. (1997) suggested that mutators are 
likely to be common in natural asexual populations, but then disappear to avoid long term fitness 
costs once favorable mutations reach fixation (Taddei et al. 1997; Giraud et al. 2001; Wielgoss 
et al. 2013). 
While it might be common for a eukaryotic organism such as yeast to have lost MMR 
functions (see Thompson et al. 2006; Raynes et al. 2012), there is little evidence that these 
functions can be recovered through horizontal gene transfer (Liti and Louis 2005).  One 
approach that yeast could employ to avoid long-term fitness effects associated with a mutator 
phenotype is mating to a non-mutator strain, followed by sporulation and segregation of 
genotypes so that the mutator locus and a beneficial mutation are no longer linked.  Such a 
strategy is considered effective because outcrossing has the potential to generate new genotypes 
at a much higher frequency than spontaneous mutation (Ruderfer et al. 2006).  This strategy 
predicts that a hybrid diploid in which the mutator phenotype is recessive would be observed in 
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nature.  
We developed a model to explain how a genetic incompatibility involving the DNA 
mismatch repair genes MLH1 and PMS1 could arise in yeast (Figure 1; Bui et al. 2015; Heck et 
al. 2006; Demogines et al. 2008).  We define incompatibility as a negative epistatic interaction 
between MLH1 and PMS1 genes that results in an elevated mutation rate.  In this model, based 
on ideas first proposed by Dobzhansky and Muller as a mechanism for speciation (Muller and 
Pontecorvo 1940; Muller 1939; Dobzhansky 1936; Orr 1995), a common ancestral state gives 
rise to derived strains (S288c, SK1 in our case) that acquire neutral or beneficial mutations in the 
MLH1 and PMS1 MMR genes. Mating between these divergent populations would create a 
hybrid genotype. In laboratory experiments MMR incompatible spore progeny of the hybrid 
combination were shown to confer a higher mutation rate, and provide a fitness advantage to 
adapt to high salt (Bui et al. 2015; Heck et al. 2006).  These studies suggested that such an 
advantage would be transient because the mutator genotype would result in a long-term fitness 
cost (Heck et al. 2006).  Consistent with a fitness cost, none of 65 wild, lab, and clinical 
strains/isolates examined displayed the incompatible genotype (Demogines et al. 2008). 
However, the number of strains/isolates examined was too small to determine if their absence in 
the incompatibility group was lower than expected by chance if there were no epistatic 
interactions involving MLH1and PMS1 genes.  An attractive explanation for this observation is 
that incompatible isolates exist transiently to provide an adaptive advantage, but mechanisms 
such as outcrossing restore the compatible genotype.  Consistent with this idea is a sequence 
analysis of a 32 kb genomic region 
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Figure 1. A model proposing that an incompatibility involving the MMR genes MLH1 and 
PMS1 drives adaptive evolution. In this model (Panel A), an ancestral isolate bearing MLH1 Gly 
761 and PMS1 Arg 818/822 alleles acquire neutral or beneficial mutations that lead to the 
derived S288c (purple, Asp 761, Arg 818/822) and SK1 (green, Gly 761, Lys 818/822) group 
isolates. Mating between the derived isolates can yield an allele combination (MLH1 Asp 761, 
PMS1 Lys 818/822) that displays negative epistasis and thus a mutator phenotype.  Previous 
work suggested that recombination has occurred between the two derived classes, leading to 
exchange of genetic information and a hybrid mutator genotype that can also remate to 
reconstruct derived or ancestral genotypes (Heck et al. 2006).  As described in the text, 
sequences of MLH1 and PMS1 genes from 1,010 S. cerevisiae from worldwide collections 
genomes were grouped according to their amino acid residues 761 (G or D) in MLH1 and 818 (R 
or K) in PMS1 (File S1; File S2). One isolate maps to the predicted hybrid mutator category. Of 
the 1,010 isolates, 904 are homozygous for the MLH1 761 and PMS1 818/822 genotypes.  The 
distribution in each genotype is shown here and a list of isolates in the S288c and SK1 derived 
classes is shown in Table S2.  Panel B. 106 isolates are heterozygous for the MLH1 761 and/or 
PMS1 818/822 genotypes, with the distribution shown. On the left are the genotypes which can 
lead to both mutator and non-mutator progeny (see Table 1 and text).  On the right are genotypes 
that can lead only to non-mutator progeny.   
 
 
Heterozygous genotypes: 106 isolates 
  
S288c/S288c MLH1-S288c/SK1 PMS1   
                   (1 isolate) 
S288c/SK1 MLH1-SK1/SK1 PMS1  
                  (3 isolates) 
S288c/SK1 MLH1-S288c/S288c PMS1   
                (56 isolates) 
SK1/SK1 MLH1-S288c/SK1 PMS1  
                (32 isolates) 
S288c/SK1 MLH1-S288c/SK1 PMS1   
  (14 isolates) 
i.  MLH1-PMS1: Predicted Mutator   
ii. MLH1-PMS1, MLH1-PMS1, MLH1-PMS1:  
                           Predicted Non-Mutators 
 
MLH1-PMS1, MLH1-PMS1, MLH1-PMS1:  
             Predicted Non-Mutators 
Homozygous genotypes: 904 isolates 
S288c 
MLH1-PMS1 
 Derived 
(182 isolates) 
 MLH1-PMS1  
Ancestral 
(693 isolates) 
 
 
 
   
MLH1-PMS1  
Predicted Mutator 
(1 isolate) 
SK1 
MLH1-PMS1 
Derived 
(28 isolates) 
 
 
    Predicted  
recombination 
Bui et al. Fig 1 
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Table 1. Nineteen natural isolates that contain incompatible MLH1-PMS1 
combinations. 
 
Isolate name  
  Genotype 
MLH1 PMS1   
Ploidy (n)         Origin          
(ecological, geographical) 
CLIB324_2 SK1/S288c SK1/S288c 2  bakery, Vietnam 
CBS4455 S288c SK1/S288c 3  beer, South Africa 
CECT1462 SK1/S288c SK1/S288c 4  beer, United Kingdom 
NCYC_2780 SK1/S288c SK1/S288c 4  human clinical, Belgium 
2680 SK1/S288c SK1/S288c 4  human clinical, Spain 
YS8(E) SK1/S288c SK1/S288c 4  bakery, Unknown 
SD-15 SK1/S288c SK1/S288c 4  bakery, Italy 
WLP001 SK1/S288c SK1/S288c 4  beer, USA 
WLP013 SK1/S288c SK1 4  beer, United Kingdom 
WLP006 SK1/S288c SK1 4  beer, Unknown 
UCD_06-645 SK1/S288c SK1/S288c 4  fruit, Davis, California 
Win-8B SK1/S288c SK1 2  beer, United Kingdom 
Ponton 11 SK1/S288c SK1/S288c 2  human clinical, Spain 
CLI_16 SK1/S288c SK1/S288c 4  human clinical, France 
CLI_19 SK1/S288c SK1/S288c 2  human clinical, France 
CLI_23 SK1/S288c SK1/S288c 4  human clinical, France 
CLI_26 SK1/S288c SK1/S288c 4  human clinical, France 
YJM521 SK1/S288c SK1/S288c nt human clinical, California 
YJM523 S288c SK1 nt human clinical, California 
1,010 isolates were genotyped at amino acids 761 for MLH1 and 818 in PMS1.  Isolates were 
genotyped as S288c if they contained the S288c amino acids (D761 in MLH1, R818 in PMS1), 
and SK1 if they contained the SK1 amino acids (G761 in MLH1, K822 in PMS1). SK1/S288c 
indicates that both SK1 and S288c alleles were detected in the strain at the indicated locus.  We 
analyzed the yeast genomes of the 1,010 isolates by placing them into clades. We then computed 
the mean, median, standard deviation and standard error for the number of singletons within 
these clades and compared the number of singletons of the 19 isolates to their associated clades.  
We did not observe an excess of singletons for any of the isolates (1002 Yeast Genomes Project -
 http://1002genomes.u-strasbg.fr/).  Ploidy was determined by FACS, and all but CLIB324_2, 
WLP001, and Win-8B are capable of sporulating (Materials and Methods). nt = not tested. 
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of yeast (Chr. XIV, 445 to 477 kb) which provided evidence for recombination between the 
S288c and SK1 groups Heck et al. 2006; Demogines et al. 2008; Steinmetz et al. 2002).   
 A challenge to the above model is that several studies have estimated that the number of 
clonal generations that two yeast strains would have experienced prior to outcrossing is very 
high, one outcrossing event per 12,500 to 62,500 generations (Ruderfer et al. 2006; Magwene et 
al. 2011).  While such observations suggest that yeast has primarily an asexual lifestyle, random 
mating between natural strains can be achieved at high rates in the lab and can be elevated in 
different environments, such as in the gut of the fruit fly (Murphy and Zeyl 2010; Reuter et al. 
2007).  It is also worth noting that population structure analyses of domestic and wild yeasts 
showed evidence for many different natural recombinant/mosaic genomes (Liti et al. 2009; 
Strope et al. 2015), and outcrossing rate is likely to be different depending on the ecological 
origin of the isolates and their stress conditions; e.g. a high outcrossing rate was observed for 
domestic isolates (reviewed in Marsit and Dequin 2015).  Thus isolates heterozygous for MMR 
genotypes could in stress conditions undergo sporulation and yield incompatible haploid 
progeny. 
Previously, we showed that incompatible strains display a transient fitness advantage Bui 
et al. 2015).  In the present study, we looked to see if evolved incompatible strains maintain 
fitness in non-stress and stress conditions. Our work showed that such strains rapidly displayed 
fitness defects in non-stress conditions. This observation encouraged us to survey 1,010 S. 
cerevisiae wild, clinical, industrial and lab strains from worldwide collections for their MLH1 
and PMS1 genotypes.  We identified and carefully characterized one clinical isolate (YJM523) 
that displayed the homozygous incompatible MLH1-PMS1 genotype.  Long-term fitness costs 
appeared to have been avoided in this strain through extragenic mutations that suppressed its 
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mutation rate.  Based on the above we hypothesize that in natural populations a mutator state can 
be created to transiently promote adaptive evolution, but can then be suppressed once beneficial 
mutations go to fixation. 
 
Materials and Methods 
Strains and media  
Saccharomyces cerevisiae spore clones from the S288c strain background were analyzed in 
competition assays (Table S1; Figure 2; Winston et al. 1995).  These strains were grown in YPD 
(yeast extract, peptone, dextrose) and YPD + 1.2 M NaCl (Rose et al. 1990). Natural and S288c 
derived strains transformed with pEAA613 (ARS-CEN NatMX, kanMX::insE-A14; Table S1; 
Table S2) were maintained in YPD media containing 50 µg/ml nourseothricin.  Yeast 
transformations were performed as described (Gietz and Schiestl 2007).   
EAY1365 (MATa, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2::insE-A14, 
mlh1Δ::KanMX4, pms1Δ::KanMX4), an S288c derived strain, was used to measure reversion to 
Lys+.  This strain was transformed with ARS-CEN, LEU2, cMLH1 (pEAA213 and derivatives) 
and ARS-CEN, HIS3, cPMS1 (pEAA238 and derivatives) plasmids, and were grown in minimal 
selective media lacking histidine and leucine (Table S1; Rose et al. 1990).  In this paper genes 
derived from the S288c background are designated with a “c” (e.g. cMLH1) and those derived 
from SK1 with a “k” (e.g. kMLH1). YJM555 is a homozygous diploid strain derived from the 
natural isolate YJM523 (see details in (Strope et al. 2015). YJM523 and YJM555 were obtained 
from the FGSC collection (http://www.fgsc.net/). 
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Plasmids  
pEAA213 (cMLH1, ARSH4 CEN6, LEU2) and pEAA214 (kMLH1, ARSH4 CEN6, LEU2) were 
described previously (Argueso et al. 2003; Heck et al. 2006; Table S3).  MLH1 expression is 
driven in both plasmids by the S288c MLH1 promoter.  MLH1 from YJM555 was cloned into 
pEAA213 by amplifying MLH1 from genomic DNA (Rose et al. 1990; Hoffman and Winston 
1987) using Roche high fidelity polymerase (Roche) and primers AO324 and AO821 (Table S4). 
The PCR amplified product containing the entire MLH1 open reading frame was digested with 
BamH1-and NheI and inserted into the corresponding sites of pEAA213. The entire PCR 
fragment was DNA sequenced. All of the resulting constructs expressed MLH1 via the S288c 
MLH1 promoter.  
pEAA238 (cPMS1, ARSH4, CEN6, HIS3) and pEAA239 (kPMS1, ARSH4, CEN6, HIS3) 
were described previously (Table S3; Argueso et al. 2003; Heck et al. 2006). In both plasmids 
PMS1 expression is driven by the S288c PMS1 promoter. PMS1 from YJM555 was cloned into 
pEAA238 by amplifying PMS1 from genomic DNA using Roche high fidelity polymerase and 
primers AO548 and AO481 (Table S4). The PCR amplified product containing the entire PMS1 
open reading frame was digested with AatII-and MluI and inserted into the corresponding sites of 
pEAA238. The entire PCR fragment was DNA sequenced.  All of the resulting constructs 
expressed PMS1 via the S288c PMS1 promoter.  
pEAA613 contains the URA3 promoter-kanMX::insE-A14  reversion reporter constructed 
using overlap PCR (Ho et al. 1989).  Briefly, this reporter is expressed via the URA3 promoter  (-
402 to the ATG start site).  A 55 bp sequence containing a +1 frameshift in the 14 bp 
homopolymeric A run (insE-A14; Tran et al. 1997) was inserted immediately after the URA3 
ATG, followed by codons 18 to 269 of the KanMX open reading frame derived from pFA6-
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KanMX, and 159 bp of KanMX downstream sequence that contains a transcription termination 
sequence (also derived from pFA6-KanMX; Goldstein and McCusker 1999).  This reporter 
construct was inserted into pLZ259 (ARS-CEN, NatMX, kindly provided by Dr. Lu Zhu. 
Derivatives of pEAA613 that contain homopolymeric tracts of 10 A (in frame, pEAA611) and 
11 A residues (+1 out of frame, pEAA612) residues were also constructed. Finally, a set of 
reporter constructs (pEAA614-616) were built in which the kanMX::insE-A14 reporter was 
expressed via the LEU2 promoter (-308 to the ATG start site of the LEU2 promoter fused to the 
KanMX ORF).    
 
Spore clone competitions  
Clones derived from incompatible strains (cMLH1::KanMX, kPMS1::HIS3, pmr1) evolved in 
high salt for 70 generations (EAY3688, EAY3689, EAY3690 containing pmr1 mutations T459A, 
T412C, T2G, respectively; Bui et al. 2015) were mated with the unevolved and compatible strain 
EAY3241 (kPMS1::HIS3, kMLH1::NatMX, PMR1; Table S1).  Diploids were selected on YPD 
plates containing clonNAT (100 µg/ml) and genecitin (200 µg/ml) and then sporulated on 2% 
agar media containing 1% potassium acetate.  The resulting spore clones were genotyped for 
PMR1 by isolating chromosomal DNA (Holm et al. 1986) from individual clones and 
sequencing the PCR amplified PMR1 locus. These clones were genotyped for MLH1 by testing 
for resistance to genecitin and clonNAT, and for the MAT locus by mating to tester strains.   
Spore clones of the same mating type and of the four possible genotypes (kMLH1-
kPMS1(compatible)-PMR1, kMLH1-kPMS1(compatible)-pmr1, cMLH1-kPMS1(incompatible)-
PMR1, and cMLH1-kPMS1(incompatible)-pmr1) were grown overnight in YPD and then mixed 
in equal proportions (Transfer 0).  4, 3, and 3 spore clones of each genotype were competed from 
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the matings involving pmr1-T459A, pmr1-T412C, pmr1-T2G, respectively. Ten competitions in 
total were performed, and different spore clones obtained from different tetrads were pooled to 
minimize effects of background mutations that might arise in evolved populations. 2 x107 cells 
of the initial mixed culture (Transfer 0) were transferred into 6 ml of YPD or YPD + 1.2 M NaCl 
and then grown for 24 hrs at 30oC (~7 generations of growth).  The same amount of cells (to 
achieve an initial OD600 of 0.1, Shimadzu UV-1201 spectrophotometer) was used in subsequent 
transfers, with cells grown under the same conditions.  At transfer numbers indicated in Figure 3, 
cells in the culture were genotyped for compatibility (kPMS1::HIS3, kMLH1::NatMX) and 
incompatibility (kPMS1::HIS3, cMLH1::KanMX) on YPD plates containing geneticin (200 
µg/ml) or clonNAT (100 µg/ml).  
  
DNA sequencing analysis 
1,010 S. cerevisiae isolates were investigated in the context of the 1002 yeast genome project 
(File S1; File S2). Illumina reads were mapped against the S. cerevisiae 288c reference genome 
R64-1-1 with bwa 0.7.4-r385 and the sequence of the MLH1 and PMS1 genes were inferred for 
all isolates with GATK (FastaAlternateReferenceMaker). 
The 2.3 kb MLH1 and 2.6 kb PMS1 open reading frames from YJM521 and YJM523 
(Table 1, Tables S1, S2) were determined by sequencing PCR amplified DNA from 
chromosomal DNA (Hoffman et al. 1987) using Expand High Fidelity Polymerase (Roche Life 
Sciences).  Primers AO324 and AO821 were used to amplify the MLH1 open reading frame and 
primers AO481 and AO548 were used to amplify the PMS1 open reading frame (Table S4).  
PCR products were sequenced by the Sanger method in the Cornell BioResource Center. 
Duplicate clones from the strain stocks were sequenced for confirmation purposes.  To further 
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show that YJM523 was not heterozygous for sequences at the Mlh1 (amino acid position 761) 
and Pms1 (amino acid position 818) incompatibility loci, 20 different PCR products, derived 
from unique PCR primer combinations, were sequenced using primer AO328 for MLH1 and 
primer AO485 for PMS1 (Table S4).  In no case was heterozygosity detected at the MLH1 or 
PMS1 incompatibility loci. 
 
Flow cytometry 
Cells from isolates shown in Table 1 were fixed overnight in cold ethanol (70% final), washed, 
and re-suspended at 1.2 x 107 cells/ml in 50 mM sodium citrate (pH 7).  They were then treated 
for 1 hr with RNAse A at a final concentration of 1 mg/ml, after which they were stained with 
propidium iodide at a final concentration of 40 µg/ml. Flow cytometry was performed on a 
Cyflow Space, Partec. 
 
Sporulation test 
Isolates shown in Table 1 were sporulated for 2–3 days on sporulation medium (10 g/L 
potassium acetate, 20 g/L agar) at 30°C. 
 
lys2-A14 reversion assays   
Independent colonies of EAY1365 (relevant genotype lys2-A14) containing the ARS-CEN, MLH1 
and ARS-CEN, PMS1 plasmids presented in Table S3 were inoculated YPD overnight and then 
plated onto LYS, HIS, LEU dropout and HIS, LEU dropout synthetic plates.  These strains were 
analyzed for reversion to Lys+ as described previously (Bui et al. 2015; Tran et al. 1997). The 
95% confidence intervals were determined as described by Dixon and Massey (1969).  The 
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Mann-Whitney U test (Mann and Whitney 1947) was performed to determine the significance of 
the differences in median reversion rates. 
 
kanMX::insE-A11-14  reversion assays 
EAY1369 (cMLH1-cPMS1, compatible), EAY1370 (cMLH1-kPMS1, incompatible), EAY1372 
(msh2∆), and YJM555 were transformed with pEAA613 or pEAA616 and grown on YPD media 
containing clonNAT (100 µg/ml).  Independent transformants were subsequenty grown 
overnight in YPD + clonNAT and then plated on to YPD + clonNAT (50 µg/ml) and YPD + 
clonNAT (50 µg/ml), genecitin (300 µg/ml). These strains were analyzed for reversion to 
resistance to genecitin using methods described previously (Bui et al. 2015; Tran et al. 1997).  
The 95% confidence intervals were determined as described by Dixon and Massey (1969). Pair-
wise Kruskal–Wallis tests were performed to determine the significance of the differences in 
median reversion rates.  Mann-Whitney U tests were performed to determine the significance of 
the differences in median reversion rates  (Mann and Whitney 1947; Wilcoxon 1945). 
 As controls, we measured resistance to genecitin (G418) for EAY1369 and YJM555 
lacking the kanMX::insE-A11-14 reporter plasmid.  Ten independent overnight cultures were 
analyzed for each strain.  We did not observe resistant colonies in any of the cultures and thus 
estimate median frequencies of resistance to be < 9.7 x 10-10 for EAY1369, and <6.9 x 10-10 for 
YJM555; these values correspond to mutation rates that are < 2 x 10-10, indicating that 
spontaneous reversion to G418r would not interfere with the detection of G418r using the 
kanMX::insE-A11-14 reporter plasmids. 
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YJM x EAY3235 cross 
To determine if a single locus is present in YJM555 that suppressed MLH1-PMS1 
incompatibility, we mated meiotic spores of YJM555 to the incompatible strain EAY3235 
(MATa, lys2-A14, ura3, trp1, leu2, MLH1S288c::KanMX, PMS1S288c-R818K::HIS3).  Four 
independent Ura+ G418r colonies were sporulated and tetrad dissected.  The spore clones from 
four-viable spore tetrads all displayed 2:2 segregation for lys2-A14/LYS2, trp1/TRP1, and 
ura3/URA3.  The sporulation viability of the diploid was 82%, with 62% of tetrads displaying 
four viable spores (79 tetrads dissected).   
42 lys2-A14 spore clones (one Lys- spore clone chosen per tetrad) were tested using a 
patch assay for reversion to Lys+.  The 42 spore clones all displayed ~1:1 ratios for 
MLH1S288c::KanMX/MLH1YJM555 segregation (the open reading frames for MLH1YJM555 and 
MLH1S288c are identical; Figure 4), PMS1YJM555/PMS1S288cR818K::HIS3 (genotyped using PCR 
primers that distinguished between the presence or absence of the HIS3 insertion), trp1/TRP1, 
leu2/LEU2, and ura3/URA3 (Table S4).  To confirm phenotype testing, the PMS1 gene was PCR 
amplified from three PMS1YJM555 and two PMS1S288cR818K::HIS3 spore clones. 700 bp of the 
PMS1 gene surrounding the incompatibility site at amino acid 818 were sequenced; all five spore 
clones displayed DNA sequences that corresponded to the assigned phenotype.  To determine 
mutator phenotypes, each of the 42 lys2-A14 spore clones was struck to single colonies on YPD 
media.  Five ~2 mm in diameter colonies from each spore clone were then patched onto 1.5 cm x 
1.5 cm squares on lysine dropout plates.  It is important to note that colony morphology and size 
varied somewhat between spore clones, and for four spore clones, the colonies grew to ~ 1 mm 
in diameter.   Plates were scored for Lys+ reversion colonies after 3 days of growth at 30 C, with 
the median number of colonies recorded per patch.   
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Strains and plasmids are available upon request, and the DNA sequences of the MLH1 
and PMS1 genes from 1010 isolates is present in Files S1 and S2. Supporting information 
contains all detailed descriptions of all supplemental files. 
 
Results 
Incompatibility confers a fitness cost in evolved strains in non-stress conditions  
In Bui et al. (2015), we showed that haploid yeast containing the incompatible S288c MLH1-SK1 
PMS1 genotype (abbreviated as cMLH1-kPMS1) displayed a transient growth advantage in high 
salt that resulted from mutations in the PMR1 gene.  This observation encouraged us to 
determine the time frame in which incompatible strains that display an initial transient adaptive 
advantage can maintain fitness in non-stress and stress conditions.  To answer this, we mated 
three different high-salt evolved clones, constructed to contain the incompatible cMLH1-kPMS1 
combination, to the unevolved compatible strain EAY3241.  These incompatible strains, 
EAY3688 (pmr1-T459A), EAY3689 (pmr1-T412C), and EAY3690 (pmr1-T2G), were evolved 
for 70 generations in high salt (Bui et al. 2015; Table S1).  This window was chosen because 
incompatible strains displayed an adaptive advantage over compatible strains when evolved for 
70 generations that was lost after 120 generations (Bui et al. 2015).  The diploids were then 
sporulated and the resulting spores genotyped for incompatibility, mating type, and PMR1 
(Figure 2).  We then created for each pmr1 allele mixed cultures that contained equal proportions 
of the same mating type spore clones that were PMR1 compatible, pmr1 compatible, PMR1 
incompatible, or pmr1 incompatible, and grew them overnight, followed by subsequent transfers, 
in YPD or YPD + 1.2 M NaCl (roughly seven generations of growth per transfer; Materials and  
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Figure 2. Competition experiments of spore clones from post adaptation strains. Clones derived 
from incompatible strains evolved in high salt for 70 generations (EAY3688-pmr1-T459A, 
EAY3689-pmr1-T412C, EAY3690-pmr1-T2G; Bui et al. 2015) were mated with the unevolved 
and compatible strain EAY3241 (Table S1).  The resulting diploids were sporulated and 
genotyped for PMR1, MLH1, PMS1, and mating type.  Spore clones of the same mating type and 
of the four possible genotypes (kMLH1-kPMS1(compatible)-PMR1, kMLH1-
kPMS1(compatible)-pmr1, cMLH1-kPMS1(incompatible)-PMR1, and cMLH1-
kPMS1(incompatible)-pmr1) were grown overnight in YPD and then mixed in equal proportions 
(Transfer 0).  4, 3, and 3 spore clones of each of the genotypes (12 to 16 in total per competition) 
were competed from the matings involving pmr1-T459A, pmr1-T412C, pmr1-T2G, respectively. 
2 x107 cells of the initial mixed culture (Transfer 0) were transferred into 6 ml of YPD or YPD + 
1.2 M NaCl and then grown for 24 hrs (~7 generations of growth).  The same amount of cells 
was used in subsequent transfers.  At the indicated transfers cells were genotyped for 
compatibility (kPMS1::HIS3, kMLH1::KanMX) and incompatibility (kPMS1::HIS3, 
cMLH1::KanMX) on YPD plates containing geneticin or nourseothricin.    
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Methods).  Our goal in these studies was to determine if the incompatible strains would 
ultimately display a fitness defect in rich media due to the accumulation of recessive mutations, 
as predicted by Heck et al. (2006).  We also tested whether the rapidly evolved incompatible 
strains would continue to show an adaptive advantage in high salt media.   
We measured in rich media fitness differences between incompatible and compatible 
strains.  As shown in Table 2, Table S5, and Figure 3, we observed a gradual decrease in fitness 
of incompatible cells.  This observation supports the idea that being incompatible is not 
favorable shortly after adaptation (Bui et al. 2015).  At the end of the transfer experiment most 
competitions resulted in a higher proportion of compatible cells and all 28 independent clones 
(half compatible, half incompatible) isolated from Transfer 24 were PMR1, indicating that all 
three pmr1 mutations were deleterious in rich media.   
For competitions in YPD +1.2 M NaCl, we observed a general decline in the fitness of 
incompatible strains compared to compatible strains in the first 50 generations of competition.  
In the next 100 generations some incompatible strains displayed increased fitness (Figure 3; 
Table 2; Table S5).  Sequencing of 24 clones (12 compatible, 12 incompatible clones) at 
Transfer 24 showed that all retained their initial adaptive pmr1 mutations.  These results showed 
that further adaptive advantages beyond the initial transient one were likely countered by the 
accumulation of deleterious mutations. 
 
Natural isolates were identified that display the incompatible genotype  
Previously Heck et al. (2006) identified one site each in MLH1 (aa 761, Asp (D) in S288c, Gly 
(G) in SK1) and PMS1 (aa 818/822, Arg (R) in S288c, Lys (K) in SK1) that accounted for the 
MMR incompatibility seen in progeny derived from crossing S288c and SK1 strains, with only 
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Table 2. Fitness of evolved incompatible and compatible strains as a function of transfer in 
YPD and YPD + NaCl media. 
 
        Fitness, w +/-SEM     
     Transfer         YPD     YPD+NaCl                  n               
___________________________________________________________ 
3 0.98± 0.01 0.98± 0.01 10  
4 0.97± 0.02 0.95± 0.02 6 
8 0.95± 0.01 0.93± 0.03 10 
12 0.93± 0.03 1.06± 0.09 6 
14 0.92± 0.02 1.06± 0.05 10 
16 0.92± 0.02 1.05± 0.06 10 
20 0.91± 0.02 1.06± 0.06 10 
24 0.90± 0.03 1.09± 0.05 10 
___________________________________________________________ 
The proportion of compatible and incompatible genotypes was determined after the indicated 
number of transfers for spore clone competitions performed in YPD and YPD+ 1.2 M NaCl 
(Figure 3).  Fitness (w) values were calculated as w = ((pt/qt)/(po/qo))1/t, where t equals the 
number of generations after T transfers (7 generations per transfer; Hartl and Clark 2007), po and 
qo are the number of incompatible and compatible cells, respectively at Transfer 0, and pt and qt 
are the number of incompatible and compatible cells, respectively, at the indicated Transfer.  n is 
the number of unique competitions performed for each data set.  In this table the average fitness 
of the three pmr1 genotypes is presented.  In Table S5, the fitness values for each pmr1 genotype 
are shown. 
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Figure 3. Fitness of post-adaptation incompatible and compatible strains in YPD and YPD-1.2 
M NaCl.  Fitness (w) was determined in cultures genotyped for MLH1-PMS1 compatible and 
incompatible clones in YPD and YPD + 1.2 M NaCl as described in the Materials and Methods 
and Table 2 and Figure 2. Ten same mating-type competitions (competitions 1-4 for pmr1-T459A 
evolved, 5-8 for pmr1-T412C evolved, and 9-10 for pmr1-T2G evolved) are shown. For the YPD 
transfer experiments, 14 incompatible and 14 compatible clones at Transfer 24 (6, 4, 4, each 
from pmr1-T459A, pmr1-T412C and pmr1-T2G, respectively) were genotyped for PMR1.  For 
the YPD + 1.2 M NaCl transfer experiments, 12 incompatible and 12 compatible clones at 
Transfer 24 (four each from the pmr1-T459A, pmr1-T412C and pmr1-T2G) were genotyped for 
PMR1. 
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MLH1-D761 / PMS1-K818 conferring a mutator phenotype (Figure 1; Heck et al. 2006; 
Demogines et al. 2008).  We took advantage of a recent whole-genome sequencing analysis of a  
world-wide collection of 1,010 Saccharomyces cerevisiae isolates to determine if the 
incompatible combination exists in nature (File S1; File S2; full genomes and their analyses will 
be presented in the 1002 Yeast Genomes Project - http://1002genomes.u-strasbg.fr/).  All 1,010 
isolates displayed D and/ or G at amino acid position 761 in MLH1 and R and/or K at position 
818/822 in PMS1. 
In total, 904 of the 1,010 isolates are homozygous for polymorphisms in MLH1 and 
PMS1.  As shown in Figure 1 and Table S2, 693 of these isolates (MLH1-G761 / PMS1-R818) 
mapped to the ancestral group, 182 to the S288c group (MLH1-D761 / PMS1-R818), 28 to the 
SK1 group (MLH1-G761 / PMS1-K818), and one (the YJM523 clinical isolate) to the 
incompatible group (MLH1-D761 / PMS1-K818).  The isolates in both the S288c and SK1 
groups are not closely related, suggesting that the incompatible genotype could arise 
independently, or are different combinations of mosaic genomes derived from a common event 
(Strope et al. 2015; Schacherer et al. 2009).  A Fisher’s Exact test of the observed number of 
isolates in each category showed that the number of isolates in the incompatible group was lower 
than expected by chance if there were no negative epistatic interactions involving this 
combination of MLH1-PMS1 (p = 0.018).  These data suggest that there may be active selection 
against the incompatible genotype.  We hypothesize that because of the long-term fitness cost 
associated with the incompatibility, there would be few if any natural isolates maintained as 
incompatible.   
Among the 1,010 isolates, 106 are heterozygous for the MLH1 761 and/or PMS1 818/822 
genotypes.  Previously we showed in experiments where both incompatible and compatible 
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genotypes were present that the incompatible genotype is recessive (Argueso et al. 2003). In 
total, 18 of the 106 isolates have the potential to generate incompatible progeny from meiotic 
spores, assuming that they are diploids competent to undergo meiosis and form haploid spores 
(Table 1). Of the eighteen, twelve are tetraploid, four are diploid and one is triploid, with most 
capable of sporulating.  Eight were obtained from human clinical samples, six from breweries, 
and three from bakeries, and one from fruit. 
14 of the 18 isolates display heterozygous S288c/SK1 MLH1 (amino acid 761) and 
S288c/SK1 PMS1 (amino acid 818/822) genotypes, suggesting that they could have been created 
through matings between homozygous strains containing S288c and SK1 MLH1-PMS1 
genotypes.  Sporulation of isolates with these genotypes would yield meiotic progeny in which 
one quarter would have the incompatible genotype (see YJM521 in Figure 4A).  One isolate 
(CBS4455) displays an S288c MLH1-S288c/SK1 PMS1 genotype and three an S288c/SK1 
MLH1-SK1 PMS1 genotype, possibly generated through crosses between compatible and 
incompatible strains.  If sporulated, half of the meiotic progeny from these four isolates would 
display the incompatible genotype. These results suggest that the potential to generate 
incompatible progeny is present in compatible natural isolates and this potential may facilitate 
adaptive evolution by providing a brief increase in the mutation rate.  
The above results encouraged us to look more closely at YJM523, which is the only one 
of 1,010 isolates homozygous for the incompatible genotype (Figure 1; Figure 4; File S1; File 
S2).  YJM523 is a clinical isolate sampled from Stanford University Hospital (Stanford, 
California; Strope et al. 2015; deposited in the Phaff Yeast Culture Collection, University of 
California, Davis).  A previous genome-wide phylogenetic analysis of 93 S. cerevisiae strains 
showed that a spore clone derivative of YJM523, YJM555, is closely related to the compatible  
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Figure 4. Polymorphisms observed in the closely related YJM555 and YJM320b S. cerevisiae 
strains.  A. DNA sequence, as shown by chromatogram traces, of the MLH1 and PMS1 
incompatibility sites in YJM521 and YJM523.  DNA sequencing reactions are shown for 
two MLH1 and PMS1 sequences that were independently PCR amplified (using primers AO324, 
A0821 for MLH1, A0548, AO481 for PMS1; Table S4) from YJM521.  Sequencing reactions 
were performed on ten MLH1 and PMS1 DNA fragments independently PCR amplified from 
YJM523; one such reaction is shown for MLH1 and PMS1 (see Materials and Methods and 
Table S4 for details). Amino acids in the MLH1 and PMS1 ORFs are shown that correspond to 
the presented DNA sequences.  These are Gly (G) or Asp (D) at amino acid 761 in MLH1, Arg 
(R) or Lys (K) at amino acid 818/822 in PMS1. Homo = homozygous for genetic information at 
an incompatibility site; het = heterozygous.  B. Haplotype structure of MLH1 (11 polymorphic 
sites) and PMS1 (32 polymorphic sites) based on the genome sequence of S288c, SK1, YJM320 
and YJM523. YJM555 is a strain derived from the isolate YJM523 (Strope et al. 2015), and 
YJM523 and YJM555 contain identical and homozygous MLH1 and PMS1 sequences.  
Sequences identical to S288c (purple font) and SK1 (green font) are indicated.  Synonymous 
sites are shown as blue asterisks.  Sites in MLH1 and PMS1 that contribute to MMR 
incompatibility are shown by the red “i”. Sequences in black font were not found in S288c or 
SK1; those in black and underlined were not seen in 1007 of the other 1008 yeast isolates that 
were sequenced (they were seen in the closely related strain YJM554 (Strope et al. 2015).  The 
12 bp insertion seen in the SK1 PMS1 open reading frame (Table 3) is indicated by a +.  For 
MLH1 nucleotide position of each polymorphic site in the open reading, from left to right, are: 
486, 720, 812, 834, 997, 1044, 1237, 1875, 2032, 2108, 2282.  For PMS1 the positions are: 122, 
177, 210, 213, 258, 333, 335, 465, 552, 558, 708, 711, 810, 855, 858, 939, 1150, 1175, 1191, 
1199, 1201, 1249 (insertion), 1329, 1538, 1575, 1691, 1782, 1821, 2303, 2322, 2364, 2453. 
Bui et al. Fig 4 
                     MLH1                                       PMS1 
 S288c 	CCTCGTTTGCA
 SK1 	TACTACCCATG
YJM523 	CCTCGTTTGCA
YJM320 	CCCTGCCCATG 
ATGCTGTCTTATGGTTTACCG   CAGCTAATGG  
GTGTCCCTACGCCATAGACGG + CTCCCGAGAA  
ACATCCTTTCGCGGCAGTTGT + TAGTCGGGAA
ACATCCTTTCGCGGCAGTTGT + TAGTCGGGAA
*  * *** ***** *********  *     * * ** **  
 + 12 bp insertion 	synonymous  
      sites 	
*	
i i 
i  incompatibility loci 
MLH1-761 PMS1-818/821 
D 
G/D 
G/D R/K 
R/K 
K 
YJM521 
   het 
YJM521 
   het 
YJM523 
  homo 
A 
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strain YJM320 (Strope et al. 2015; Table 3; Figure 4B).  We speculate that YJM523 and 
YJM320 are recently derived from the same origin, perhaps created by a single mating event 
between S288c and SK1 group isolates (see below and Discussion).  It is important to note that at 
the genome-wide level, it does not appear that YJM523 is the result of a “direct” cross between 
S288c and SK1. If this was the case, then the YJM523 genome would show a mosaic of large 
regions identical to S288c interspersed with regions of high sequence divergence corresponding 
to SK1, but this was not observed (A. Friedrich and J. Schacherer, 1002 Yeast Genomes Project -
 http://1002genomes.u-strasbg.fr/).   
Previously we showed that the distribution of sequence polymorphisms among ten S. 
cerevisiae strains for a 32 kb region indicated evolutionarily recent recombination among S288c 
and SK1 class strains, with YJM320 showing extensive evidence of recombination with the 
S288c group (Heck et al. 2006).  At that time we speculated that the incompatible genotype was 
generated through inter-strain crosses but was not observed in our earlier sampling due to fitness 
costs.  The phylogenetic and single nucleotide polymorphism (SNP) data presented in Strope et 
al. (2015) and Table 3 and Figure 4 strengthen this model, suggesting that YJM523 resulted from 
a cross between S288c and SK1 group isolates that yielded the incompatible genotype. 
Consistent with this hypothesis is the finding that YJM523 displayed a PMS1 SNP pattern 
consistent with an SK1 class origin (sixteen nucleotide positions identical to the SK1 sequence 
vs. six identical to S288c), and an MLH1 SNP pattern consistent with an S288c class origin (all 
eleven sites identical to S288c sequence).  YJM320 is consistent with an SK1 class origin for 
both PMS1 (sixteen nucleotide positions identical to the SK1 sequence vs. six identical to S288c) 
and MLH1 (eight sites identical to the SK1 sequence vs. three identical to the S288c sequence).  
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Table 3. Non-synonymous substitutions in MLH1 and PMS1. 
 
    Amino acid position in MLH1 
Strain  240  271*  333  678 703 761 
S288c  S L E D P D    
SK1  R P K N L G    
YJM523 S L E D P D 
YJM320 S P E N L G 
 
    Amino acid position in PMS1 
Strain  41 112 384 392 400 401   416** 513 564 768 818 
S288c  N I F E T A        T Y A K R 
SK1  S T V E S A   TCEGT   F A K K    
YJM523 N I V V S S   TCEGT Y V R K   
YJM320 N I V V S S   TCEGT Y V R K 
All substitutions that result in amino acid changes are shown relative to the S288c strain.  S288c, 
SK1, YJM320 are compatible for the MLH1-PMS1 genotype, YJM523 are incompatible. 
*Proline residue at MLH1-271 partially suppresses the cMLH1-kPMS1 incompatibility 
(Demogines et al. 2008). **Compared to S288c, SK1, YJM523 and YJM320b strains/isolates 
contain a four amino acid insertion (CEGT) after T416 in PMS1.   
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That the pattern for synonymous sites matches the non-synonymous sites gives us confidence 
that it reflects evolutionary history and not selective convergence of amino acid residues. 
 
The MLH1-PMS1 incompatible combination derived from a natural isolate confers a 
mutator phenotype in the S288c strain background  
We used the highly sensitive lys2-A14 reversion assay to assess the mutator phenotype of the 
MLH1 and PMS1 gene combinations from YJM523. The lys2-A14 allele contains a 
homopolymeric run of 14 A residues inserted out of frame within the LYS2 gene.  In this assay 
wild-type and MMR null strains display a roughly 10,000-fold difference in the rate of reversion 
to Lys+ (Tran et al. 1997). The MLH1 and PMS1 genes from YJM523 were cloned into ARS-
CEN vectors and transformed into an mlh1Δ pms1Δ S288c strain that was used previously to 
characterize MLH1-PMS1 combinations from 65 natural isolates (Demogines et al. 2008). The 
YJM523 MLH1-YJM523 PMS1 combination confers a 196-fold higher mutation rate compared 
to the cMLH1-cPMS1 combination (Table 4).  This mutation rate is higher than that seen for the 
cMLH1-kPMS1 incompatibility (75-fold), indicating that there are likely to be other 
polymorphisms present in the two genes that enhance the incompatibility (Demogines et al. 
2008).  Together these data indicate that the MLH1-PMS1 combination from YJM523 displays a 
strong incompatibility in the S288c strain background.  
 
Strain containing the MLH1-PMS1 incompatible combination displays a low mutation rate 
Table 4 shows that the YJM523/555 MLH1-PMS1 gene combination confers a mutator 
phenotype in the S288c strain background. However, neighbor-joining analysis of the genomes 
of this and other strains presented by Strope et al. (2015) shows that the branch on the tree  
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Table 4. Mutation rates in an S288c strain containing MLH1 and PMS1 genes derived from 
S288c, SK1 and YJM523. 
 
MLH1-PMS1 genotype   Lys+ reversion rate (10-7), (95% CI (10-7))   Relative rate    (n)     
____________________________________________________________________________ 
S288c-S288c, compatible  4.1 (1.7-13.8)    1  13 
S288c-SK1, incompatible  311 (111-919)*   75  16   
YJM523/555-YJM523/555  808 (566-4,450)*   196  39 
mlh1Δ, pms1Δ    45,300 (13,170-126,800)*  10,970  10 
___________________________________________________________________________ 
EAY1365 (relevant genotype mlh1Δ::KanMX4, pms1Δ::KanMX4) was transformed with ARS-
CEN plasmids containing the MLH1 and PMS1 genes obtained from the indicated strain or 
isolate (Tables S1, S2).  Independent cultures (n) were examined for reversion to Lys+.  Median 
mutation rates are presented with 95% confidence intervals, and relative mutation rates 
compared to the wild type strain are shown.  *Significantly different from S288c-S288c (p < 
0.001, Mann Whitney test). 
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leading to YJM555, a spore clone derivative of YJM523, is not unusually long, and is similar to 
that seen for compatible strains, suggesting that YJM523 may not have been a mutator for a long 
evolutionary period.  One way to reconcile this observation is that the MLH1-PMS1 
incompatibility formed in YJM523 facilitated a rapid increase in mutation rate that was then 
returned to normal by the occurrence of suppressor mutations that restored normal MMR 
functions. To further test this idea, we constructed a set of vectors (Figure 5; Table S3; Materials 
and Methods) that can be transformed into natural yeast strains to serve as a proxy to estimate 
genome mutation rate.  We introduced homopolymeric A sequences into the KanMX open 
reading frame immediately after its methionine 17 codon, with the goal of creating a sensitive 
mutation detection assay.  Previous work showed that homopolymeric runs undergo DNA 
slippage in a variety of DNA repair mutant backgrounds (Tran et al. 1997), and such events 
occur at an especially high frequency in MMR defective strains.  For example, msh2Δ strains 
display a 10,000-fold increase in mutation rate compared to wild-type in strains bearing the 
lys2A14 reporter (Tran et al. 1997). 
The mutation reporter plasmids contain ARS-CEN and NatMX markers and a 
kanMX::insE-A14 construct whose expression is driven by URA3 or LEU2 promoters.  These 
promoters replaced the strong TEF promoter that drives KanMX expression in pFA6-KanMX; 
we found that the TEF promoter prevented the detection of large differences in reversion 
frequency between in and out of frame KanMX::insE constructs, presumably due to high rates of 
transcriptional slippage.  In the URA3 promoter-kanMX::insE-A14  reporter in pEAA613, a 55 bp 
sequence containing a +1 frameshift in the 14 bp homopolymeric A run (insE-A14; Tran et al. 
1997) was inserted immediately after the URA3 ATG.  This sequence was immediately followed 
by codons 18 to 269 of the KanMX open reading frame. Derivatives were constructed that  
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Figure 5. Use of a URA3 promoter-kanMX::insE-A14 plasmid to measure mutation rates in 
natural yeast isolates.  A. The ARS-CEN vector pEAA613 contains a NatMX selectable marker 
and a frameshift reporter in which the insE-A14 sequence from Tran et al. (1997) was inserted 
immediately after methionine 17 in the KanMX open reading frame.  In this reporter the URA3 
gene promoter drives expression of KanMX, using the methionine 17 in the KanMX open reading 
frame as the initiation codon. The resulting construct contains a +1 frameshift mutation that 
disrupts KanMX function. A reporter construct that contains the insE-A10 insertion and does not 
disrupt the KanMX open reading frame is shown as an in-frame control.  Frameshift mutation 
events (e.g. a -1 deletion in the homopolymeric A run) are detected on YPD plates containing 
nourseothricin and geneticin. B. Examples of reversion assays performed using the URA3 
promoter-kanMX::insE-A14 plasmid.  EAY1369 (cMLH1-cPMS1 compatible), EAY1370 
(cMLH1-kPMS1 incompatible) and EAY1372 (msh2Δ) were transformed with pEAA613 and 
plated in dilutions from 10 ml of a 10X concentrated overnight culture to 10 ml of 100, 10-1, 10-2, 
10-3, 10-4, 10-5 dilutions onto YPD nourseothricin (50 µg/ml), geneticin (300 µg/ml) plates.  C.  
Example of the reversion assay performed for YJM555 is shown. 
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contained a 10 bp in-frame insertion (pEAA611), or utilized the LEU2 promoter to drive 
expression (pEAA616; Table S3).  
We tested the sensitivity of our reporter assay by transforming pEAA613 and pEAA616 
into compatible, incompatible and MMR defective (msh2Δ) S288c strains (Table 5; Table S6).   
For strains containing pEAA613 we found that the msh2Δ strain displayed a 2,000-fold higher 
rate of reversion to genecitin resistance compared to the compatible strain, and that the 
incompatible strain showed a ten-fold higher mutation rate compared to the compatible strain 
(Figure 5; Table 5; Materials and Methods).  Importantly, sequencing of the kanMX::insE-A14 
reporter from geneticin resistant clones showed that a -1 frameshift had occurred in the 
homopolymeric A sequence in all of the clones (n=14).  While this range is less sensitive than 
was seen in the lys2-A14 reversion assay (~75 fold in an assay with a 10,000 fold range between 
wild-type and MMR defective; Table 4), this reporter construct provides the opportunity to 
estimate mutation rates in natural strains that lack genetic markers.  We then transformed the 
URA3 promoter-kanMX::insE-A14  and LEU2 promoter-kanMX::insE-A14  plasmids into YJM555 
to determine if this strain showed a mutator phenotype consistent with a MMR incompatibility.  
As shown in Figure 5, Table 5, and Table S6, the overall mutation rate in YJM555 was similar to 
that seen in the S288c strain, indicating that YJM555, a well-behaved strain derived from a 
YJM523 spore clone (Strope et al. 2015), compensated for the increased mutation rate conferred 
by the MLH1-PMS1 incompatibility.  
 
Suppression of incompatibility in YJM555 appears to involve more than one locus.  
To determine if a single suppressor locus is present in YJM555 that suppressed MLH1-PMS1 
incompatibility, we mated spores of YJM555 to the incompatible strain EAY3235 (relevant  
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Table 5. Reversion assay using the URA3 promoter-kanMX::insE-A14 plasmid. 
 
strain  genotype     reversion G418r (10-7)  95% CI relative rate  n 
____________________________________________________________________________ 
EAY1369 wild-type  6.1   3.1-7.0   1 17 
EAY1370 incompatible  59.8 *   25.7-239  9.9 17 
EAY1372 msh2Δ   13,451*  7,230-46,090  2,142 11 
YJM555    9.8**   6.5 -10.7  1.6 14 
____________________________________________________________________________ 
The indicated strains (Table S1) were transformed with ARS-CENURA3 promoter-kanMX::insE-
A14 plasmid pEAA613.  Independent cultures (n) were examined for reversion to genecitin 
resistance as described in the Materials and Methods.  Median mutation rates are presented with 
95% confidence intervals, and relative mutation rates compared to EAY1369 (S288c compatible) 
are shown.   
*Significantly different from EAY1369 (p < 0.001, Mann-Whitney test) 
**Significantly different from EAY1369 (p < 0.01, Mann-Whitney test) 
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genotype lys2-A14, MLH1S288c::KanMX, PMS1S288c-R818K::HIS3) and sporulated the resulting 
diploids.  We used the lys2-A14 reversion assay to analyze spore clones because it is currently the 
most sensitive assay to measure DNA mismatch repair incompatibility (Heck et al. 2006). While 
it is possible that lysine auxotrophy could alter a complex phenotype, our initial goal was to 
determine if suppression involved the contributions of more than one locus. 
 We picked 42 lys2-A14 spore clones and tested them for reversion to Lys+ using a colony 
reversion patch assay (Materials and Methods). As shown in Figure 6 and Table S7, the 
compatible control strain EAY3234 displayed a median reversion of 0 colonies (n =10) and the 
incompatible control strain EAY3235 showed a median reversion of 91 (n = 10).  These values 
fit with the ~two orders of magnitude difference in mutation rate between the two strains (Table 
4; Heck et al. 2006).  It is important to note that YJM555 displayed a mutation rate that was 
slightly higher than observed in S288c strains (Table 5), and so it is likely that the median colony 
number would be slightly higher than seen in EAY3234 if YJM555 bearing a lys2-A14 allele was 
tested for Lys+ reversion. 
As shown in Figure 6, the mutator phenotype of the 42 spore clones distributed into 
roughly four groups, with one group showing Lys+ colony numbers close to EAY3234 (3 spore 
clones, 1-6 median colony number).  A second group displayed Lys+ colony numbers that fell 
between those found for the compatible and incompatible controls (18 spore clones, 18-48 
median colony number). A third group displayed phenotypes similar to EAY3235 (8 spore 
clones, 68-107 median colony number), and a fourth displayed colony numbers that were higher 
than EAY3235 (13 spore clones, >120 median colony number).  If a single locus was responsible 
for a suppressor phenotype, and suppression was specific to PMS1YJM555 (the MLH1 ORF 
sequence is the same in MLH1S288c and MLH1YJM555; Figure 4), then 25% of the spore clones  
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Figure 6. Mutator phenotype of 42 spore clones derived from YJM555 x EAY3235 cross. 
42 lys2-A14 spore clones were tested for reversion to Lys+ in a colony patch assay (Materials and 
Methods).  The median number of colonies from each spore clone assay is shown, from lowest to 
highest.  Assays performed on compatible (EAY3234) and incompatible (EAY3235) control 
strains are shown in red. 
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would have been expected to show a suppressor phenotype, with the remainder showing 
phenotypes similar to that seen in EAY3235 (showing a bimodal distribution).  50% of spore  
clones would show a suppressed mutator phenotype if a single locus suppressor could interact 
with either PMS1YJM555 or PMS1S288c-R818K (also showing a bimodal distribution).  The fact that 
we see a range of mutator phenotypes, rather than a biomodal distribution, with only 3/42 spore 
clones showing phenotypes similar to compatible, and 13/42 showing phenotypes more severe 
than the incompatible, suggests that the suppression of mutator phenotype in YJM555 is unlikely 
to involve a single suppressor locus.  A reasonable way to explain how the suppressor in 
YJM555 arose is that incompatible and compatible ancestral strains had mated, yielding spores 
that were incompatible and displayed an initial adaptive advantage.  These spore clones then 
incurred a large number of mutations, some of which were beneficial, and in combination, 
suppressed the incompatible mutator phenotype, ultimately yielding YJM555.  We cannot 
exclude the possibility that the spectrum of mutator phenotypes seen in the progeny results from 
suppressor loci interactions in combination with incompatibilities involving other genome 
stability loci (see Demogines et al. 2008).   
 
Discussion 
MMR Incompatibility is effective only as a short-term strategy for adaptation to new 
environments  
We performed competitions involving populations of yeast that contained different combinations 
of evolved, unevolved, MMR compatible, and MMR incompatible genotypes (Figure 2 and 
Figure 3).  In these repetitive transfer experiments we observed long-term fitness costs for MMR 
incompatibility, suggesting that there is an elevated mutation rate associated with MMR 
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incompatibility that could not be stably maintained in natural populations.  We proposed that 
following a transient adaptive advantage provide by MMR incompatibility, incompatible strains 
can mate to compatible strains to maintain beneficial mutations, and thus return to MMR 
compatibility.  Such a strategy would avoid the long-term fitness cost of being a mutator.  This 
model is consistent with our survey of 1,010 yeast isolates showing that there while there are a 
significant number (18 isolates; Table 1) heterozygous for MMR incompatibility, which is 
recessive, only one (YJM523) is homozygous, and is not maintained as a mutator (Table 1; Table 
5; Bui et al. 2015; Wielgoss et al. 2013; Heck et al. 2006; Demogines et al. 2008; Argueso et al. 
2003).  
As indicated above we identified a single yeast isolate from 1,010 sampled (YJM523) 
that is homozygous for the incompatible genotype. Importantly, our data suggest that there are 
unknown mutations elsewhere in the genome of YJM523 that contribute to suppressing the 
mutator phenotype associated with incompatibility (see below).  The molecular evolution 
experiments presented in Figure 3, our genotyping analysis of 1,010 yeast isolates, and the 
associated contingency test, suggest that once an adaptive mutation reached fixation a mutator 
state would no longer be favorable and would in fact become a liability. Consistent with this idea 
are observations made by Taddei et al. (1997), who proposed that a modestly elevated rate in an 
E. coli population would facilitate adaptation, but once adaptive mutations were fixed, the 
mutation load present in individuals in the population, through the accumulation of deleterious 
mutations throughout their genomes, would lead to a decrease in their frequency.  Genomic 
analyses (Figure 4B; Strope et al. 2015) and direct mutation rate measurements indicate that 
YJM523, the parent of YJM555, is not a mutator (Table 5; Table S6; Heck et al. 2006; 
Demogines et al. 2008). YJM555 displays an overall mutation rate similar to that seen for S288c 
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compatible strains, and whole genome neighbor joining analysis suggests that YJM555 is not an 
outlier compared to other genomes (Figure 4B; Table 5; Table S6; Strope et al. 2015).  As 
outlined below, we hypothesize that the MLH1-PMS1 incompatibility seen in YJM523 was 
formed through a single mating between S288c and SK1 groups (Figure 1), and that these strains 
rapidly acquired extragenic suppressors that lowered their cellular mutation rates.  In this 
scenario incompatible strains containing a beneficial mutation for adaptation continue to rapidly 
acquire mutations; among these are suppressors of the mutator phenotype that reduce genetic 
load (Wielgoss et al. 2013). Such a scenario has been observed in single cell organisms that have 
relatively large population sizes (e.g. E. coli; Wielgoss et al. 2013).  
There are likely to be other strategies to suppress the mutator phenotype associated with 
incompatibility.  For example, among the 1,010 isolates analyzed, the frequency of a known 
intragenic suppressor of the mutator phenotype (MLH1-L271P, see Table 3 and Demogines et al. 
2008) is very high. In total, 812 of 937 isolates (73 could not be genotyped due to ambiguity at 
the 271 position, possibly due to heterozygosity) contained this polymorphism, but YJM523 does 
not contain it. The fact that the MLH1-P271 suppressor is so common supports the idea 
that there is an abundant availability of this apparently non-deleterious suppressor polymorphism 
that can allow strains to minimize mutation rates.  
We recently learned that Helen Murphy and colleagues (Skelly et al. 2016) analyzed 
strains presented in Strope et al. (2015) for incompatible MLH1-PMS1 combinations.  They also 
found that YJM555, which contains the incompatible MLH1-PMS1 combination, displays a 
much lower mutation rate than predicted based on its incompatible genotype, and their genomic 
analysis does not suggest evidence for an elevated mutator phenotype in YJM555.  They 
postulated, as we demonstrated in our work, that MLH1-PMS1 incompatibility is suppressed by 
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background genetic modifiers.  
Finally, in this study we focused on a haploid model because we can uncover recessive 
phenotypes and monitor genotypes rapidly. However it is clear that most yeast in nature are 
diploid (1002 Yeast Genomes Project - http://1002genomes.u-strasbg.fr/).  Our identification of 
isolates heterozygous for incompatibility indicate that in stress conditions that result in 
sporulation haploid progeny will be produced which display incompatible MLH1-
PMS1 genotypes.  At present we cannot determine if the incompatible haploids will diploidize 
before their contribution of adaptation, but we plan to further characterize the heterozygous 
diploids (Table 1), with the hope that future analyses will better address these concerns.  For 
example, we are intrigued about the possibility that loss of heterozygosity (LOH), which can 
result in the rapid fixation of recessive mutations (See Gerstein et al. 2014), provides a means to 
generate a homozygous incompatible genotype in the absence of sporulation. 
 
How was the MLH1-PMS1 incompatible in YJM523 generated?   
YJM523 is a clinical isolate from Stanford University hospital; it appears to have an unmapped 
mutator suppressor(s) elsewhere in its genome because MLH1-PMS1 combinations from this 
isolate conferred a higher mutation rate in the S288c background compared to its native 
backgrounds (compare data in Tables 4 and 5).  How it acquired extragenic suppressors remains 
unclear. The SNP polymorphism data presented in Figure 4 appear consistent with YJM523 and 
YJM320 being created through a single mating between S288c and SK1 group strains followed 
by sporulation and the segregation of markers.  This model is consistent with the presence of 
PMS1 SNP variants that are identical in YJM523 (incompatible) and YJM320 (compatible; 
Figure 4). Furthermore, there are four PMS1 SNPs (Figure 4B) and two PMS1 amino acid 
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polymorphisms (V392, V564; Table 3) in these two isolates that are not found in 1,007 of the 
1,010 yeast isolates (they were found in the closely related strain YJM554 (Strope et al. 2015), 
and YJM320 is on the same branch as YJM555 (Figure 4B; Strope et al. 2015). Taken together, 
this pattern suggests that SK1 and S288c group isolates mated to yield compatible and 
incompatible MLH1-PMS1 genotypes. This suggests that YJM523 experienced an elevated 
mutation rate, presumably providing an adaptive advantage to a stress environment, which was 
subsequently suppressed by extragenic suppressor(s) (Table 4; Table 5). However, we cannot 
exclude the possibility that YJM523 never encountered situations where it had entered a mutator 
state in response to a changing environment, and was instead created in a background where the 
initial mutation rate was low and could tolerate an incompatible genotype.  Unfortunately, the 
data are not available to further test this idea.  We do not favor such a hypothesis based on the 
complexity of the suppression phenotype seen in YJM555 (Figure 6), and previous work 
showing that genomic mutation rates tend to vary by less than an order of magnitude in 
organisms such as E. coli, Neurospora crassa, and S. cerevisiae (Zeyl and Devisser 2001; Drake 
et al. 1998), suggesting that deviations from a typical rate would be selected against.  
 
Development of a reporter construct to sensitively detect mutation rates in natural yeast 
isolates   
The ARS-CEN KanMX::insE-A10-14 reporter construct described in the paper provides a new 
approach to measure mutation rates in a large number of isolates that lack markers that are 
typically used for genetic manipulation and whose chromosome content can vary with respect to 
ploidy and chromosome copy number (Strope et al. 2015; Storchova 2014). In these constructs 
the NatMX antibiotic resistance marker is used to select for the plasmid, and the KanMX marker 
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is used to identify frameshift reversion events (Figure 5).  The pEAA613 construct displayed a 
2000-fold difference in mutation rate between wild-type and MMR null.  This difference is only 
five-fold lower than that seen using an integrated lys2-A14 reporter, which to our knowledge is 
the most sensitive assay developed to measure differences in frameshift reversion frequency 
between wild-type and MMR mutants (Table 5; Tran et al. 1997). Importantly, our reporter 
plasmid assay was capable of distinguishing between mutation rates in wild-type and MMR 
incompatible strains. In the lys2-A14 assay this difference was 75 to 100-fold in a 10,000-fold 
range; in the KanMX::insE-A10-14 assay it was 10-fold in a 2000 fold range (Tables 4, 5).  We 
believe that this sensitive plasmid-based assay, in conjunction with whole-genome sequencing 
data and classical mutation accumulation analyses (Nishant et al. 2009, 2010; Lujan et al. 2014), 
will allow groups to accurately measure variation in mutation rate in natural isolates and 
determine if this rate varies under different environmental conditions.  Furthermore, one can 
modify the sequences present in the insE part of the reporter to examine reversion to genecitin 
resistance due to base substitution and other types of frameshift events. pEAA613 and 
derivatives can also be easily modified to integrate the KanMX::insE-A10-14  reporter at a specific 
chromosomal location. 
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Table S1. Strains used in this study.  
____________________________________________________________________________ 
EAY235 MATa, ura3-52, leu2Δ1, trp1Δ63 
EAY280 MATa, ura3-52, leu2Δ1, trp1Δ63, msh2Δ::hisG 
EAY1365  MATa, ura3-52, leu2Δ1, trp1Δ63, his3 Δ 200, lys2::insE-A14, mlh1Δ::KanMX4,  
  pms1Δ::KanMX4 
EAY1369 MATalpha, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2::insE-A14, cPMS1::HIS3, 
cMLH1 
EAY1370 MATalpha, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2::insE-A14, kPMS1::HIS3, 
cMLH1 
EAY1372 MATa, ura3-52, leu2Δ1, trp1Δ63, lys2::insE-A14, msh2∆::hisG 
EAY3191 MATa, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, kPMS1::HIS3, kMLH1::KanMX 
EAY3234 MATa, lys2::insE-A14, ura3-52, trp1Δ63, leu2Δ1, cMLH1::KanMX, cPMS1::HIS3 
EAY3235 MATa, lys2::insE-A14, ura3-52, trp1Δ63, leu2Δ1, cMLH1::KanMX, kPMS1::HIS3 
EAY3236 MATalpha, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, cMLH1::KanMX, kPMS1::HIS3  
EAY3241 MATa, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, kPMS1::HIS3, kMLH1::NatMX 
EAY3242 MATalpha. ura3-52, leu2Δ1, trp1Δ63, his3Δ200, kPMS1::HIS3, kMLH1::NatMX 
EAY3688 EAY3236, pmr1-T459A 
EAY3689 EAY3236, pmr1-T412C 
EAY3690 EAY3236, pmr1-T2G 
YJM521 Natural isolate obtained from John McCusker, Duke University 
YJM523 Natural isolate obtained from John McCusker, Duke University 
YJM555 Homozygous diploid strain derived from a spore clone of YJM523 (Strope et al. 
2015) 
____________________________________________________________________________ 
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Table S2. List of S288c derived and SK1 derived MLH1-PMS1 isolates. 
_____________________________________________________________________ 
 
S288c derived isolates (182) 
YJM280_b, YJM326_b, YJM428_1b, YJM436_1b, CBS3093_1b, DBVPG4651_1b, EM93_3, 
TL229S2.2, CLIB413_1b, CLIB483_1b, Y10_1b, YJM269_1b, DBVPG1339_1b, UC8_1b, 
WE372_1b, CLIB208_1, CBS7765, CBS7962, CBS7964, CBS2973, CBS4454, CBS1252, 
CBS4456, CBS7959, CBS1464, CBS1385, CBS7961, CBS1544, CBS6333, CBS7963, 
CBS3081, CBS3093, CBS1487, E4, MC8, MC10, CLQCA_02-003, CLQCA_10-027, 
CLQCA_17-060, SJ5L16, SJ5L18, DBVPG6696, A-6, A-18, CBS1250, CBS4903, CBS5378, 
CBS420, CBS1257, CBS2087, CBS2421, YJM308, CECT10497, CECT10266, CH02, CH06, 
CH10, CH11, CH14, CH13, 2282, 2644, MAJ_G, CLIB650, CLIB651, CLIB653, CLIB654, 
EXF-5042, EXF-5046, EXF-7145, CLIB484, CLIB485, CLIB552, CLIB655, CLIB1060, 
CLIB1077, DBVPG1076, DBVPG1080, DBVPG1105, DBVPG1122, DBVPG1123, 
DBVPG1125, DBVPG1126, DBVPG1145, DBVPG1163, DBVPG1339, DBVPG1490, 
DBVPG1523, DBVPG1584, DBVPG1594, DBVPG1608, DBVPG1975, 368428S, 269521J, 
2698, DBVPG1841, DBVPG1843, DBVPG1848, DBVPG1880, DBVPG1895, DBVPG4317, 
DBVPG4460, DBVPG4651, DBVPG6302, DBVPG6350, M.9.1, RP.10.14, SM.9.1.AL1, 
SM.9.1.BL7, SM.9.2.BR3(L), 4LBI-3, DBVPG3051, 1, CECT10331:9-1, CECT10351-1B, 
CECT10171-5B, DBVPG1620-1A, N34:2-4(a), N26-1-10:7-5(a), N134:7-1(a), ho_SB, 
UCD_40-49, UCD_05-780, UCD_09-448, UCD_11-601, Lib61, SRC 120, SRC 147, SRC 213, 
CLI_1, CLI_2, CLI_3, CLI_4, CLI_5, CLI_6, CLI_7, CLI_8, CLI_9, CLI_10, CLI_11, CLI_12, 
CLI_13, CLI_14, UL G84F88I90, ultra lev. 1127, CLI_15, CLI_17, CLI_18, CLI_20, CLI_21, 
CLI_24, SM.9.4.BR2, SM.8.7.BR1, SM.8.8.BL1, SA.10.1.VL1, RP11.4.1, RP11.4.11, 
RP11.4.14, 1560, FTPW4, FTPW3, FTPW32, FTPW35, RB3-7Sc2, SC2-37, W303, 273614N, 
YJM451, YJM682, YJM683, YJM1199, YJM1242, YJM1252, YJM1311, YJM1386, YJM1433, 
YJM1450, YJM1463, YJM1477, YJM1527, YJM1549, YJM1078 
 
SK1 derived isolates (28) 
CBS2165a, CBS1388a, YJM320b, YJM653_1b, CBS2441, CBS1428, CBS1509, CBS1463, 21-
4-114, CBS1239, M9, Y1, 2281,CLQCA_10-386, CLIB1085, CLIB1083, B9b-1, B9c-1, Ponton 
12, Ponton 14, CLQCA_17-111, SK1, YJM681, YJM1307, YJM1381, YJM1385, YJM1419, 
YJM1478 
 
Incompatible isolate (1) 
YJM523 
______________________________________________________________________ 
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Table S3. Plasmids.  
  Relevant genotype 
_________________________________________________________ 
pRS413  ARS-CEN HIS3 
pRS415 ARS-CEN, LEU2 
pRS416 ARS-CEN, URA3 
pLZ259 ARS-CEN, NATMX 
pEAA611 ARS-CEN, NATMX,URA3 promoter-KANMX::insE-A10 
pEAA612 ARS-CEN, NATMX,URA3 promoter-kanMX::insE-A11 
pEAA613 ARS-CEN, NATMX,URA3 promoter-kanMX::insE-A14 
pEAA614 ARS-CEN, NATMX,LEU2 promoter-KANMX::insE-A10 
pEAA615 ARS-CEN, NATMX,LEU2 promoter-kanMX::insE-A11 
pEAA616 ARS-CEN, NATMX,LEU2 promoter-kanMX::insE-A14 
pEAA609 ARS-CEN, LEU2, MLH1-YJM523/YJM555 
pEAA213 ARS-CEN, LEU2, MLH1-S288c 
pEAA214 ARS-CEN, LEU2, MLH1-SK1 
pEAA610 ARS-CEN, HIS3, PMS1-YJM523/YJM555 
pEAA238 ARS-CEN, HIS3, PMS1-S288c 
pEAA239 ARS-CEN, HIS3, PMS1-SK1 
___________________________________________________________ 
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Table S4. DNA primers used to sequence MLH1 and PMS1 from YJM521 and YJM523. 
 
Primers used to sequence MLH1  
AO324 5’ATAGTGTAGGAGGCGCTG           
AO325 5’CATGTGGCAACAGTCACAGTAACG            
AO327 5’ATGTAAGCCACTCCCAAGAGGCAG       
AO328 5’GACGAGTTAAATGACGATGCTTCC                
AO821 5’ AACTTTGCGGCCGCGGATCCAGCCAAAACGTTTTAAAGTTA     
AO3567 5’CAGGAAATAAACAAAAAACTTTGG                        
AO3568 5’AACAAAAAACTTTGGTATTACAGC                                            
AO3569 5’CTTTGGTATTACAGCCAAAACG                                            
 
Primers used to sequence PMS1 
AO480 5’CCCAAAAGAATGTGCTCACAATCAGAAC          
AO481 5’CCACGTTCATATTCTTAATGGCTAAGC         
AO483 5’GAGAAAGAATATATCCTCAG         
AO485 5’ AAAGTA TCTGACGTTAACAGTTTC                 
AO548 5’CGATTCTAATACAGATTTTAATGACC                                    
AO3564 5’TCATATTTCGTAATCCTTCGAAAATG                                    
AO3565 5’TTCGTAATCCTTCGAAAATGAGCTCC                   
AO3566 5’ATCCTTCGAAAATGAGCTCCAATCACG                  
 
Ten primer-pairs used to make MLH1 PCR products, with the expected sizes  
AO324 (205 bp upstream of ATG), AO821 (19 bp downstream of stop codon):   2.5 kb  
AO325 (315 bp downstream of ATG), AO3567 (48 bp downstream of stop codon):  2.0 kb  
AO325 (315 bp downstream of ATG), AO3568 (39 bp downstream of stop codon):  2.0 kb 
AO325 (315 bp downstream of ATG), AO3569 (30 bp downstream of stop codon):  2.0 kb  
AO327 (1309 bp downstream of ATG), AO3567 (48 bp downstream of stop codon):  1.0 kb  
AO327 (1309 bp downstream of ATG), AO3568 (39 bp downstream of stop codon):  1.0 kb  
AO327 (1309 bp downstream of ATG), AO3569 (30 bp downstream of stop codon):  1.0 kb  
AO324 (205 bp upstream of ATG), AO3567 (48 bp downstream of stop codon):   2.6 kb  
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Table S4 (continued) 
 
AO324 (205 bp upstream of ATG), AO3568 (39 bp downstream of stop codon):   2.6 kb  
AO324 (205 bp upstream of ATG), AO3569 (30 bp downstream of stop codon):   2.5 kb  
 
Ten primer-pairs used to make PMS1 PCR products, with the expected sizes 
AO548 (125 bp upstream of ATG), AO481 (146 bp downstream of stop codon):   2.9 kb  
AO480 (1090 bp downstream of ATG), AO3564 (at stop codon):     1.5 kb  
AO480 (1090 bp downstream of ATG), AO3565 (6 bp upstream of stop codon):   1.5 kb  
AO480 (1090 bp downstream of ATG), AO3566 (12 bp upstream of stop codon):   1.5 kb  
AO483 (633 bp downstream of ATG), AO3564 (at stop codon):      2.0 kb  
AO483 (633 bp downstream of ATG), AO3565 (6 bp upstream of stop codon):   2.0 kb  
AO483 (633 bp downstream of ATG), AO3566 (12 bp upstream of stop codon):  2.0 kb  
AO548 (125 bp upstream of ATG), AO3564 (at stop codon):                  2.7 kb  
AO548 (125 bp upstream of ATG), AO3565 (6 bp upstream of stop codon):   2.7 kb  
AO548 (125 bp upstream of ATG), AO3566 (12 bp upstream of stop codon):  2.7 kb  
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Table S5. Fitness of evolved incompatible and compatible strains as a function of transfer 
in YPD and YPD + NaCl media. 
  
Fitness, w +/-SEM 
 Transfer pmr1 genotype        YPD    YPD+NaCl  n                
3 pmr1-T459A 0.99±0.01 0.97±0.01 4 
  pmr1-T412C 0.96±0.02 0.97±0.03 4 
  pmr1 -T2G 0.97±0.01 1.00±0.01 2 
4 pmr1-T459A 0.99±0.01 0.98±0.01 4 
 
pmr1-T412C 0.92±0.01 0.88±0.02 2 
8 pmr1-T459A 0.97±0.01 0.97±0.03 4 
  pmr1-T412C 0.93±0.03 0.92±0.08 4 
  pmr1 -T2G 0.92±0.01 0.88±0.05 2 
12 pmr1-T459A 0.97±0.02 1.04±0.03 4 
 
pmr1-T412C 0.84±0.01 1.09±0.32 2 
14 pmr1-T459A 0.98±0.02 1.12±0.04 4 
  pmr1-T412C 0.86±0.03 1.04±0.13 4 
  pmr1 -T2G 0.93±0.04 0.96±0.01 2 
16 pmr1-T459A 0.96±0.02 1.11±0.05  4 
 
pmr1-T412C 0.87±0.04 1.03±0.15  4 
 
pmr1 -T2G 0.93±0.02 0.97±0.02 2 
20 pmr1-T459A 0.94±0.02  1.09±0.05  4 
  pmr1-T412C 0.88±0.06  1.04±0.16 4 
  pmr1 -T2G 0.89±0.03 1.01±0.07 2 
24 pmr1-T459A 0.94±0.02 1.11±0.06 4 
 
pmr1-T412C 0.83±0.04 1.08±0.13 4 
  pmr1 -T2G 0.95±0.07 1.05±0.12 2 
The proportion of compatible and incompatible genotypes were determined after the indicated 
number of transfers for spore clone competitions performed in YPD and YPD+ 1.2 M NaCl (Fig 
2; Fig 3).  Fitness (w) values were calculated as w = ((pt/qt)/(po/qo))1/t, where t equals the number 
of generations after T transfers (7 generations per transfer; Hartl and Clark 2007), po and qo are 
the number of incompatible and compatible cells, respectively at Transfer 0, and pt and qt are the 
number of incompatible and compatible cells, respectively, at the indicated Transfer.  n is the 
number of unique competitions performed for each pmr1 genotype. 
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Table S6. Reversion assay using the LEU2 promoter-kanMX::insE-A14 plasmid.  
 
strain  genotype           reversion G418r (10-7) 95% CI     relative rate  n 
____________________________________________________________________________ 
EAY1369 wild-type  6.9   5.3-8.9  1  36 
EAY1370 incompatible  32.6*   3.3-38.5 4.7  29 
EAY1372 msh2Δ   6,070*   1,843-7,778 878  29 
YJM555    7.2   4.9-10.4 1.04  35 
____________________________________________________________________________ 
The indicated strains (Table S1) were transformed with ARS-CEN LEU2 promoter-kanMX::insE-
A14 plasmid pEAA616.  Independent cultures (n) were examined for reversion to genecitin 
resistance as described in the Materials and Methods.  Median mutation rates are presented with 
95% confidence intervals, and relative mutation rates compared to EAY1369 (S288c compatible) 
are shown.  *Significantly different from EAY1369 (p < 0.001, Mann-Whitney test) 
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Table S7. Phenotype of spore clones obtained by crossing spores of YJM555 with 
EAY3235. 
 
 
The proportion of compatible and incompatible genotypes was determined after the indicated 
number of transfers for spore clone competitions performed in YPD and YPD+ 1.2 M NaCl 
(Figure 2; Figure 3).  Fitness (w) values were calculated as w = ((pt/qt)/(po/qo))1/t, where t equals 
the number of generations after T transfers (7 generations per transfer; Hartl and Clark 2007), po 
and qo are the number of incompatible and compatible cells, respectively at Transfer 0, and pt 
and qt are the number of incompatible and compatible cells, respectively, at the indicated 
Transfer.  n is the number of unique competitions performed for each genotype in each transfer. 
Table S7. Phenotype of spore clones obtained by crossing spores of YJM555 with EAY3235.
PMS1 genotype MLH1 genotype: Lys+ colonies/patch Lys+ median Leu+/- Ura+/- Trp+/-
G418 resistance
Controls
EAY3234PMS1-S288c::HIS3 resistant 0, 0, 0, 0, 0, 0, 1, 1, 1, 17  0 - - -
EAY3235PMS1-S288c-R818K::HIS3 resistant 34, 38, 66, 73, 90, 91, 94, 107, >120, >120 91 - - -
YJM555 PMS1-YJM555 sensitive not tested + + +
Spore clones
2_1 PMS1-YJM555 resistant 5, 4, 8, 13, 5 5 - - -
2_2 PMS1-S288c-R818K::HIS3 resistant 38, 17, 35, 22, 42 35 - - -
2_3 PMS1-YJM555 resistant 2, 9, 19, 63, 22 19 - - +
2_4 PMS1-YJM555 resistant 17, 19, 23, 24, 15 19 - + -
2_5 PMS1-S288c-R818K::HIS3 resistant >120, 83, >120, 79, 81 83 - + -
2_6 PMS1-YJM555 sensitive >120, >120, >120, >120, >120 >120 - - -
2_7 PMS1-S288c-R818K::HIS3 sensitive 66, >120, >120, >120, 117 >120 + - -
2_8 PMS1-S288c-R818K::HIS3 sensitive >120, >120, 115, >120, >120 >120 - + +
2_9 PMS1-S288c-R818K::HIS3 resistant 7, 13, 42, 40, 34 34 - - +
2_10 PMS1-S288c-R818K::HIS3 sensitive 44, 37, 48, 25, 25 37 + - -
2_11 PMS1-S288c-R818K::HIS3 resistant 72, >120, >120, >120, 76 >120 + - +
3_1 PMS1-YJM555 sensitive 107, >120, 88, 96, >120 107 + + -
3_2 PMS1-S288c-R818K::HIS3 sensitive >120, 47, 37, 106, 45 47 - - -
3_3 PMS1-S288c-R818K::HIS3 sensitive 45, 71, 77, 64, 105 71 + + +
3_4 PMS1-S288c-R818K::HIS3 resistant 10, 20, 13, 51, 42 20 - + +
3_5 PMS1-YJM555 sensitive 106, >120, 104, 69, >120 106 + - +
3_6 PMS1-S288c-R818K::HIS3 sensitive 31, 82, 113, 39, 68 68 + + -
3_7 PMS1-YJM555 resistant >120, >120, >120, >120, >120 >120 + + -
3_8 PMS1-S288c-R818K::HIS3 sensitive 50, 27, 46, 17, 82 46 - + -
3_9 PMS1-S288c-R818K::HIS3 resistant >120, >120, 54, >120, 86 >120 + + +
3_10 PMS1-YJM555 resistant >120, >120, >120, >120, >120 >120 - + +
3_11 PMS1-S288c-R818K::HIS3 resistant 20, 41, 38, 9, 8 20 + - +
4_1 PMS1-S288c-R818K::HIS3 resistant 46, >120, 29, 43, 3 43 + - -
4_2 PMS1-S288c-R818K::HIS3 resistant 14, 28, 6, 5, 1 6 + - -
4_3 PMS1-S288c-R818K::HIS3 sensitive 86, >120, 80, 89, >120 89 - + +
4_4 PMS1-YJM555 resistant >120, >120, >120, >120, >120 >120 + - -
4_5 PMS1-S288c-R818K::HIS3 resistant 17, 36, 5, 18, 46 18 - - +
4_6 PMS1-S288c-R818K::HIS3 resistant 36, 69, 23, 28, 99 36 - + -
4_7 PMS1-S288c-R818K::HIS3 sensitive >120, 37, 30, 35, 67 37 + - +
4_8 PMS1-YJM555 sensitive >120, >120, >120, >120, >120 >120 + + +
4_9 PMS1-YJM555 sensitive 115, 26, >120, 48, 37 48 + - -
4_10 PMS1-YJM555 sensitive >120, >120, >120, >120, >120 >120 - + +
4_11 PMS1-YJM555 resistant 112, 36, 8, 38, 3 36 - - +
5_1 PMS1-YJM555 sensitive >120, >120, >120, >120, >120 >120 - + +
5_2 PMS1-S288c-R818K::HIS3 sensitive >120, 85, 30, 47, >120 85 + - +
5_3 PMS1-YJM555 sensitive 91, >120, >120, >120, >120 >120 + + -
5_4 PMS1-YJM555 resistant 1, 0, 1, 18, 63 1 - - +
5_5 PMS1-S288c-R818K::HIS3 sensitive 65, 0, 30, 30, 20 30 - + +
5_6 PMS1-S288c-R818K::HIS3 sensitive 58, 44, 5, 64, 0 44 - + -
5_7 PMS1-S288c-R818K::HIS3 sensitive 25, 24, 13, 56, >120 25 + - +
5_8 PMS1-YJM555 resistant 85, 113, 71, >120, 25 85 + - +
5_9 PMS1-S288c-R818K::HIS3 sensitive >120, >120, >120, >120, >120 >120 + - -
See Materials and Methods for details.  EAY3234 is compatible, EAY3235 is incompatible.
